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Abstract 
Dengue is one of the most significant health problems that has magnified its impact globally 
by affecting about 390 million people annually across 110 countries. The causative agent of 
this life-threating disease is a positive single stranded RNA arbovirus known as dengue virus 
(DENV), which uses species of Aedes mosquitoes as vectors. To date, there is no effective 
available vaccine or cure for dengue, and the control options primarily rely on vector control 
strategies, mostly through the application of pesticides. However, reports of resistance in 
Aedes mosquitoes against pesticides has limited this option as well. Therefore, there is an 
urgent need for alternative approaches to control the spread of DENV. One of the novel 
options involves the use of the endosymbiotic bacterium Wolbachia, that has successfully 
limited the ability of Aedes aegypti mosquitoes to transmit a number of life-threatening 
mosquito-borne viruses such as DENV and Zika virus. Despite its effectiveness to inhibit 
replication of DENV, very little is known about the mechanism(s) that Wolbachia uses to 
impart this antiviral effect. In this study, we looked into Ae. aegypti host factors that affect 
DENV replication and their potential manipulations by Wolbachia to find molecular 
mechanism(s) that Wolbachia utilizes to limit DENV replication.  
Recently, studies have shed light on the role of chromodomain DNA binding helicases in 
Human Immunodeficiency virus (HIV) and Influenza A virus. In Chapter 1, we have identified 
three Ae. aegypti homologs of chromodomain helicase DNA binding proteins (CHD) and 
determined their modulation in response to Wolbachia and DENV infections. We have found 
that among the three CHD members, AeCHD7/Kismet levels are significantly decreased in 
Wolbachia infection. Further investigations demonstrated that AeCHD7 is significantly 
increased in the case of DENV replication suggesting that it may facilitate DENV replication. 
Knock down studies of AeCHD7 confirmed this assumption as it resulted in significant 
reductions in DENV replication and virion production. In this study, we have identified 
AeCHD7 as an Ae. aegypti pro-DENV host factor that is downregulated by Wolbachia which 
may contribute in limiting DENV replication. 
Vago is an insect-specific secretory protein that has been identified in Culex quinquefasciatus 
to play an important role in the crosstalk between the mosquito’s immune pathways and 
reduce West Nile virus (WNV) replication. In Chapter 2, by in-silico identification of Vago 
characteristic SVWC domain and secretory signal, we identified two potential homologs of the 
Vago protein in Ae. aegypti and looked at their expression pattern in the case of Wolbachia 
infection to find that AeVago1 is highly induced in Ae. aegypti upon Wolbachia infection. 
 iii 
 
However, we found no induction of AeVago1 expression in Ae. aegypti mosquitoes infected 
with DENV. Further, AeVago1 knockdown studies demonstrated that there was a significant 
increase in DENV replication in Wolbachia infected cells in AeVago1 deficient cells. However, 
there was no effect on Wolbachia density in AeVago1 depleted cells. The outcomes of this 
study suggest that in the presence of Wolbachia the immune gene AeVago1 is induced, which 
might also contribute towards inhibition of DENV replication. 
Pelo has been recently reported as a positive regulator of Drosophila C virus (DCV) 
replication. However, its role in the case of DENV replication has not been elucidated yet. In 
Chapter 3, we looked into the possible involvement of pelo in the case of Wolbachia-Ae. 
aegypti-DENV interactions. We found that the pelo protein levels increase during DENV 
replication. Silencing of pelo led to severe reduction of DENV virion production, suggesting its 
important role in DENV replication. However, in the case of Wolbachia infection, specifically in 
female Ae. aegypti mosquitoes, there was a significant decrease in the transcript levels of 
pelo. Further experiments confirmed that Wolbachia changes the subcellular localization of 
the pelo protein, suggesting that it might be a novel Ae. aegypti host factor that is used by 
Wolbachia to limit DENV replication. In addition, we found that Wolbachia-mediated down-
regulation of pelo transcripts might be regulated by aae-miR-2940-5p, which is highly induced 
by Wolbachia. This study has identified a novel molecular mechanism that is used by 
Wolbachia to limit DENV replication in Ae. aegypti mosquitoes. Nevertheless, this mechanism 
of inhibition does not seem to be universally seen in Wolbachia-host-virus interactions. 
Overall, in this study we have identified three novel host genes that play important roles in 
DENV replication and that regulation of these genes in the presence of Wolbachia may 
contribute towards virus blocking in Ae. aegypti mosquitoes. 
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1. Introduction 
Arthropod-borne diseases, such as malaria, leishmaniasis, filariasis, onchocerciasis and 
dengue, impose huge risks to human health (Hill et al., 2005). According to WHO report, there 
is an increased risk of emergence of a number of arthropod-borne diseases with more than 
half of the world population being at risk of getting one of these diseases (WHO, 2014). All of 
the aforementioned diseases need hematophagous arthropod vectors such as mosquitoes 
and ticks for transmission between humans and/or animals (Gubler, 1998; Kalluri et al., 2007). 
Among the arthropod-borne diseases, the ones caused by viruses are of immense importance 
and are generally referred to as arboviral diseases. Centre of Disease Control and Prevention 
has reported more than 600 arboviruses, among which 80 can infect humans (Conway et al., 
2014). The majority of arboviruses belong to four viral families Togaviridae, Bunyaviridae, 
Reoviridae and Flaviviridae (Karabatsos, 1978). Flaviviridae is the most important arboviral 
family because it harbors highly pathogenic viruses to humans such as yellow fever virus, 
West Nile virus (WNV), Zika virus (ZIKV) and dengue virus (DENV) (Fernandez-Garcia et al., 
2009). 
1.1. Dengue Virus 
DENV is a major arbovirus that uses Aedes spp. mosquitoes as vector to be transmitted to 
humans (Gubler, 2006). There are estimated 390 million DENV infections annually putting 
major burden on global health (Bhatt et al., 2013). Currently, there is no specific therapy or 
approved vaccine available while the treatment available is just supportive. Despite, 
substantial efforts to control DENV through vector control, it is still geographically expanding 
rapidly (Tatem et al., 2006).  
DENV belongs to the Flaviviridae family that comprises lipid-enveloped, positive-sense single 
stranded ribonucleic acid (RNA) viruses (Clyde et al., 2006). DENV is classified into four 
antigenically distinct but closely related serotypes, represented as DENV-1 to DENV-4. The 
length of DENV genome is about 10.7 kilobases comprising a single open reading frame 
flanked by highly conserved 5’ and 3’ untranslated regions. A single ORF encodes a 
polyprotein of approximately 3391 amino acids, which is further processed by the host cellular 
proteases furin and signalase and viral NS2B/NS3 protease complex to generate three 
structural (C, prM and E) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, 
NS4B and NS5) (Bartenschlager and Miller, 2008) (Figure 1). 
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Figure 1. DENV Genome Structure. DENV RNA contains a single open reading frame 
encoding a polyprotein, which is cleaved by the host and viral proteases to produce 3 
structural and 7 non-structural proteins, flanked by 5′ and 3′ UTRs. Conserved RNA 
secondary structures in the UTRs and in the coding region have been determined to function 
at various stages of the viral life cycle. Adapted from (Clyde et al., 2006).   
1.2. DENV Life Cycle 
1.2.1. Viral Entry 
DENV is mostly introduced to humans by infected Aedes mosquitoes with the main vector 
being Aedes aegypti. After the introduction, DENV particularly targets mononuclear phagocyte 
lineage cells including the skin resistant Langerhans cells (Jessie et al., 2004; Wu et al., 
2000). However, in mosquitoes DENV is thought to initially target midgut and then spread and 
replicate in other peripheral tissues (Rodenhuis-Zybert et al., 2010).   
DENV can infect a very diverse range of cell lines including human, mosquito, monkey, 
hamster and murine cell linages. This suggests that either DENV uses a ubiquitous receptor 
or it uses multiple receptors for its entry (Rodenhuis-Zybert et al., 2010). In mosquito cells, 
different independent groups have reported a number of potential DENV receptors such as 
prohibitin (Mishra et al., 2006), heat shock protein 70 (Hsp70), R80, R60 and a 45 kDa protein 
(Rodenhuis-Zybert et al., 2010). Recently, a group has demonstrated, both in vivo and in vitro, 
the interaction of Ae. aegypti C-type lectin 3 with DENV-2 envelope protein, and further 
suggested the possibility that DENV-2 may use multiple C-type lectins as receptors to gain 
entry into mosquito cells (Liu et al., 2014). In humans, heparan sulfate (Germi et al., 2002), 
Hsp90 (Reyes-Del Valle et al., 2005), CD14 (Chen et al., 1999), GRP78/BiP 
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(Jindadamrongwech et al., 2004), and a 37/67-kDa high-affinity laminin receptor (Thepparit 
and Smith, 2004) have been identified as potential receptors for DENV. C-type lectin 
receptors (CLR) are involved in the interaction of DENV particles with human myeloid cells 
(Fernandez-Garcia et al., 2009). These include DC-specific intracellular adhesion molecule 3 
(ICAM-3)-grabbing no integrin (DC-SIGN, CD209) (Lozach et al., 2005; Navarro-Sanchez et 
al., 2003; Tassaneetrithep et al., 2003), mannose receptor (MR) (Miller et al., 2008) and C-
type lectin domain family 5, member A (CLEC5, MDL-1) (Chen et al., 2008). 
Similar to other flaviviruses, after adsorption to receptors DENV is endocytosed by cells in a 
clathrin dependent manner and then is further transported into endosomes (Stiasny et al., 
2011) (Figure 2). However, according to one study, DENV can adopt a clathrin-independent 
pathway as well to gain entry, in particular, into mammalian cells (Acosta et al., 2009).   
1.2.2. Viral Replication 
Following the entry, DENV nucleocapsid is released into the cytosol after acidic pH triggered 
rearrangement of its envelope protein in late endosomes leading to fusion of viral envelope 
and the cellular endosome membrane (Harrison, 2008; Modis et al., 2004). The nucleocapsid 
disassembles and viral genome is translated by ER-located ribosomes generating numerous 
copies of viral proteins. NS5 and other viral non-structural proteins along with various host 
proteins establish replication complexes (Welsch et al., 2009). At the replication complex, the 
viral polymerase (NS5) transcribes the negative strand viral RNA, which serves as a template 
for the synthesis of subsequent positive strand viral RNA copies.  Viral replication is regulated 
by 5’-3’ UAR sequences (upstream of AUG region) present in 5’ and 3’ UTRs, which are 
actively involved in the circularization of DENV RNA (Villordo and Gamarnik, 2009). These 
newly synthesized positive strand DENV RNAs interact with capsid proteins to assemble into 
nucleocapsids (Ivanyi-Nagy and Darlix, 2010). These nucleocapsids bud into the lumen of the 
endoplasmic reticulum (ER) thereby become enveloped in a membrane bilayer carrying the 
viral prM and E proteins (Welsch et al., 2009) (Figure 2). These immature particles are 
transported through the cellular secretory pathway, where the furin protease cleaves prM, 
resulting in the formation of mature virus particles capable of infecting naïve cells (Li et al., 
2008).  
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Figure 2. DENV replication cycle. Virions bind to cell-surface attachment 
molecules/receptors such as heparan sulfate or DC-SIGN and are internalized through 
endocytosis. The low pH of the late endosomes triggers fusion of virions with endosomal 
membrane releasing viral RNA into the cytoplasm. Viral RNA is translated by the cellular 
machinery and viral non-structural proteins form the replication complexes where the viral 
RNA is amplified. Virions bud into the lumen of the ER. Virion maturation occurs during their 
transport through the secretory pathway. New round of infection can be initiated by the mature 
virions once they are released. Adapted from (Sampath and Padmanabhan, 2009).   
1.3. DENV-Mosquito Interactions 
In nature, almost every organism engages in ecological or molecular interactions with other 
organisms, whether in antagonistic or mutualistic associations, to thrive and excel. These 
interactions are major drivers of diversification and adaptive evolution. Among these 
interactions, the most fascinating examples are those involved in invertebrate susceptibility to 
pathogens (Schmid-Hempel and Ebert, 2003).   
In the case of DENV, it is evident that despite the pathogenic nature of the virus in humans, its 
interaction with Ae. aegypti mosquito is somehow non-pathogenic. Studies have identified a 
specific RNA sequence present in the 3’UTR of DENV which is essential for virus replication 
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in mosquito cells but is not important in the case of virus replication in mammalian cells 
(Villordo and Gamarnik, 2013). Furthermore, it has been shown that DENV2 encodes a 
miRNA-like small RNA from its 3’UTR which targets the NS1 gene of DENV to autoregulate 
the DENV replication to keep the virus replication under check in the mosquitoes (Hussain 
and Asgari, 2014). DENV has evolved to overcome the host mosquito’s defenses and 
manipulate its cellular machinery by largely unknown mechanisms that facilitate its replication 
without interfering too much with the normal growth of the mosquitoes.  Similar to other 
insects, mosquitoes generally lack an adaptive immune system to counter pathogens, thus 
innate immunity is the sole mechanism for defence against pathogen infections especially 
viruses. These defences commonly comprise of either RNA interference (RNAi) or antiviral 
protein-based responses. 
1.3.1. The RNA Interference Pathway 
RNAi is an evolutionary conserved defense response constituting a major component of the 
mosquito innate immune response to virus infections (Blair, 2011). RNAi response is generally 
triggered by detection of endogenous or exogenous (virus genome or virus replication 
intermediates) double stranded RNA (dsRNA) (Fire et al., 1998) by a ribonuclease III (RNase 
III) enzyme called Dicer, which processes dsRNA into 20-21 nucleotide short RNA duplexes 
(Hutvagner et al., 2001) (Figures 3). These small RNA duplexes are further unwound and one 
of the strands, having less thermostability, is loaded into the RNA-induced silencing complex 
(RISC) (Czech et al., 2009). The short interfering RNA (siRNA) along with the RISC complex 
is directed towards the target RNA sequences, based on sequence complementarity, which 
generally leads to the cleavage of the targeted RNA through slicer endonuclease activity of 
Argonaute-2 (Ago2) (Miyoshi et al., 2005; Schwarz et al., 2002). 
In mosquitoes, RNAi plays an important role in antiviral defense, which was first discovered in 
Anopheles gambiae limiting the replication of O’nyong-nyong virus (ONNV) (Keene et al., 
2004). In Ae. aegypti mosquitoes, silencing of key RNAi components Dicer-2 and R2D2 leads 
to significant increases in DENV titer (Sanchez-Vargas et al., 2009). It has been demonstrated 
that DENV elicits the RNAi response in Ae. aegypti, but it is unable to completely repress viral 
replication. Instead, it may just modulate virus replication to maintain persistent viral infection 
in order to ensure long-term survival of infected mosquitoes (Sanchez-Vargas et al., 2009). 
Given that DENV successfully develops persistent infection in mosquitoes despite their RNAi 
response, the precise mechanism of RNAi evasion is definitely a significant point of interest. 
Recent studies have shown that DENV might employ two different mechanisms to inhibit the 
RNAi pathway, involving RNAi suppressor protein NS4B and the subgenomic flavivirus RNA 
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(sfRNA). DENV encoded nonstructural protein NS4B has been reported to suppress the RNAi 
pathway in human Huh-7 cells by a mechanism that is still not fully understood (Kakumani et 
al., 2013). Furthermore, sfRNA produced by DENV is thought to reduce the RNAi response in 
both human and mosquito by inhibiting Dicer-mediated cleavage of dsRNA and through direct 
interaction with Ago2, which is an important component of the RISC complex (Moon et al., 
2015; Schnettler et al., 2012). However, a recent study demonstrated that neither of those 
mechanisms could be involved in RNAi suppression, but the capsid protein, which sequesters 
dsRNA and protects it from cleavage by Dicer. The capsid protein, therefore, could be the true 
viral suppressor of RNAi in flaviviruses as this function of the protein seems to be conserved 
among a number of flaviviruses tested (Samuel et al., 2016). 
1.3.2. The Toll Pathway 
Generally, the Toll pathway has been associated with the infection of Gram positive bacteria 
and fungi (Lemaitre and Hoffmann, 2007). However, this pathway has been reported to play 
an important role in the antiviral defense in both mosquitoes (Christophides et al., 2002) and 
fruit flies (Zambon et al., 2005). The Toll pathway is triggered by the pattern recognition 
receptors (PRRs)-mediated activation of an insect cytokine Spätzle, leading to the activation 
of a cascade of events that result in the degradation of Cactus. Cactus, with the help of the 
adaptor protein MyD88, is a negative regulator of Nuclear factor kappa B (Nf-kb)-like 
transcription factor Rel1 (Bischoff et al., 2004; DeLotto and DeLotto, 1998; Michel et al., 2001) 
(Figure 3). Cactus degradation initiates nuclear translocation of Rel1 and transcriptional 
activation of effectors genes (Frolet et al., 2006; Nicolas et al., 1998).  
In DENV infection, the Toll pathway plays an important role in antiviral response in the Ae. 
aegypti midgut. Studies have demonstrated activation of major Toll pathway genes such as 
Spätzle, Toll and Rel1a upon DENV infection suggesting that the pathway is activated as an 
antiviral response against DENV infection (Sim et al., 2012; Xi et al., 2008). In addition, a 
follow up study has further functionally characterized the role of important Toll pathway genes 
in the case of DENV infection by performing dsRNA-mediated silencing assays and found that 
in the midgut of Ae. aegypti mosquitoes silencing of Cactus significantly decreased the DENV 
titer, while silencing of MyD88 led to increases in DENV titer (Xi et al., 2008).  
1.3.3. The Immune Deficiency (IMD) Pathway 
The IMD pathway plays an important role in the insect defense system especially against 
gram negative bacteria (Georgel et al., 2001; Kaneko and Silverman, 2005). This pathway is 
similar to tumor necrosis factor signaling pathway in mammals (Aggarwal and Silverman, 
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2008). In Drosophila melanogaster, activation of the IMD pathway occurs through pathogen 
detection by membrane bound class of peptidoglycan recognition proteins (PGRPs), leading 
to the activation of a signaling cascade through the adaptor IMD protein along with a number 
of caspases and kinases, which in turn process Relish 2 (Rel2) into its active form by 
removing its carboxyl end and exposing its nuclear localization signal for nuclear export 
(Stoven et al., 2003) (Figure 3). After translocation into the nucleus, Rel2 activates 
transcription of a number of antimicrobial peptides such as cecropin A and other defense 
related genes (Antonova et al., 2009; Lemaitre and Hoffmann, 2007). Recent studies have 
shed light on the antiviral role of the IMD pathway in D. melanogaster against Cricket paralysis 
virus and Sindbis virus (Avadhanula et al., 2009; Costa et al., 2009). Regarding the role of the 
IMD pathway in DENV infection, a study conducted on DENV-susceptible strains of Ae. 
aegypti by silencing key components of the IMD pathway showed no effect on DENV titer in 
the midgut (Xi et al., 2008). However, a recent study has demonstrated increase in DENV 
titers in IMD silenced Ae. aegypti mosquitoes of a DENV-resistant strain, which seems to 
suggest that the IMD pathway might be an important antiviral defense against DENV in the 
mosquito (Sim et al., 2013). This was further strengthened by a recent finding in Culex 
quinquefasciatus, which found that in Rel2 depleted cells there was a significant increase in 
WNV titer (Paradkar et al., 2014). 
1.3.4. The Janus Kinase/Signal Transducers and Activators of Transcription 
(JAK/STAT) Pathway 
The JAK/STAT pathway was initially identified in mammalian cells as an interferon-induced 
signaling pathway important for antiviral immunity and is named for the kinase (JAK) and the 
transcription factor (STAT) (Fu et al., 1992; Schindler et al., 1992). The key components of 
this pathway are conserved across most of the species, highlighting their evolutionary 
importance in antiviral immunity (Arbouzova and Zeidler, 2006). In D. melanogaster, the 
JAK/STAT pathway is generally activated by the attachment of Unpaired peptide ligand to the 
extracellular region of the transmembrane receptor Dome, leading to conformational changes 
and dimerization of Dome (Figure 3). Activation of Dome is followed by auto-phosphorylation 
of its associated JAK kinases which later phosphorylates the cytoplasmic tail of the Dome 
receptor as well to generate docking sites for recruitment of STAT proteins. After recruitment 
of the STAT proteins at the activated Dome-JAK complex, there is also a phosphorylation 
event of the STAT proteins resulting in their dimerization and activation. The activated STATs 
translocate into the nucleus and induce the expression of effector genes. Use of D. 
melanogaster has led to the identification of the antiviral role of the JAK/STAT pathway in 
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insects (Arbouzova and Zeidler, 2006; Hombria and Brown, 2002; Zeidler and Bausek, 2013). 
In the case of mosquitoes, there are several reports suggesting its major role in antiviral 
immunity. In An. gambiae, ONNV replication was significantly increased by silencing STAT-A, 
demonstrating its potential role in antiviral defense (Carissimo et al., 2015). Studies carried 
out to validate the role of the JAK/STAT pathway in Ae. aegypti have found that silencing of 
Dome and JAK significantly enhanced DENV replication in the midgut, while the opposite 
effect on DENV replication was observed when the pathway was activated through the 
silencing of protein inhibitor of activated STAT (PIAS), which is a negative regulator of the 
JAK/STAT pathway (Souza-Neto et al., 2009). In the same study, two JAK-STAT regulated 
DENV effector genes, DVRF1 and DRF2, were identified that were able to restrict DENV 
replication in the midgut tissue of Ae. aegypti (Souza-Neto et al., 2009).   
1.3.5. Crosstalk Between Innate Immunity Pathways 
The concept of a single type of pathogen leading to the activation of a single immune pathway 
is becoming obsolete. There is sufficient evidence to suggest that both the Toll and the IMD 
pathways perform dual functions in mounting immune response against both bacterial and 
viral infections (De Gregorio et al., 2002; Tanji et al., 2007). However, there lies a huge grey 
area of the potential crosstalk between the innate immunity pathways to activate a 
synchronized response to counter a pathogen challenge. Although there is limited data 
available to prove crosstalk between different immune pathways, one prime example is Dicer-
2 (Dcr2) mediated activation of the antiviral peptide Vago in response to Drosophila C virus 
(DCV) and WNV infection in D. melanogaster and Cx. quinquefasciatus, respectively, in an 
RNAi independent manner (Deddouche et al., 2008; Paradkar et al., 2012). In Cx. 
quinquefasciatus, further elucidation of the mechanism of Vago activation revealed that upon 
sensing viral dsRNA, Dcr2 activates TNF receptor associated factor (TRAF) leading to Rel2 
activation (transcription factor of the IMD pathway), which in return through binding to the NF-
b motif in the Vago promoter induces Vago transcription (Paradkar et al., 2014) (Figure 3). In 
contrast to D. melanogaster, Cx. quinquefasciatus Vago activates the JAK/STAT pathway to 
restrict WNV replication (Paradkar et al., 2012). Vago activation in Cx. quinquefasciatus 
presents a very novel example of a potential crosstalk between RNAi-IMD and JAK/STAT 
pathways, and provides a new way of studying insect immune response. 
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Figure 3. Mosquito innate immune signaling and RNAi pathways. In the Toll pathway 
signaling, detection of pathogen-derived ligands by pattern recognition receptors (PRRs) such 
as PGRP-SA and -SD triggers proteolytic cleavage of the cytokine Späetzle, which binds to 
and activates the Toll receptor. This triggers signaling through the adaptor proteins MyD88, 
Tube, and Pelle, resulting in the phosphorylation and degradation of Cactus, a negative 
regulator which binds to and sequesters the Rel1 transcription factor in the cytoplasm. Cactus 
degradation allows Rel1 translocation to the nucleus to activate transcription of Toll-pathway 
regulated genes. The IMD pathway is activated by ligand binding to PGRP-LCs and -LEs. This 
triggers signaling through IMD and various caspases and kinases, leading to a functional split 
in the pathway. One branch triggers JNK signaling to activate the transcription factor AP1, 
while the other results in the phosphorylation of the Rel2 transcription factor and its 
subsequent DREDD-mediated cleavage. Activated Rel2 translocates into the nucleus to 
activate IMD-regulated transcription. The JAK-STAT pathway is triggered by Unpaired (Upd) 
binding to the receptor Dome, activating the receptor-associated Hop Janus kinases, which 
phosphorylate each other and subsequently recruit and phosphorylate the STAT transcription 
factor. Phosphorylated STATs dimerize and translocate into the nucleus to activate JAK-
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STAT-regulated transcription. The exogenous siRNA pathway is activated when virus-derived 
long dsRNA is recognized and cleaved by Dcr2 into siRNAs, usually 21 bases in length. 
siRNAs are loaded onto the multi-protein RISC complex, which degrades one strand of the 
duplex and uses the other for targeted degradation of complementary single stranded viral 
RNA. Sensing of viral dsRNA by Dcr2 also activates TRAF, leading to Rel2 cleavage and 
activation via a distinct pathway. Rel2 activates transcription of Vago, a secreted peptide 
which subsequently triggers the JAK-STAT signaling pathway. Adapted from (Sim et al., 
2014). 
1.4. Vector Control Strategies for DENV Prevention 
Arbovirus-mediated diseases are very important medical ailments causing very high mortality 
and morbidity rates around the world, in particular, in developing countries. Recent increases 
in unplanned urbanization, ease of travel and environmental changes have led to increased 
risks of becoming infected by these viruses. In regards to DENV, this has been exacerbated 
by unavailability of potent vaccines and medicines against the virus, which has limited the 
disease prevention towards the control of the major vectors, Ae. aegypti and Ae. albopictus. 
So far, the widely-adopted methods to suppress vector populations have been the application 
of insecticides or reduction of the breeding sites of the mosquitoes. The aforementioned 
techniques have found limited success to control mosquito populations. In particular, the 
recent emergence of resistance in Ae. aegypti to available insecticides have urged the need 
for development of novel strategies (Marcombe et al., 2012). Currently, two of the important 
potential novel options are development of genetically modified mosquitoes with elevated 
immune/antiviral responses to make mosquitoes resistant to DENV infection (Beaty et al., 
2010), and more recently the use of Wolbachia as a biological control agent to limit a number 
of arboviruses including DENV, ZIKV, and WNV (Bian et al., 2010; Kambris et al., 2009; 
Moreira et al., 2009). In addition, a non-radiation sterile male technique based on genetic 
manipulation of Ae. aegypti is being trialed by releasing insects that carry a dominant lethal 
gene (Carvalho et al., 2014). Amongst these, application of Wolbachia has been quite 
promising and more widespread. 
1.5. Wolbachia-Mosquito Interactions 
Wolbachia pipientis in an obligate endosymbiotic bacterium which is known to infect 40-60% 
of insect species belonging to diverse insect families, as well as other arthropods and 
nematodes (Hilgenboecker et al., 2008; Zug and Hammerstein, 2012). Wolbachia is a 
maternally transmitted bacterium and is usually associated with manipulation of host 
 12 
 
reproduction such as cytoplasmic incompatibility (CI) (Hornett et al., 2010), male killing 
(Riparbelli et al., 2012) and feminization (Werren et al., 2008). Among reproduction 
manipulations, CI is considered as the highly prevalent one. Wolbachia-infected female 
mosquitoes can produce viable offspring if they mate with uninfected males or the males 
infected with similar strain of Wolbachia, whereby infected male mosquitoes can only give rise 
to viable offspring when mated with female mosquitoes infected with a similar strain of 
Wolbachia (Stouthamer et al., 1999). Although the exact mechanism that leads to CI is still 
elusive, recent studies have demonstrated that two Wolbachia prophage genes CiF-A and 
CiF-B are the main contributors towards CI (LePage et al., 2017). CI gives Wolbachia means 
to rapidly spread across an uninfected insect population (Hoffman and Turelli, 1997). Apart 
from imposing fitness costs on the host, Wolbachia protects its hosts from viral infections, 
especially against RNA viruses (reviewed in Johnson, 2015). This antiviral property of 
Wolbachia has provided an ideal opportunity to use this bacterium in order to limit the 
transmission of life threatening arboviruses including DENV by introduction of Wolbachia to 
Ae. aegypti.  Wolbachia is not a natural host of Ae. aegypti, so there was a lot of challenges to 
transinfect the highly proliferating Wolbachia strain wMelPop from D. melanogaster directly 
into Ae. aegypti. In order to overcome these challenges, wMelPop was first transinfected into 
Ae. albopictus cell line Aa23.T, and after adapting wMelPop to the cells for up to 2.5 years, 
the wMelPop isolated from infected Aa23.T cells (now called cell line adapted wMelPop; 
wMelPop-CLA) was used to successfully infect the RML12 cell line (originally thought to be an 
Ae. aegypti cell line but turned out to be from Ae. albopictus (Voronin et al., 2010) 
(McMeniman et al 2008).  After adapting wMelPop to mosquito cell lines, wMelPop-CLA was 
successfully introduced into Ae. aegypti mosquitoes by embryonic injections (Walker et al., 
2011), reducing the life span of female Ae. aegypti by 50% (McMeniman et al., 2009), and 
successfully inhibited replication of several pathogens including DENV (Moreira et al., 2009). 
Using a similar strategy, another Wolbachia strain (wMel) was transinfected into Ae. aegypti 
mosquitoes. Unlike wMelPop-CLA strain, wMel showed minimal fitness cost on mosquitoes, 
but lesser viral protection as compared to wMelPop-CLA (Walker et al., 2011). Recently, 
superinfected Ae. aegypti mosquitoes with two Wolbachia strains (wMel and wAlbB) has been 
produced, which showed less fitness cost on the mosquitoes and higher viral protection as 
compared to mosquitoes infected only with wMel (Joubert et al., 2016).  The exact mechanism 
with which Wolbachia produces this antiviral effect is still not well understood. Recently, a 
study carried out in a D. melanogaster cell line (JW18) demonstrated that Wolbachia-
mediated restriction of Semliki Forest virus occurs at the early stage of infection (Rainey et al., 
2016). Nonetheless, there is a good amount of evidence suggesting that in some Wolbachia-
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host-virus associations only tolerance to virus replication is established without much of an 
effect on virus titer (Osborne et al., 2009; Teixeira et al., 2008). 
In Ae. aegypti mosquitoes, a number of studies have linked the increased reactive oxygen 
species (ROS), differential microRNA (miRNA) expression and DNA methylation patterns in 
the presence of Wolbachia with the antiviral effect against DENV replication (Hussain et al., 
2011; Pan et al., 2012; Ye et al., 2013; Zhang et al., 2013). However, due to the limitations of 
these studies to one particular host species, Ae. aegypti, which is a transinfected host, there is 
still a lack of understanding of the exact molecular mechanism(s) that cause Wolbachia-
mediated antiviral effect in general.  
So far, there are two major possible hypotheses that are perceived to impart Wolbachia-
mediated antiviral defense, which are competition for resources and induction of immune 
response commonly known as immune priming (Figure 4).  
1.5.1. Competition for Resources 
Wolbachia like other members of Rickettsiales, is unable to synthesize its own cholesterol, so 
it solely relies on its host cholesterol reserves for its efficient growth and reproduction (Molloy 
et al., 2016). On the other hand, almost all mosquito-borne flaviviruses and alphaviruses also 
depend on the host cholesterol for their successful, infectivity, replication, virion assembly, 
and release from the infected cells (Fernandez-Garcia et al., 2009; Kielian et al., 2010). Given 
that the Wolbachia-mediated antiviral protection is density dependent, it seems logical that at 
higher density Wolbachia consume more host resources, thus making the host cells’ 
environment non-conducive for viruses to propagate. A study conducted in D. melanogaster 
has shown that cholesterol levels modulated by Wolbachia play an important role in the 
antiviral protection of D. melanogaster flies against DCV (Caragata et al., 2013). Another 
evidence of involvement of Wolbachia in cholesterol competition comes from the study that 
has demonstrated that Wolbachia induces autophagy, which is well known to modulate lipid 
profile of host cells (Molloy et al., 2016; Voronin et al., 2012). Furthermore, flaviviruses, in 
particular DENV, also depend on the autophagy pathway for successful replication (Heaton 
and Randall, 2010). Thus, it seems that there could be direct competition of resources 
between Wolbachia and viruses for the host cholesterol.  
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Figure 4: Schematic representation of proposed hypotheses for Wolbachia-mediated antiviral 
defense. 
 
1.5.2. Immune Priming 
Immune response is the main line of defense of any organism against pathogen invasion. 
Wolbachia has been reported to activate immune genes in transinfected hosts such as Ae. 
aegypti.  This induction involves upregulation of immune genes belonging to all the three main 
innate immune pathways including the Toll, IMD and JAK/STAT pathways (Kamtchum-
Tatuene et al., 2016; Rainey et al., 2014; Rances et al., 2012). Studies have also shown the 
activation of reactive oxygen species (ROS) in response to Wolbachia infection in both flies 
and mosquitoes. The above study further demonstrated the ROS-mediated modulation of the 
Toll pathway which led to restricted DENV replication in Ae. aegypti mosquitoes (Pan et al., 
2012). However, this is not the case in D. melanogaster flies, which show no change in 
immune genes in the case of Wolbachia infection. Although immune priming is not universal in 
Wolbachia-host interactions, in particular in natural Wolbachia hosts, it might still aid in 
mounting antiviral response against viruses specially in transinfected mosquitoes.  
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1.5.3. Induction of MiRNAs  
miRNAs represent one of the shortest functional classes of non-coding RNAs (ncRNAs) 
depicting the hottest area of gene regulation research. Discovered in 1993 in the round worm 
Caenorhabditis elegans (Lee et al., 1993), these 20 - 24 nucleotide-long ncRNAs have been 
demonstrated to be encoded by a diverse range of organisms including plants, humans, 
insects and even viruses (Almeida et al., 2011). Historically, miRNAs were thought to regulate 
gene expression either by degradation of particular target mRNA or inhibition of translation 
(Baek et al., 2008; Guo et al., 2010), however, recent studies have revealed that these small 
ncRNAs can also activate target gene expression through mRNA stabilization (Fabian et al., 
2010; Vasudevan et al., 2007). Recently, studies have shown miRNAs as critical effectors in 
the case of bacterial infections (Staedel and Darfeuille, 2013). In insects, studies have 
demonstrated changes in the expression profile (Hussain et al., 2011), structure and 
localization of miRNAs in response to Wolbachia infection in transinfected Ae. aegypti 
mosquitoes (Mayoral et al., 2014). In particular, Wolbachia upregulates aae-miR-2940-5p in 
Ae. aegypti mosquitoes which leads to upregulation of metalloprotease m41 FtsH (Hussain et 
al., 2011) and downregulation of DNA methyltransferase Dnmt2 (Zhang et al., 2013) both of 
which are essential for high density of Wolbachia, which is important for viral inhibition. 
1.6. Concluding Remarks 
Given that there is an increasing impact of DENV on global health along with lack of 
publically available vaccines and antiviral treatment, there is an urgent need for greater 
understanding of vectors and devising novel vector control strategies that can be employed to 
limit DENV transmission. Currently, several studies have pointed out towards the potential use 
of Wolbachia as an invaluable tool for limiting DENV replication in mosquitoes, and thus 
reducing the risk of virus transmission to humans. Despite its potential, there is a lack of 
understanding of the exact mechanism(s) that Wolbachia uses to limit viral replication. In this 
project, we aimed to deepen our understanding of the potential mechanism(s) that Wolbachia 
employs in general, or in Ae. aegypti in particular, to induce the antiviral effect, especially 
against DENV. 
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2.1. Abstract 
Dengue virus (DENV) is a mosquito-transmitted virus imposing a significant burden on human 
health around the world. Since current control strategies are not sufficient, there is an urgent 
need to find alternative methods to control DENV transmission. It has been demonstrated that 
introduction of Wolbachia pipientis in Aedes aegypti mosquitoes can impede DENV 
transmission with the mechanism(s) not fully understood. Recently, a number of studies have 
found the involvement of chromodomain DNA binding helicases in case of Human 
Immunodeficiency virus (HIV) and Influenza A virus infection. In this study, we have identified 
three chromodomain helicase DNA binding protein (CHD) genes in Ae. aegypti and looked at 
their response in the case of Wolbachia and DENV infections. Foremost amongst them we 
have found that AeCHD7/Kismet is significantly downregulated in the presence of Wolbachia 
infection only in female mosquitoes. Furthermore, AeCHD7 levels showed significant increase 
during DENV infection, and AeCHD7 depletion led to severe reduction in the replication of 
DENV. Our data have identified AeCHD7 as a novel Ae. aegypti host factor that is important 
for DENV replication, and Wolbachia downregulates it, which may contribute towards the 
mechanism(s) of limiting DENV replication.  
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2.2. Introduction 
Among arboviruses, dengue virus (DENV) is one of the most important flaviviruses having the 
potential to affect two-thirds of the world’s population 1,2. DENV is primarily transmitted to 
humans through the bite of mosquito vector Aedes aegypti, leading to dengue infection and 
potentially dengue haemorrhagic fever 3-5. Lack of availability of an effective vaccine and 
proper medical care has narrowed DENV management strategies to vector control. One of the 
strategies used to overcome DENV vector Ae. aegypti is through the application of pesticides, 
but due to their severe consequences on the environment and the emergence of resistance to 
pesticides, their potential application seems bleak in the near future 6. Therefore, new 
strategies for vector control are urgently needed. One of the novel options is the use of an 
endosymbiotic bacterium Wolbachia which has recently been demonstrated to limit DENV, 
West Nile virus (WNV), and Zika virus (ZIKV) replication in Ae. aegypti 7-10.  
Wolbachia pipientis is an alphaproteobacterium that naturally infects almost 40-60% of insect 
species 11,12. This bacterium is maternally transmitted and is usually associated with 
manipulations of host reproduction, such as feminization 13 and male killing 14, to promote 
successful colonization of its host species. Wolbachia naturally infects several mosquito 
species, including Aedes albopictus and Culex pipiens 15. However, there is no natural 
Wolbachia infection in the case of Ae. aegypti, which is the most notorious vector for several 
arboviruses. In order to exploit Wolbachia’s potential to limit arbovirus transmission, three 
strains of Wolbachia, wAlbB (from Ae. albopictus) 16, wMel (from Drosophila melanogaster) 17 
and wMelPop-CLA (from D. melanogaster) 18 have been successfully transinfected into Ae. 
aegypti. Among these three strains, wMel and wMelPop-CLA are the most promising ones for 
virus blocking 7-10,19,20. However, the exact mechanism(s) by which Wolbachia blocks viral 
replication in Ae. aegypti mosquitoes is still elusive. Few studies that have looked into the 
transcriptional changes in Ae. aegypti mosquitoes upon Wolbachia infection have found 
increased redox and mitochondrial activity along with differential serine protease activity 21-23. 
However, very little is known about the role of chromatin remodelers in the case of DENV-
Aedes-Wolbachia molecular interactions. 
Chromodomain helicase DNA binding proteins (CHD) represent a class of ATP-dependent 
chromatin remodelling enzymes that contribute towards invoking changes in the interaction 
between DNA and nucleosomes 24, influencing a wide array of cellular processes such as 
replication, transcription, recombination, repair and development 25. Members of the CHD 
family have been found to be involved in replication of Human Immunodeficiency virus (HIV) 
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and Influenza A virus 26,27. All the CHD protein family members have a pair of chromodomains 
at their N-terminus along with one sucrose non-fermenting (SNF2) domain in the centre 25. In 
humans, the CHD family has nine members. These are further classified, on the basis of 
additional motif features, into three subfamilies: CHD1-2 (class I), CHD3-5 (Class II) and CHD 
6-9 (class III) 25,28. In D. melanogaster, there are three well characterized CHD members 
named CHD1 29, Mi2 30 and Kismet/CHD7 31. CHD1 is essential for the fecundity of both 
males and females and is indirectly involved in transcriptional elongation 32, whilst Mi2 actively 
participates in transcriptional repression and is vital for expression of heat shock proteins 33,34. 
Drosophila Kismet, that is a homolog of human CHD7, mediates transcriptional elongation 35. 
Apart from characterization of the CHD family members’ role in development and chromatin 
modification, very little is known about their potential role in host-pathogen interactions. 
In this study, we have identified functional homologs of the CHD family members in Ae. 
aegypti and looked at the effect of Wolbachia infection on their expression. There was 
significant reduction in the expression of all CHD family members in the presence of 
Wolbachia. Furthermore, we found that AeCHD7 is highly induced during DENV infection in 
Ae. aegypti mosquitoes. A silencing assay demonstrated that AeCHD7 is required for the 
efficient replication and virion production of DENV. This study will help to understand the role 
of AeCHD7 in DENV-Aedes-Wolbachia interactions. 
2.3. Results 
2.3.1. Screening of the CHD family genes during Wolbachia infection  
Three CHD genes were identified in the Ae. aegypti genome using Vectorbase 36. Blastp was 
run to identify their homologs in D. melanogaster and Culex quinquefasciatus, and these were 
determined as AeCHD1 (AAEL004716) having 58% identity with D. melanogaster CHD1 
protein (NP_477197.1), AeCHD3 (AAEL013136) that showed 70% identity with D. 
melanogaster CHD3 protein (AAD17276.1) and AeCHD7 (AAEL002230) showing 58% identity 
with D. melanogaster Kismet/CHD7 protein (NP_001245820.1). qPCR primers were designed 
for all the three AeCHD family members to experimentally validate their expression in Ae. 
aegypti mosquitoes by RT-qPCR, and the effect of Wolbachia (wMelPop) infection on their 
expression level. For this, we selected two age groups of Ae. aegypti mosquitoes, 4-day- and 
12-day-old. While expression of all the three AeCHD genes was confirmed in the mosquitoes, 
they were all mostly downregulated in Wolbachia-infected mosquitoes (Figure 1A-F), except 
for AeCHD3, which was found to be non-significantly upregulated in 4-day-old Wolbachia-
infected mosquitoes (Figure 1C). However, AeCHD7 showed the highest change of 2.9-fold 
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downregulation in 4-day-old Ae. aegypti female mosquitoes (Figure 1E), which led us to 
further characterise the gene. 
                  
Fig. 1: Relative expression of AeCHD genes in uninfected and Wolbachia-infected Ae. 
aegypti mosquitoes. RT-qPCR based quantification of (A-B) AeCHD1, (C-D) AeCHD3, and 
(E-F) AeCHD7 genes in both Wolbachia-infected (Pop) and uninfected (Tet) 4-day-old and 12-
day-old female mosquitoes, respectively showing an overall reduction in the level of AeCHD 
genes in the presence of Wolbachia except AeCHD3 which was found to the upregulated in 
the presence of Wolbachia in the 4-day-old mosquitoes. Error bars represent standard error of 
mean (SEM) from three biological replicates with two technical replicates (*, p<0.05; A-C and 
E unpaired t-test; D and F Wilcoxon test). 
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2.3.2. AeCHD7 is ubiquitously expressed in all mosquito tissues 
In order to determine the relative abundance of AeCHD7 across different tissues, the salivary 
gland, midgut, muscle, ovary and fat body were isolated from 3-day-old female Ae. aegypti 
mosquitoes. Following RT-qPCR detection of AeCHD7 mRNA transcripts, it was found that 
AeCHD7 is ubiquitously expressed in all tissues with the highest expression level in the 
salivary gland, which was 2.1-fold higher than its expression level in the fat body which 
showed the lowest relative abundance of AeCHD7 transcripts (Figure 2). These results are 
consistent with the previous findings which showed that AeCHD7 is expressed in all human 
tissues 37. 
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Fig. 2: Tissue-specific expression of AeCHD7 in Ae. aegypti mosquitoes. RT-qPCR 
results of AeCHD7 transcript levels in the salivary gland, midgut, muscles, ovaries and fat 
body of 3-day-old tetracycline treated female mosquitoes showing that AeCHD7 is 
ubiquitously expressed in all tested tissues. Error bars represent SEM of the mean in three 
biological replicates with two technical replicates.  
2.2.3. Specific Wolbachia-mediated downregulation of AeCHD7 in female Ae. aegypti  
To find out whether Wolbachia-mediated downregulation of AeCHD7 is gender specific, we 
evaluated the transcript levels of AeCHD7 in 4-day-old female and male Ae. aegypti 
mosquitoes with and without Wolbachia infection. RT-qPCR results showed that Wolbachia 
downregulates AeCHD7 only in female mosquitoes and not in their male counterparts (Figure 
3A). This is interesting in the sense that Wolbachia has a gender specific effect on gene 
expression in the mosquitoes. To examine if the effect can consistently be seen in cell lines as 
well, we cross-validated the AeCHD7 mRNA expression levels in Ae. aegypti cell lines, Aag2 
and Aag2 infected with wMelPop-CLA (Pop) and found a similar trend of AeCHD7 transcript 
downregulation in Wolbachia-infected cells (Figure 3B). 
  34 
               
A BAe. aegypti
D. melanogaster
A
ag
2
P
op
0.14
0.16
0.18
0.20
0.22
0.24
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
 o
f 
C
H
D
7
***
Te
t4
D
-f
em
al
es
P
op
4D
-f
em
al
es
Te
t4
D
-m
al
es
P
op
4D
-m
al
es
0.0
0.1
0.2
0.3
0.4
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
 o
f 
C
H
D
7
**
ns
C
Aag2 cells
Te
t-
fe
m
al
es
P
op
-f
em
al
es
Te
t-
m
al
es
P
op
-m
al
es
0.0000
0.0005
0.0010
0.0015
R
e
la
ti
v
e
 e
x
p
re
s
s
io
n
 o
f 
K
is
m
e
t
ns
ns
 
Fig. 3: Modulation of AeCHD7/Kismet by Wolbachia infection in male and female 
mosquitoes and flies, and mosquito cell lines. A) RT-qPCR analysis of AeCHD7 transcript 
levels in 4-day-old female and male mosquitoes, both uninfected (Tet) and infected with 
Wolbachia (Pop) showing reduction in the transcript levels of AeCHD7 in 4-day-old female 
mosquitoes only. B) Relative expression of AeCHD7 in Aag2 and Aag2 cells infected with 
wMelPop-CLA (Pop) confirmed the downregulation of AeCHD7 transcripts in Wolbachia-
infected cells. (C) Relative expression of the D. melanogaster Kismet gene, homolog of 
AeCHD7, in uninfected (Tet) and Wolbachia-infected (Pop) flies showing that there was no 
significant difference in the expression in the case of Wolbachia infection. Error bars represent 
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SEM from three biological replicates with two technical replicates with two technical replicates 
(**, p<0.01; ***, p<0.001; ns, not significant; A and B; One-way ANOVA, and C; unpaired t-
test, respectively). 
Furthermore, to evaluate if Wolbachia has a similar effect on the CHD7 gene in its natural host 
D. melanogaster, four 7-day-old male and female flies infected with Wolbachia (wMelPop 
strain) were examined for the relative expression of CHD7. RT-qPCR results confirmed that 
there was no significant change in the level of CHD7 mRNA in both male and female D. 
melanogaster flies infected with Wolbachia (Figure 3C). 
2.3.4. AeCHD7 is upregulated upon DENV infection 
Considering the virus blocking effect of Wolbachia in Ae. aegypti mosquitoes, we examined 
the transcript levels of AeCHD7 in the context of mosquito-DENV interaction. For this, the 
transcript levels of AeCHD7 in DENV-injected mosquitoes at three different time points of 2, 6 
and 12 days post-infection (dpi) were analysed. To have a more consistent and high success 
rate of DENV infection, mosquitoes were injected rather than orally fed with the virus. The 
results revealed that there was an increase in the AeCHD7 transcript levels upon DENV 
infection at all the time points (Figure 4A-C); however, the upregulation was only significant at 
2 and 12 dpi, which was 2-fold (Figure 4A) and 4-fold higher than that in uninfected 
mosquitoes (Figure 4C), respectively. The aforementioned findings were further confirmed in 
the Ae. aegypti cell line, Aa20. Cells were infected with DENV2 at 0.1 multiplicity of infection 
(MOI) and were harvested at two different time points that were 1 and 5 dpi. RT-qPCR 
analysis showed significant increase in AeCHD7 transcript levels in the case of DENV 
infection at both 1 and 5 dpi (Figure 4D). Infection was confirmed by relative quantification of 
DENV genomic RNA levels, which showed gradual increase in DENV genomic RNA over time 
(Figure 4E). 
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Fig. 4: Expression pattern of AeCHD7 in DENV infected female Ae. aegypti. A-C) RT-
qPCR quantification of AeCHD7 transcript levels at 2, 6 and 12 days post DENV infection of 
female Ae. aegypti mosquitoes showing an overall trend of upregulation of AeCHD7 
transcripts in the case of DENV infection. D) Relative transcript levels of AeCHD7 in Aa20 
cells infected with 1 MOI of DENV2 analysed at 1 and 5 dpi confirmed the increase in 
AeCHD7 at the RNA level. E) RT-qPCR quantification of DENV2 genomic RNA in samples 
used in (D) confirming virus infection and replication. Error bars show SEM from three 
biological replicates with two technical replicates (*, p<0.05; ***, p<0.001; ****, p<0.0001; ns, 
not significant; A-B unpaired t-test; C Wilcoxon test; D and E One-way ANOVA). 
2.3.5. AeCHD7 is required for efficient DENV replication 
The upregulation of AeCHD7 in DENV-infected cells suggested that the gene could be 
beneficial for the virus. To investigate whether AeCHD7 is required for efficient DENV 
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replication, we knocked down AeCHD7 transcripts in Aa20 cells and challenged these cells 
with DENV at 1 MOI for 72 h. The effect of CHD7 knockdown on DENV was evaluated both at 
the genomic and the virion levels using RT-qPCR and plaque assay. RT-qPCR results 
confirmed ~50% decrease in AeCHD7 mRNA level (Figure 5A), which led to 2-fold reduction 
in DENV genomic RNA (Figure 5B). RT-qPCR results were further validated with plaque 
assay, which confirmed reduction in DENV virion production in AeCHD7 knocked down cells 
as compared with dsGFP or mock-transfected Aa20 cells (Figure 5C). These results indicate 
that AeCHD7 is a host factor that is used by DENV to facilitate its replication in Ae. aegypti 
female mosquitoes, and Wolbachia downregulates AeCHD7 as shown above, which may 
contribute to restricting DENV replication. 
 
Fig. 5: Depletion of AeCHD7 impairs DENV replication both at the genomic and the 
virion levels. A) RT-qPCR analysis of Aa20 cells transfected with either no RNA (Mock) or 
with dsRNA against GFP as a control or with dsRNA against AeCHD7 confirming significant 
knockdown of AeCHD7 in dsAeCHD7 transfected cells as compared to controls. RPS17 was 
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used to normalize the qPCR data. Error bars show SEM from three biological replicates with 
two technical replicates (*, p<0.05; **, p<0.01; One-way ANOVA). B) RT-qPCR analysis of 
Aa20 cells treated as in (A) followed by DENV infection at 1 MOI using DENV-specific primers 
to quantify viral genomic RNA showed a significant decrease in the genomic RNA level of 
DENV in dsAeCHD7 treated cells. Error bars show SEM from three biological replicates (**, 
p<0.01; One-way ANOVA). C) Viral plaque visualization by in vitro cell plaque assay 
conducted on the supernatant media from cells treated as in (A and B). 
2.4. Discussion 
There is accumulating experimental evidence showing the effectiveness of Wolbachia in 
suppressing the replication of several flaviviruses, including DENV, ZIKV, WNV, and the 
alphavirus chikungunya virus (CHIKV) in both mosquitoes and mosquitoes-derived cell lines 
8,10,38. Perhaps the most well studied is the case of DENV replication that is severely 
compromised in the presence of Wolbachia 39-41. However, the exact mechanism(s) of how 
Wolbachia imparts this antiviral effect is not yet fully understood. In this study, we provide 
experimental evidence that chromodomain DNA binding helicase 7 (AeCHD7) is an Ae. 
aegypti host factor that is exploited by DENV to facilitate its replication, and its downregulation 
by Wolbachia may contribute to limit DENV replication.  
Wolbachia is an endosymbiontic bacterium infecting 40-60% of insect species naturally 11 by 
manipulating host reproduction 12. Despite fitness costs, Wolbachia may benefit its host by 
blocking a variety of RNA viruses15,42. However, Wolbachia has not been found naturally 
infecting the most notorious vector Ae. aegypti, that is responsible for transmitting multiple 
viral diseases 18. McMeniman et al transinfected different strains of Wolbachia into Ae. aegypti 
mosquitoes 43 and found that they successfully inhibited replication of DENV and CHIKV 38. 
Further studies also demonstrated Wolbachia’s ability to block WNV and ZIKV in the mosquito 
8-10. Wolbachia’s potential to be used as an invaluable tool for disease control and prevention 
represents an increasingly promising approach to limit several mosquito-borne viral diseases, 
and it is fascinating to explore the exact mechanism(s) that induce the antiviral effect. Apart 
from one study shedding light on the effect of Wolbachia infection on the global DNA 
methylation pattern in mosquitoes 44, there lies a huge grey area of the role of chromatin 
remodelers, in Wolbachia-host interactions and possibly the Wolbachia-mediated antiviral 
effect.  
CHD proteins represent a class of proteins that belong to SNF2 superfamily of ATP-
dependent chromatin modifiers. In mammals, there are 1-9 CHD proteins; however, in D. 
melanogaster, there are only three CHD proteins named CHD1, Mi2 and Kismet 25. Members 
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of the CHD family are involved in conducting a wide array of functions, including ATPase 
activity to maintain chromosome structure and regulation of heterochromatic elements 29, 
nucleosome mobilization 45, transcriptional regulation and elongation 46-49, and development 
and differentiation 31. Despite extensive characterization of CHD family proteins, their role in 
shaping host-pathogen interactions has not been much investigated. Yet, there are few 
reports supporting the involvement of CHD1 in the case of influenza A virus, and both CHD1 
and CHD2 in the case of HIV as positive regulators 26,27. Furthermore, RNAi screen carried 
out in D. melanogaster S2 cells identified the involvement of CHD7/Kismet in antimicrobial 
humoral response 50. The aforementioned facts led us to investigate the possible role of the 
CHD family in Wolbachia-Aedes-DENV interactions. Data mining in VectorBase resulted in the 
identification of three potential AeCHD proteins encoded in the Ae. aegypti genome. Protein 
blast results identified them as AeCHD1, AeCHD3/Mi2 and AeCHD7/Kismet. In order to find 
out whether Wolbachia regulates the AeCHD genes during infection, RT-qPCR was 
performed to examine the transcript levels of all the three AeCHDs with and without 
Wolbachia infection in whole mosquitoes. Our results showed that there was a uniform trend 
of downregulation of the transcript levels of the AeCHD genes in Wolbachia-infected 
mosquitoes (Figure 1A-F), except those of AeCHD3 in 4-day-old Wolbachia-infected female 
mosquitoes, which showed a non-significant upregulation (Figure 1C). The reduction in the 
CHD genes was more pronounced in 12-day-old mosquitoes, which could be due to increases 
in the Wolbachia load as the mosquitoes ages. In particular, the wMelPop strain is a virulent 
strain that may cause tissue damage and sickness. The reductions in the AeCHD genes at 
this late stage may not be of benefit in affecting DENV replication. However, AeCHD7 showed 
the highest fold change reduction (Figure 1E-F) in both 4- and 12-day-old Wolbachia-infected 
mosquitoes, which prompted us to further investigate this gene in the context of Wolbachia-
Aedes-DENV interactions.  
AeCHD7/Kismet belongs to subfamily III of the CHD proteins that comprises CHD5-9 proteins. 
This subfamily is defined by the presence of two chromodomains at the N-terminus, one 
SNF2-like ATPase domain located in the central region of the protein structure (9,10) and a 
Brahma and Kismet (BRK) domain at the C-terminus 25.  To find out whether the Ae. aegypti 
homolog fulfils this particular protein signature, NCBI conserved domain finder was used to 
detect the conserved domains 51. Results confirmed the presence of all the domains 
characteristic of CHD7/Kismet proteins (Figure S1). Furthermore, in order to check the 
conservation of CHD7 across species, CHD7/Kismet amino acids were retrieved from Uniprot 
(Figure S2A) and subjected to maximum likelihood phylogenetic tree construction. 
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Phylogenetic results showed that Ae. aegypti CHD7 is closely related to that of Cx. 
quinquefasciatus but not to that of D. melanogaster or Homo sapiens (Figure S2B). To find out 
the tissue-specific expression of AeCHD7, RT-qPCR was performed, which revealed that it is 
ubiquitously expressed across all main mosquito tissues (Figure 2), which is consistent with 
the findings in humans 37. 
In this study we found that AeCHD7 was significantly downregulated in Wolbachia-infected 
mosquitoes. To further investigate whether this Wolbachia-mediated downregulation of 
AeCHD7 in female Ae. aegypti is gender specific and can also be seen in its natural host D. 
melanogaster, RT-qPCR was employed. Interestingly, we found that in the presence of 
Wolbachia AeCHD7 was specifically downregulated in female Ae. aegypti only (Figure 3), and 
there was no change in CHD7/Kismet transcript levels in both female and male D. 
melanogaster with and without Wolbachia (Figure 3C). This difference in Wolbachia-mediated 
regulation of CHD7/Kismet in Ae. aegypti and D. melanogaster may be due to the fact that 
Wolbachia is a natural symbiont in D. melanogaster with a long association, while it has been 
recently transinfected into Ae. aegypti 52. In regards to the mechanism by which Wolbachia 
infection may affect expression of AeCHD7, one can only speculate at this stage as there is 
very little information in regards to how Wolbachia manipulates its host at the molecular level. 
Only very recently, some molecular data have become available showing that Wolbachia 
infection leads to changes in the transcriptome or small RNA profiles of infected mosquitoes 
23,53. Regulation of host gene expression could be due to components secreted from the 
endosymbiont, including small non-coding RNAs 54, or host response to accommodating the 
endosymbiont, in particular in new associations. However, how Wolbachia infection leads to 
these changes in the host remains to be investigated. 
Viruses are the master manipulators of their host environment for their own benefit. Recently, 
it has been reported that CHD1 and CHD2 proteins play a pivotal role in the replication of 
influenza and HIV viruses 26,27. Both viruses replicate inside the nucleus. Interestingly, it has 
further been demonstrated that CHD1 interacts with RNA polymerase II to facilitate the 
replication of influenza A virus 27. Little is known about the role of CHD7/Kismet in the context 
of virus infection. However, the presence of conserved chromodomains and a SNF2 domain 
makes it highly likely that all the CHDs share similar functions 25. We were intrigued to find 
what happens to AeCHD7 during DENV infection. RT-qPCR performed in DENV-infected 
mosquitoes at different time points suggested a continuous trend of upregulation during DENV 
infection (Figure 4A-C), which points to the fact that it might play an important role in DENV 
replication. To investigate the role of AeCHD7 in DENV replication further, AeCHD7 
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knockdown study was carried out, which revealed that AeCHD7 is vital for DENV replication 
and virion production (Figure 5A-C). Very few studies that have been carried out on the 
involvement of CHDs in virus replication have predominantly focused on viruses that replicate 
inside the nucleus. Therefore, the role of CHDs in the replication of viruses that multiply in the 
cytoplasm (such as DENV) is not known. However, it has been demonstrated that DENV 
capsid 55,56 and NS5 proteins go inside the nucleus 57,58 with NS5 known to be involved in 
disrupting nucleosome formation 59. Therefore, these viral proteins may play a role in 
modulating AeCHD7 expression during virus infection. While we have found the involvement 
of AeCHD7 in mosquito-DENV interaction, the exact mechanism(s) that govern the interaction 
need further investigation.  
In summary, we have demonstrated that AeCHD7 facilitates DENV replication, and 
Wolbachia-mediated downregulation of AeCHD7 in female Ae. aegypti may contribute to 
restriction of DENV replication. However, this mechanism is highly specific to female Ae. 
aegypti mosquitoes and does not appear to be a universal mechanism which Wolbachia 
employs across different hosts to block viral replication.  
2.5. Materials and Methods 
2.5.1. Mosquitoes and flies 
For Wolbachia studies, mosquitoes had been previously generated by McMeniman et al. 
(2009) by transinfecting wMelPop-CLA strain of Wolbachia (Pop) into Ae. aegypti embryos, 
and uninfected mosquitoes were obtained through tetracycline (Tet) treatment of the infected 
mosquitoes 43. w1118 fly line stably infected with wMelPop-CLA and the tetracycline cured line 
were generated by Min et al. (1997) 60 and kindly provided by Dr Karyn Johnson from the 
University of Queensland.  
For DENV infection studies, Ae. aegypti eggs were collected in Townsville in August 2015 and 
reared in insectary at Public Health Virology FSS.  Five-day-old Ae. aegypti (F3) were used for 
the experiments. DENV2 NGC strain obtained from Prof. Roy Hall’s Lab (University of 
Queensland, School of Chemistry & Molecular Biosciences, Brisbane, Australia), was diluted 
in Opti-MEM (GIBCO Life Technologies, Grans Island, NY) supplemented with 3% foetal 
bovine serum (FBS, In Vitro Technologies, Australian origin) and intrathoracically injected 
(200l) in 5-day-old mosquitoes at 105.8/mL (102.1 per dose).  Mosquitoes were placed into 
netted 900 mL containers at 28°C with light:dark (L:D) 12:12 hours cycle and at high humidity. 
Mosquitoes were offered 15% honey water ad libitum. Mosquitoes were collected at 2, 6 and 
12 dpi for downstream applications.  
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2.5.2. Cell cultures 
Ae. aegypti Aag2 cell line and Aag2 cells infected with wMelPop-CLA, previously described by 
61, were maintained in 1:1 Mitsuhashi-Maramorosch and Schneider’s insect medium 
(Invitrogen) supplemented with 5-10% FBS, while Aa20 cells were maintained in L15 medium 
(Invitrogen) supplemented with 10% tryptose phosphate broth (TPB) and 5% FBS (Bovogen 
Biologicals, French origin). All mosquito cell lines were kept at 28C and passaged every 3-4 
days. 
Vero cells were maintained in OptiMEM medium supplemented with 2% FBS and were kept at 
37C in the presence of 5% CO2. 
2.5.3. RT-PCR and qPCR analyses 
Total RNA was extracted from mosquitoes (5 mosquitoes per biological replicate) or flies (5 
flies per biological replicate) using Qiazol (Qiagen) and then treated with Turbo DNase 
(Ambion) according to the manufacturers’ instructions. 750-1000 ng of total RNA was then 
used to make the 1st strand cDNA using Superscript III (Invitrogen) with either oligo-dT primer 
for cellular transcripts or with DENV-qR primer in order to amplify the DENV genomic RNA.  
For qPCR, cDNA produced as above was diluted in 1:5 ratios with nuclease free water. 2l of 
the diluted cDNA was used for downstream qPCR reaction. Both forward and reverse gene-
specific primers were used to amplify the target genes (primer sequences in Table S1), using 
QuantiFast SYBR Green (Qiagen) in a Rotorgene qPCR machine (Qiagen). For Ae. aegypti 
samples, RPS17 transcript levels were used for the normalization of RNA templates, while 
RPL32 was used for normalization of D. melanogaster samples. Each qPCR reaction was 
performed in duplicates with at least three biological replicates. All qPCR data were 
normalized with Qiagen analysis templates. The average of normalized values of each group 
with at least three biological replicates was subjected to normal distribution test by using 
Shapiro-Wilk normality test in Prism 7.0. The data set passing the normality test was further 
analysed by Prism 7.0 using parametric tests. Unpaired t-test was used to determine 
statistical significance between two individual groups while One-way ANOVA with Tukey’s 
post-hoc test was performed to find statistical significance between more than two groups of 
data. The data sets which failed the normal distribution test were analysed by the non-
parametric Wilcoxon test using JMP software to determine the significance level between 
groups.  
2.5.4. RNAi-mediated gene silencing 
In order to knockdown the AeCHD7 gene for functional analysis in DENV life cycle, primers 
were designed to amplify a 586 bp product from the AeCHD7 gene with the addition of the T7 
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promoter sequences at both ends (Table S1). MEGAscript T7 Transcription kit was then used 
according to the manufacturer’s instructions in order to synthesize dsRNA targeting the 
AeCHD7 transcripts. A similar approach was followed to synthesize dsRNA against GFP 
RNA. For knockdown experiments, Aa20 cells were double transfected with 2-5g of dsRNA 
per well against the target gene. dsGFP RNA was used as non-specific control. 
2.5.5. Virus infection and plaque assay  
For virus inoculation experiments, Ae. aegypti Aa20 were seeded at the density of 3x105 cells 
per well in 12-well plates. Cells were first double transfected with dsRNA against the target 
gene or GFP control and after 6 h cells were infected with DENV2 (New Guinea strain) at a 
multiplicity of infection (MOI) of 1. Media were collected 72 h post-infection for plaque assay. 
To perform plaque assay, Vero cells were seeded in a 96-well plate and were allowed to form 
monolayers. Virus containing media from the experiments were serially diluted into 100 ,101 
,102 ,103 dilutions and added to Vero cells in duplicates. Cells were incubated with virus at 
room temperature with continuous shaking on shaker for 1 h and then incubated at 37ºC for 
one additional hour. After 2 h of incubation, media were aspirated and an overlay was added 
to the cells which comprised of 1.5% carboxymethyl cellulose (CMC) and 2.5% FBS in Opti-
MEM medium (Sigma). Cells were then incubated for 72 h at 37oC and 5% CO2 and fixed with 
80% ice-cold acetone in 1PBS for 20 min at -20ºC. Plates were then air dried overnight and 
blocked with 5% skimmed milk in 1PBST at 37oC for 30 min. Cells were then incubated with 
the primary antibody against DENV2-Envelope (human) in 1:1000 dilution in 0.1% skimmed 
milk in 1PBST for 2 h at 37oC as described previously 62. Plates were washed 3 times with 
1PBST and incubated with the secondary antibody (IRDye 800CW goat anti-human LICOR) 
for 1 h at 37oC. Plates were washed and dried as above and were dried and scanned on the 
Odyssey imager (LI-COR Biosciences) at 41M resolution. 
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 2.11. Supplementary Material 
 
Fig. S1 Diagramed illustration of AeCHD7 conserved domains: Conserved domains were 
found in AeCHD7 by putting AAEL002230-PA amino acid sequences as query in NCBI 
conserved domain finder, and the domains characteristic of CHD7 proteins are shown. Red 
color shows chromodomain, green color shows SNF2 domain and yellow color shows BRK 
domain.  
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Fig. S2: A) Table of protein sequences used in this study. B) Maximum likelihood 
phylogenetic tree computed for the protein sequences in (A) showing that AeCHD7 protein in 
Ae. aegypti is more closely related to C. quinquefaciatus than its homolog in D. melanogaster.  
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Table S1. Primers used in this study. 
Gene Name Primer Sequence (5’-3’) 
Ae-CHD1-qF GATCGGGGAGACCGATCCTA 
Ae- CHD1-qR GGCGGATAGTAACCACTCGG 
Ae- CHD3-qF GGTGAAACTGTTGCGACACC 
Ae- CHD3-qR CTTGGACCACTCCACCATCC 
Ae- CHD7-qF TGAGTACTCCGCCTCCTTCA 
Ae- CHD7-qR CCGACTCGTCATCCGAGAAG 
Ae-RPS17-qF CACTCCGAGGTCCGTGGTAT 
Ae-RPS17-qR GGACACTTCGGGCACGTAGT 
Dm-Kismet-qF GCTAGAATTTTGCGTTAAACGATCA 
Dm-Kismet-qR AGGAGTAGTGCACATTTCGGT 
Dm-RPL32-qF GACGCTTCAAGGGACAGTATCTG 
Dm-RPL32-qR AAACGCGGTTCTGCATGAG 
Ae-CHD7-RNAi-F TAATACGACTCACTATAGGGGAATCCGCCGTAAGCGAAAC 
Ae-CHD7-RNAi-R TAATACGACTCACTATAGGGTCGTTGCTGGTGTACTGGTC 
DENV-qF GGTATGGTGGGCGCTACTA  
DENV-qR CAAGGCTAACGCATCAGTCA 
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3.1. Abstract 
Dengue infection along with its related disease conditions poses a significant threat to human 
health. The pathogen responsible for this infection is dengue virus (DENV) which is primarily 
transmitted to humans through the bites of Aedes aegypti mosquitoes. Unavailability of a 
potent vaccine has recently sparked renewed research endeavours aimed at vector control. 
To date, Wolbachia as an endosymbiotic bacterium has shown promise as a novel biocontrol 
agent to restrict DENV replication in the vector, although the underlying antiviral mechanism 
remains elusive. Recent studies have demonstrated the potential role of Vago as a novel 
secretory protein involved in cross-talk between the innate immune pathways in Culex 
quinquefasciatus mosquitoes to restrict West Nile virus replication.  In this study, we have 
identified two homologs of the Vago protein in Ae. aegypti and looked into their modulation in 
the case of Wolbachia wMelPop strain infection. Furthermore, we have investigated the role of 
AeVago1, that is highly induced by Wolbachia, in the context of Wolbachia-mosquito-DENV 
interactions. Knockdown studies of the AeVago1 gene in Wolbachia-infected cells led to 
significant increases in DENV replication, with no effect on Wolbachia density. Our results 
suggest that the Wolbachia-induced AeVago1 in Ae. aegypti may function as a host factor to 
suppress DENV replication in the mosquito. 
Keywords: AeVago1; Aedes aegypti; Wolbachia; Dengue virus
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3.2. Introduction 
Dengue is one of the most important arboviral diseases which affect 390 million people 
throughout the world (Bhatt et al., 2013; Tatem et al., 2006). It is caused by a flavivirus, 
dengue virus (DENV), which uses Aedes aegypti as its primary and Aedes albopictus as its 
secondary vector (Gubler, 2006; Ponlawat and Harrington, 2005). Limitations such as 
unavailability of a proper cure and publically available vaccines have compounded the disease 
impact, and the disease control measures almost exclusively revolve around vector control. 
There are a number of pesticides that are being used to limit Ae. aegypti populations, 
however, recent emergence of resistance in the mosquito to a number of pesticides has urged 
the need to find alternative vector control strategies (Marcombe et al., 2012). One of the 
unique options is using Wolbachia as a novel biological control agent in mosquitoes to limit 
their ability to transmit a number of flaviviruses including DENV and Zika virus (ZIKV) (Dutra et 
al., 2016; Iturbe-Ormaetxe et al., 2011). However, very little is known about the molecular 
mechanism(s) that govern this antiviral effect.  
Wolbachia pipientis is an endosymbiotic bacterium that naturally infects 40-60% of insect 
species (Zug and Hammerstein, 2012). It is maternally inherited and is known to manipulate 
the host reproduction strategies to promote stable infection in its host (Caragata et al., 2016; 
Hoffmann et al., 1998). Despite infecting their hosts, a number of Wolbachia strains give their 
host protection against several viruses including DENV, Chikungunya virus, West Nile virus 
(WNV) and ZIKV (Dutra et al., 2016; Hussain et al., 2013; Moreira et al., 2009) in mosquitoes 
and Drosophila C virus (DCV) and flock house virus in Drosophila (Martinez et al., 2014). This 
protection is largely correlated with the density of different Wolbachia strains in host tissues 
(Martinez et al., 2014). Interestingly, there is no natural association of Wolbachia with Ae. 
aegypti mosquitoes. To exploit the potential of Wolbachia as a biological control agent against 
DENV transmission, recently two Wolbachia strains wMel and wMelPop have been isolated 
from Drosophila melanogaster and transinfected into Ae. aegypti mosquitoes (McMeniman et 
al., 2009; Walker et al., 2011). Both strains successfully inhibited the ability of Ae. aegypti 
mosquitoes to transmit DENV with the latter, being a more virulent strain, showing higher 
efficacy in limiting DENV replication (McMeniman et al., 2009; Walker et al., 2011). Despite 
the potential of Wolbachia as a novel biocontrol agent to target vector competence, little is 
known about the mechanism(s) that Wolbachia use to limit DENV replication. There are two 
potential theories in this regard: either competition for host resources between Wolbachia and 
viruses or activation of immune genes by Wolbachia to overcome viral replication (Caragata et 
al., 2016). The former theory is supported by a number of studies that have shown Wolbachia 
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modulates the host cholesterol levels in D. melanogaster which leads to protection against 
DCV. A recent study carried out in an Ae. albopictus cell line has reported depletion of 
sphingolipids in response to Wolbachia infection and suggested their potential role in limiting 
mosquito-borne viruses. Furthermore, studies have demonstrated that Wolbachia-mediated 
modulation of AeCHD7 (Asad et al., 2016), reactive oxygen species (ROS) (Pan et al., 2012) 
and immune genes (Rances et al., 2012) may play important roles in limiting DENV replication 
in transinfected host Ae. aegypti suggesting that Wolbachia elicits host response making the 
environment unfit for viral replication. Although it has been reported that immune activation 
does not play any part in Wolbachia-mediated antiviral response in its natural host D. 
melanogaster, it might play a part in transinfected hosts, such as Ae. aegypti (Rances et al., 
2012).  
In the absence of adaptive immunity in insects, they solely rely on their innate immune 
response, comprising of RNA interference (RNAi) and activation of antiviral proteins, to 
counter viruses (Buchon et al., 2014). Studies have shown that there is no role of RNAi in 
Wolbachia-mediated antiviral effect (Hedges et al., 2012; Zhang et al., 2016), which narrows 
down the search towards Wolbachia-mediated modulation of antiviral proteins in order to 
protect its host against several viruses. The protein-based innate immunity response is 
broadly centred on three important pathways that are Toll, immune deficiency (IMD) and 
Janus kinase/signal transducer and activator of transcription pathway (JAK/STAT) (Dostert et 
al., 2005; Tanji and Ip, 2005; Valanne et al., 2011). The JAK/STAT pathway is known to play a 
critical role in overcoming several viruses in insects (Dostert et al., 2005; Souza-Neto et al., 
2009). Recent studies carried out on Culex quinquefasciatus have found a new antiviral 
mechanism which involves Dicer2-Rel2-TRAF mediated activation of a secretory protein Vago 
that is able to limit WNV by activating the JAK/STAT pathway (Paradkar et al., 2014; Paradkar 
et al., 2012). In addition, Vago was shown to be antiviral against Drosophila C virus in D. 
melanogaster (Deddouche et al., 2008). However, the role of Vago is not very well understood 
in Ae. aegypti-DENV-Wolbachia interactions.  
In this study, we have investigated the role of Ae. aegypti Vago homolog proteins in the case 
of Wolbachia and DENV infections. We have found that AeVago1 is significantly upregulated 
in the presence of Wolbachia in young Ae. aegypti mosquitoes and Aag2 cell line, which might 
contribute to DENV inhibition. In addition, we studied the effect of DENV infection on AeVago1 
expression and found that the gene is not modulated. Furthermore, knockdown studies of 
AeVago1 in Wolbachia-infected cells showed significant increases in DENV modulating 
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replication, confirming its antiviral property, which could be utilized by Wolbachia as one of the 
mechanism(s) to overcome viral replication in Ae. aegypti mosquitoes. 
3.3. Material and Methods 
3.3.1. Cell lines, mosquitoes and flies used in study 
Ae. aegypti cell line Aag2 infected with wMelPop-CLA strain of Wolbachia (Pop) previously 
generated as described (Frentiu et al., 2014), and Ae. albopictus cell lines infected with wAlbB 
strain of Wolbachia (Aa23) (O'Neill et al., 1997), or treated with tetracycline (Aa23-Tet) (to 
ensure the removal of Wolbachia from cell lines) were maintained in 1:1 mixture of 
Mitsuhashi-Maramorosch and Schneider’s insect medium (Invitrogen) supplemented with 10% 
FBS (Bovogen Biologicals). For D. melanogaster cell line S2, Schneider’s insect medium 
supplemented with 10% FBS was used. All the aforementioned insect cell lines were 
maintained at 28oC.   
Ae. aegypti mosquitoes infected with wMelPop-CLA strain of Wolbachia (Pop) and Wolbachia 
free mosquitoes (Tet) used in this study were generated previously (McMeniman et al., 2009). 
Recolonization of gut microflora was also ensured by growing larvae of Tet mosquitoes on 
water used to rear natural mosquito larvae  (McMeniman et al., 2009). w1118 fly line stably 
infected with wMelPop along with tetracycline treated Wolbachia free (Tet) flies were 
generated earlier (Min and Benzer, 1997).  
For DENV infection studies, 5-day-old Ae. aegypti mosquitoes were intrathoracically injected 
with DENV2 NGC strain as described earlier (Asad et al., 2016). Injection was used for DENV 
infection to ensure a more uniform and high infection rate. Mosquitoes were placed in 900mL 
containers at 28oC with 12:12 hours dark and light cycle at high humidity. Mosquitoes were 
fed on 15% honey water ad libitum. Mosquitoes were collected at 2, 6, and 12 days post-
infection for downstream applications.  
3.3.2. qPCR studies 
Total RNA was isolated from whole mosquitoes (5 per biological replicate), flies (5 per 
biological replicate), tissues (10 mosquitoes per biological replicate) and cell lines using 
QIAzol (Qiagen) as per the manufacturer’s instructions. The extracted RNA was subjected to 
Turbo DNase (Ambion) treatment according to the manufacturer’s instructions. 1000 ng of 
total RNA was further used to synthesize complimentary DNA using Superscript III (Invitrogen) 
with oligo(dT) for host genes or DENV-qR (specifically targeting the NS2A gene of DENV-2) 
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for DENV according to the manufacturer’s instructions. In order to perform qPCR analysis, the 
cDNA was diluted 1:5 with RNase free water, then gene-specific primers (Table S1) along with 
QuantiFast SYBER Green (Qiagen) were used to quantify the relative expression of genes 
using a Rotorgene qPCR machine (Qiagen). The qPCR cycling conditions were 95°C for 5 
min for initial denaturation and hot start Taq activation, followed by 40 cycles of 95°C for 
10 sec, 60°C for 15 sec and 72°C for 20 sec. Additionally, melt curve analysis was carried out 
on default settings of the Rotorgene machine (Qiagen) to check the specificity of the qPCR 
products. For mosquito samples, ribosomal protein S17 (RPS17; AY927787.2) was used as 
the housekeeping gene to normalize the relative expression of target genes, while ribosomal 
protein L32 (RPL32; NM_079843) was used as the housekeeping gene for D. melanogaster 
samples. Each qPCR reaction was performed in duplicates with at least three biological 
replicates.  
For Wolbachia density determination, DNA extraction was performed using DNeasy Blood & 
Tissue Kit (Qiagen) as per the manufacturer’s instructions. 100ng DNA was used in each 
qPCR reaction, using primers specific to the Wolbachia surface protein (WSP; AF338346.1) 
gene along with QuantiFast SYBER Green (Qiagen) in Rotorgene qPCR machine. RPS17 
gene from Ae. aegypti was used to normalize the qPCR data. Each reaction was performed in 
triplicates with at least three biological replicates. 
For qPCR analysis, all the CT values were normalized with Qiagen analysis templates and 
further processed with Prism 7.0. All the data sets were subjected to Shapiro-Wilk normality 
test in Prism 7.0 to confirm the normal distribution of the data. For data sets that passed the 
normality test, un-paired t-test was performed to determine statistical significance between 
two individual groups. One-way ANOVA with Tukey’s post-hoc test was used to find out 
statistical significance between more than two groups. In order to evaluate the statistical 
significance, two different time points in grouped data Two-way ANOVA along with Sidak 
multiple comparison test were used. For data sets that failed the normal distribution test, 
Wilcoxon non-parametric test was employed using JMP software to determine the statistical 
significance between the individual groups. 
3.3.3. Gene silencing using RNAi 
AeVago1 (AAEL000200) was knocked down using dsRNA to find out its functional role in 
terms of Wolbachia-Aedes-DENV interactions. Briefly, primers were designed to amplify a 198 
bp product from the AeVago1 gene with the addition of T7 promoter sites at both ends. The 
PCR template was used to make dsRNA using the MEGAscript T7 Transcription kit (Ambion) 
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according to the manufacturer’s instructions. GFP-specific dsRNA was also synthesized and 
used as a non-specific control. For knockdown experiments, Pop cells were double 
transfected with 5 and 2g of dsRNA, respectively, per well against the target gene and GFP 
as control.    
3.4. Results  
3.4.1. Identification of secretory AeVago proteins 
Using BLASTp and the Vago protein from Cu. quinquefasciatus (XP_001842264.1) as 
template, we identified two homologs of the protein in the Ae. aegypti proteome. As an earlier 
report demonstrated the importance of secretion of the Vago protein in its antiviral activity 
(Paradkar et al., 2012), we subjected the potential Vago hits to SingalP (Petersen et al., 2011) 
to check whether they have a distinct secretory signal or not (Petersen et al., 2011). As a 
result, two potential Vago homologs in Ae. aegypti, which are 100-120 amino acids long with a 
distinct secretory signal as well as a von Willebrand factor type C (SVWC) domain, were 
identified (Figure S1 and S2). These were named AeVago1 (AAEL000200) and AeVago2 
(AAEL000165) with 53% and 41% amino acid sequence identity to CuVago, respectively. 
3.4.2. AeVago1 is upregulated in Wolbachia infection 
To examine whether Wolbachia affects the expression of the AeVago genes, which could 
contribute in antiviral defence, we compared the transcript levels of the genes in Wolbachia-
infected (Pop) and uninfected Aag2 cell lines. RT-qPCR results showed that there was more 
than 10-fold statistically significant increase in AeVago1 in cells that were infected with 
Wolbachia (Figure 1A), while AeVago2 was almost 3.8-fold significantly downregulated in 
Wolbachia-infected cells (Figure 1B).  
As Wolbachia is well known to block virus replication with the mechanism(s) not well 
understood, and Vago is known to be antiviral, we followed up on AeVago1. For this, we first 
looked into the relative abundance of AeVago1 transcript levels in 4 and 12-day-old female 
Wolbachia-infected (Pop) and tetracycline cured (Tet) Ae. aegypti mosquitoes. Our results 
showed that AeVago1 was 4.1-fold significantly increased in the 4-day-old Wolbachia-infected 
mosquitoes, however, there was no significant change in the levels of AeVago1 transcripts in 
the older mosquitoes (Figure 1C). 
To investigate whether Wolbachia-mediated AeVago1 induction is a conserved phenomenon 
in its natural host D. melanogaster, 7-day-old D. melanogaster flies infected with Wolbachia 
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(wMelPop) were used to check the levels of Vago in female flies. Results led us to the 
conclusion that Vago is not upregulated in wMelPop-infected D. melanogaster (Figure S3A). 
To test the hypothesis that Wolbachia-mediated upregulation of AeVago1 could most probably 
be due to transinfection of Wolbachia to a new host, that is Ae. aegypti, we checked the levels 
of the Vago homolog in Ae. albopictus (KT799989.1) Aa23 cells naturally infected with the 
wAlbB strain of Wolbachia (Kitrayapong et al., 2002; O'Neill et al., 1997). The results revealed 
no significant modulation of the Vago transcript levels in Ae. albopictus cells infected with 
Wolbachia (Figure S3B). 
 
 
Figure 1. Differential expression of AeVago genes in Wolbachia-infected cell lines and 
mosquitoes. RT-qPCR based analysis of (A) AeVago1 and (B) AeVago2 transcripts in 
uninfected (Aag2) and wMelPop-infected (Pop) Ae. aegypti Aag2 cells, showing that AeVago1 
is significantly upregulated while AeVago2 is significantly downregulated during Wolbachia 
infection. C) By RT-qPCR quantification of the AeVago1 gene in wMelPop-infected (Pop) and 
uninfected (Tet), 4- and 12-day-old female Ae. aegypti mosquitoes we found that AeVago1 
was upregulated only in the young mosquitoes i.e. in 4-day-olds but not in the older ones i.e. 
12-day-old Wolbachia-infected mosquitoes. RPS17 was used to normalize the qPCR data. 
Error bars represent standard error of mean (SEM) from three biological replicates with two 
technical replicates (*, p<0.05; ***, p<0.001; A, unpaired t-test; B, Wilcoxon test; C, One-way 
ANOVA). 
 
3.4.3. AeVago1 is not induced after DENV infection 
Vago is an antiviral gene that has been demonstrated to inhibit WNV and DCV in Cu. 
quinquefasciatus and D. melanogaster, respectively (Deddouche et al., 2008; Paradkar et al., 
2012). To determine the effect of DENV infection on the relative abundance of AeVago1 in Ae. 
aegypti, the transcript levels were measured in DENV-injected Ae. aegypti mosquitoes at 
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three different time points 2, 6 and 12 days post-infection. Results showed that there was no 
induction of AeVago1 during DENV challenge (Figure 2A). To test our experimental 
procedure, we investigated the levels of D. melanogaster Vago in the case of both DENV and 
DCV infection (used as positive control) in S2 cells. Our results validated the previous findings 
that Vago is induced upon DCV infection (Figure 2B) (Deddouche et al., 2008), but not in 
DENV infection (Figure 2C). Altogether these results confirmed that there is no significant 
change in the levels of Vago upon DENV infection.  
To further look into the lack of induction of AeVago1 by DENV, we examined the expression 
pattern of the known activators of Vago reported in the earlier studies, that are Dicer2 
(Deddouche et al., 2008), Rel2 and TRAF (Paradkar et al., 2014). We found that there was no 
significant modulation of Dicer2 and Rel2 across all infection time points (Figure 3A and B), 
however, we observed a significant upregulation of TRAF in DENV-infected mosquitoes 
during early infection that is 2 days post-infection (Figure 3C). Although there was a significant 
upregulation of TRAF at 2 days post-infection, we earlier observed no significant induction of 
AeVago1 at all stages of DENV infection (Figure 2A), which suggests that TRAF might not be 
directly involved in the activation of AeVago1. 
 
 
 
Figure 2. Effect of DENV infection on AeVago1 expression in Ae. aegypti mosquitoes 
and D. melanogaster S2 cell line. A) AeVago1 expression in DENV challenged mosquitoes 
at 2, 6 and 12 days post-infection as compared to uninfected controls was analysed through 
RT-qPCR to find that there was no significant induction of AeVago1 transcription during DENV 
infection. B) Relative expression of Vago in S2 cells infected with DCV, and (C) DENV. 
RPS17 was used to normalize qPCR data for Ae. aegypti, while Rpl32 was used for qPCR 
data normalization of D. melanogaster. Each error bar represents SEM of the mean of three 
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biological replicates with two technical replicates (****, p<0.0001; A, Two-way ANOVA; B and 
C, unpaired t-test).    
Figure 3. Effect of DENV infection on AeVago1 activators (Dicer2, Rel2 and TRAF) in 
DENV-infected mosquitoes. Relative expression of (A) Dicer2, (B) Rel2 and (C) TRAF in 
DENV-infected mosquitoes as compared to controls at 2, 6 and 12 days post-infection. RPS17 
was used to normalize qPCR data.  Error bars represent SEM of mean of three biological 
replicates with two technical replicates (**, p<0.01; Two-way ANOVA). 
 
3.4.4. Wolbachia-mediated activation of AeVago1 limits DENV replication 
To further investigate whether AeVago1 is antiviral and consequently overexpression of 
AeVago1 in Wolbachia-infected mosquitoes could contribute in limiting DENV replication, we 
knocked down AeVago1 in Pop cells by using dsRNA against the gene, followed by DENV2 
(NGC) infection at 1 multiplicity of infection (MOI). Knock down efficiency was confirmed by 
RT-qPCR, which showed ~86% knock down efficiency in the cells transfected with dsRNA 
specific to AeVago1 as compared to the controls (Figure 4A). The effect on DENV replication 
was quantified using DENV-specific primers in RT-qPCR. We found a significant increase in 
the genomic RNA levels of DENV in the cells which were depleted of AeVago1 (Figure 4B). In 
order to confirm that dsAeVago1 treatment of Pop cells has no effect on Wolbachia density 
itself that could influence antiviral effects of Wolbachia, the relative Wolbachia density was 
determined in dsAeVago1 silenced cells as compared to controls. By employing DNA based 
qPCR, we found there was no significant effect on Wolbachia density in AeVago1 depleted 
cells (Figure 4C). The results suggest that AeVago1 is an antiviral gene and its upregulation in 
the presence of Wolbachia may contribute in limiting DENV replication in Ae. aegypti. 
 
 
 
 
A B C 
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Figure 4. Silencing of AeVago1 affects DENV replication in Wolbachia-infected Ae. 
aegypti cells. A) Confirmation of AeVago1 knockdown in Pop cells through RT-qPCR. Pop 
cells were transfected with mock, dsGFP or dsAeVago1 as described in the methods followed 
by DENV infection for 3 days. B) RT-qPCR based relative quantification of the genomic RNA 
levels of DENV in Pop cells infected at 1 MOI of DENV and transfected either with no dsRNA, 
or with dsRNA against GFP (control) or AeVago1. RPS17 was used to normalize qPCR data. 
Each error bar represents SEM of the mean of three biological replicates with two technical 
replicates (*, p<0.05; ***, p<0.001; One-way ANOVA). C) Relative abundance of Wolbachia in 
AeVago1 silenced Pop cells as compared to GFP and mock transfected controls using wsp-
specific primers normalized with the RPS17 gene. Each error bar represents SEM of the 
mean of three biological replicates with two technical replicates (ns show not significant; One-
way ANOVA). 
3.5. Discussion 
Recent increases in dengue outbreaks in geographically unreported locations throughout the 
world has led to more attention towards the severity of the disease, the virus responsible for it, 
and its vector control (Organization, 2009). Recent investigations have led to the identification 
of a novel biological control agent Wolbachia, which can successfully inhibit the replication of 
several RNA viruses including DENV in the mosquito vector (Moreira et al., 2009). However, 
the exact mechanism that leads to this antiviral effect remains largely unknown. In this study, 
we have found that the AeVago1 gene is upregulated during Wolbachia infection, and it may 
contribute in limiting DENV replication in Ae. aegypti mosquitoes. 
About 40-60% of insect species are naturally infected with different strains of Wolbachia 
(Hilgenboecker et al., 2008). Wolbachia usually has a symbiotic relationship with its host and it 
manipulates host reproduction to successfully establish a permanent association, with certain 
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fitness costs to the host (Werren et al., 2008). So far, no natural association between any 
Wolbachia strains with Ae. aegypti mosquitoes has been found. In order to use Wolbachia to 
overcome arboviruses, especially DENV, wMel and wMelPop strains were isolated from D. 
melanogaster and transinfected them into Ae. aegypti, finding significant reduction in DENV 
replication (Walker et al ., 2011; McMeniman et al., 2009). Further studies have found that 
these strains can successfully inhibit other important RNA viruses such as WNV, Chikungunya 
virus and ZIKV (Dutra et al., 2016; Hussain et al., 2013; van den Hurk et al., 2012). However, 
still little is known about the mechanism(s) that Wolbachia use to overcome DENV replication. 
Few studies that have tried to find possible mechanism(s) for the virus blocking have 
demonstrated differential expression of miRNAs (Hussain et al., 2011) and immune genes 
(Rances et al., 2012), and involvement of ROS (Pan et al., 2012) in Ae. aegypti, which might 
contribute towards limiting DENV replication.  
Vago is an insect-specific antiviral protein (Deddouche et al., 2008; Paradkar et al., 2012), 
having a distinct single von Willebrand factor type C (SVWC) domain that is usually comprised 
of 8-10 cysteines residues (Chen et al., 2011). Vago has been found to suppress Drosophila 
C virus (DCV) in the fat body of D. melanogaster (Deddouche et al., 2008). In Cx. 
quinquefasciatus, it has been demonstrated that CuVago is a secretory protein, which 
performs a similar function as the mammalian interferon to block WNV replication by activating 
the JAK/STAT pathway (Paradkar et al., 2012). However, the role of Vago protein is not well 
studied in Ae. aegypti mosquitoes. In this study, we looked into the potential homologs of 
Vago in Ae. aegypti. Our analysis identified two potential Vago protein homologs in Ae. 
aegypti, named AeVago1 and AeVago2 with a distinct SVWC domain along with a secretory 
signal. We further looked into the regulation of AeVago genes in the case of Wolbachia 
infection. Our results revealed a significant upregulation of the AeVago1 gene in Wolbachia-
infected Aag2 cells, while AeVago2 was significantly downregulated in the presence of 
Wolbachia. In a previous study in Cx. quinquefasciatus, involvement of the immune genes 
Rel2 and TRAF in the activation of CuVago was shown (Paradkar et al., 2014). Examining the 
published transcriptome data from Ae. aegypti mosquitoes infected with wMelPop-CLA 
revealed that both genes are induced in the mosquitoes by 3.44 and 2.84 folds, respectively 
(Rances et al., 2012). This suggests that AeVago1 is most likely induced through the 
activation of the immune system by Wolbachia wMelPop. Interestingly, AeVago1 was found to 
be only induced in Wolbachia-infected young mosquitoes (4-day-old), however at the older 
age (12-day-old), there was no significant change in the expression of AeVago1 gene. One 
possible explanation for this difference in the expression pattern could be that wMelPop-CLA 
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strain of Wolbachia, which is a virulent strain, might cause tissue damages as the mosquitoes 
age affecting the expression of AeVago1 (Turley et al., 2009). It is known that wMelPop 
proliferates very rapidly as the host ages (Amuzu and McGraw, 2016; McGraw et al., 2002; 
McMeniman et al., 2008). 
To examine whether Wolbachia-mediated upregulation of Vago is consistent in the natural 
host of Wolbachia, we looked into the expression pattern of the gene in the females of D. 
melanogaster flies that were infected with wMelPop as compared with uninfected ones. We 
found that there was no change in the expression of the Vago gene in the case of Wolbachia 
infection in D. melanogaster flies. The possible reason behind this different Vago regulation in 
different hosts could be that Wolbachia is a natural host of D. melanogaster with a long 
evolutionary association, while Ae. aegypti is an unnatural transinfected host that has just 
recently been exposed to Wolbachia. For example, it was shown that wMel and wMelPop 
strains do not induce immune genes in D. melanogaster (Bourtzis et al., 2000), whereas they 
do (wMel to a lesser extent) in transinfected Ae. aegypti mosquitoes (Rances et al., 2012). To 
further strengthen this assumption, we examined the levels of the Vago gene in Ae. albopictus 
cells infected with the natural strain of Wolbachia wAlbB, and found that there was no change 
in the expression of Vago in Wolbachia-infected cells. However, further in-depth investigations 
are needed to follow up the effect of other transinfected strains of Wolbachia on AeVago1 in 
Ae. aegypti mosquitoes.  
In Cu. quinquefasciatus, Vago is highly induced during WNV infection (Paradkar et al., 2012). 
In the same study, the investigators also showed that Vago was induced in the case of 
DENV2 infection of Ae. albopictus RML12 cells. In the absence of evidence for Vago 
modulation in Ae. aegypti mosquitoes when challenged with DENV, we investigated the levels 
of AeVago1 expression in Ae. aegypti mosquitoes infected with DENV2 and found that despite 
the upward trend there was no significant upregulation of AeVago1 in DENV-infected 
mosquitoes. Results were cross-validated in D. melanogaster, which has been used in several 
studies to find out the host factors involved in DENV infection (Hackett et al., 2015; Sessions 
et al., 2009), indicating that there was no significant change in the levels of Vago in the case 
of DENV challenge. However, a significant increase was found in the case of S2 cells 
challenged with DCV, which is consistent with the previous report showing Vago is induced 
upon DCV infection (Deddouche et al., 2008). 
Several studies have looked into the possible mechanism(s) involved in Vago activation and 
found three possible mechanisms, involving Dicer2 (Deddouche et al., 2008), Rel2 and TRAF 
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(Paradkar et al., 2014). Since we did not find activation of Vago in DENV2 infection, we looked 
at the potential activators of Vago in the case of DENV2 infected mosquitoes at different time 
points. Our results demonstrated that there was no change in the levels of Dicer2, Rel2 and 
TRAF, except a significant upregulation in the levels of TRAF during early infection. Overall, 
the results suggest that there was no significant effect of DENV on AeVago1 and the 
expression of its three inducer genes in Ae. aegypti mosquitoes.  
To investigate the role of AeVago1 in relation to Wolbachia-mediated suppression of DENV 
replication, we knocked down the AeVago1 gene in Wolbachia-infected cells and examined its 
effect on DENV replication. Results showed a significant but modest increase in the genomic 
RNA levels of DENV in AeVago1 depleted Pop cells, but no significant effect on Wolbachia 
density. However, it will be interesting to examine AeVago1 effect on DENV replication in vivo.  
In summary, we have found that, consistent with the literature, AeVago1 is antiviral against 
DENV, and the virus may inhibit AeVago1 induction to avoid the host antiviral response. 
Interestingly, in Ae. aegypti, in the presence of Wolbachia, AeVago1 is specifically 
upregulated in young female mosquitoes, which may contribute towards the mechanism(s) to 
overcome DENV replication at early stages of infection. However, no significant effect of 
Wolbachia infection on AeVago1 in older mosquitoes suggests that AeVago1 may play a 
minor part in Wolbachia-mediated antiviral response in Ae. aegypti. Furthermore, given this 
interaction was not observed in other Wolbachia-host interactions with an older established 
association, further studies are required to find the fundamental mechanism(s) that Wolbachia 
employ to overcome the replication of RNA viruses. 
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3.8. Supplementary information 
 
Upregulation of Aedes aegypti Vago1 by Wolbachia and its effect on dengue virus 
replication 
 
Sultan Asad and Sassan Asgari 
 
 
 
Figure S1. Identification of SVWC domain and secretory signal in AeVago1 protein. A) 
Conserved domain database (CDD) analysis of AeVago1 (XP_001658930.1) protein 
sequence detected a SVWC domain (36-103 amino acids, shown in red bar) which is a 
signature domain of Vago proteins. B) SignalP4.1 analysis was carried out on the amino acid 
sequence of the AeVago1 (XP_001658930.1) protein. The output figure showed a sharp peak 
(red and blue lines) at amino acid 20 predicting a distinct secretory signal between 19th and 
20th amino acids. 
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Figure S2. Identification of SVWC domain and protein secretion signal in AeVago2. A) 
CDD server based analysis of AeVago2 (XP_001658928.1) amino acid sequence confirming 
the presence of the Vago signature SVWC domain between amino acid 35th-103rd. B) 
Detection of the secretory signal in AeVago2 was predicted between 18th and 19th amino acid 
(spike at 19th amino acid in the graph, red and blue lines) by analysing the amino acid 
sequence of AeVago2 using the SignalP4.1 server. 
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Figure S3. Effect of Wolbachia infection on Vago transcript levels in female D. melanogaster 
flies and Ae. albopictus cell lines. Relative expression of Vago in (A) female D. melanogaster 
infected with wMelPop and tetracycline cured line (Tet), and (B) in Wolbachia-infected (Aa23) 
and uninfected (Aa23-Tet) Ae. albopictus cells. RPS17 was used to normalize qPCR data in 
the case of Ae. albopictus gene, while Rpl32 was used for qPCR data normalization of the D. 
melanogaster Vago gene. Error bars represent SEM from three biological replicates with two 
technical replicates (A: p value = 0.9; B: p value = 0.11; unpaired t-test). 
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Table S1. Primers used in this study. 
Gene Name Primer Sequence (5’-3’) 
AeVago1-qF GCATTTGCCGGTCAGAGC 
AeVago1-qR CTCTTCATCGGGATCGAG 
AeVago2-qF CGACCCGGAATGTGTGAAGA 
AeVago2-qR GCAGCATTGTGGGTAGTCCT 
Ae-RPS17-qF CACTCCGAGGTCCGTGGTAT 
Ae-RPS17-qR GGACACTTCGGGCACGTAGT 
Dm-Vago-qF TGCAACTCTGGGAGGATAGC 
Dm-Vago-qR AATTGCCCTGCGTCAGTTT 
Dm-RPL32-qF GACGCTTCAAGGGACAGTATCTG 
Dm-RPL32-qR AAACGCGGTTCTGCATGAG 
AeVago1-
RNAi-F 
TAATACGACTCACTATAGGGCCATTCCTGGTGCTTGC 
AeVago1-
RNAi-R 
TAATACGACTCACTATAGGGTTAATGATAACTCACTTTTC 
Alb-Vago-qF GTGTCTTGCTCAAAGCGACC 
Alb-Vago-qR CCGGGGATGGATTTCTCCTC 
DENV-qF GGTATGGTGGGCGCTACTA  
DENV-qR CAAGGCTAACGCATCAGTCA 
WSP-qF GTCCAATATSTGATGACGAAAC 
WSP-qR CTGCACCAACAGGCCTATAAA 
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Chapter 4: Suppression of the pelo protein by Wolbachia and its effect on dengue 
virus in Aedes aegypti  
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protein by Wolbachia inhibit dengue virus virion production in Aedes aegypti. 
  76 
Suppression of the pelo protein by Wolbachia and its effect on dengue virus in 
Aedes aegypti 
 
Sultan Asad1, Mazhar Hussain1, Guangmei Zhang1 Daniel Watterson2 and Sassan Asgari1* 
1Australian Infectious Disease Research Centre, School of Biological Sciences, The 
University of Queensland, Brisbane QLD 4072 Australia  
2School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane 
QLD 4072 Australia 
 
Running title: Pelo role in dengue virus and Wolbachia infection 
 
 
 
 
 
 
* Corresponding author: Sassan Asgari, Email: s.asgari@uq.edu.au; Tel: 617-33652043; 
Fax: 617-33651655 
 
 
 current address: Institute for Glycomics, Griffith University, Gold Coast, Southport QLD 
4215 Australia.
 
 
77 
 
 
4.1. Abstract  
The endosymbiont Wolbachia is known to block replication of several important arboviruses, 
including dengue virus (DENV), in the mosquito vector Aedes aegypti. So far, the exact 
mechanism of this viral inhibition is not fully understood. A recent study in Drosophila 
melanogaster has demonstrated an interaction between the pelo gene and Drosophila C virus. 
In this study, we explored the possible involvement of the pelo protein, that is involved in 
protein translation, in Wolbachia-mediated antiviral response and mosquito-DENV interaction. 
We found that pelo is upregulated during DENV replication and its silencing leads to reduced 
DENV virion production suggesting that it facilities DENV replication. However, in the 
presence of Wolbachia, specifically in female mosquitoes, the pelo protein is downregulated 
and its subcellular localization is altered, which could contribute to reduction in DENV 
replication in Ae. aegypti. In addition, we show that the microRNA aae-miR-2940-5p, which is 
highly upregulated in Wolbachia-infected mosquitoes, might mediate regulation of pelo. Our 
data reveals identification of pelo as a host factor that is positively involved in DENV 
replication, and its suppression in the presence of Wolbachia may contribute to virus blocking 
exhibited by the endosymbiont.  
Keywords: pelo; Wolbachia; Aedes aegypti; dengue virus; microRNA
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4.2. Introduction 
Dengue virus (DENV) is one of the major medically important arboviruses (Bhatt et al., 2013; 
Gubler, 2006). It belongs to the Flaviviridae family that comprises lipid-enveloped, positive-
sense single stranded RNA viruses (Clyde et al., 2006). DENV is classified into four 
antigenically distinct but closely related serotypes, represented as DENV-1 to DENV-4. The 
bite of an infected female of either Aedes aegypti or Aedes albopictus is the most common 
mode of DENV transmission to humans (Diosa-Toro et al., 2013). Infected humans may suffer 
from dengue fever (DF), dengue shock symptom (DSS) or dengue haemorrhagic fever (DHF), 
leading to fatality (Gubler, 1998; Guzman et al., 2013). Currently, there is no specific therapy 
or approved vaccine available and the treatments available are palliative in nature. Despite 
substantial efforts to control DENV through vector control, it is still geographically expanding 
and alternate vector control strategies and therapeutic options are urgently needed (Tatem et 
al., 2006). One such strategy involves the use of a bacterial endosymbiont Wolbachia in 
transinfected Aedes spp. mosquitoes which limits DENV replication (Iturbe-Ormaetxe et al., 
2011; Lu et al., 2012). 
Wolbachia is an endosymbiotic, vertically transmitted bacterium that  infects more than 40% of 
insect species in addition to other terrestrial arthropods (Zug and Hammerstein, 2012). 
However, it is not a natural symbiont of Aedes aegypti, which is the primary vector of DENV 
transmission. Recently, several different types of Wolbachia strains have been successfully 
introduced into Ae. aegypti mosquitoes, among which Wolbachia wMel-Pop-CLA (Pop) and 
wMel strains are the most promising ones (Moreira et al., 2009; Walker et al., 2011). Both 
strains produce cytoplasmic incompatibility (CI) thus facilitate replacement of the wild 
populations through CI (McMeniman et al., 2009; Min and Benzer, 1997). Furthermore, 
introduction of Wolbachia has induced viral resistance in Ae. aegypti mosquitoes to a variety 
of arboviruses including dengue, Zika, West Nile and chikungunya viruses (Dutra et al., 2016; 
Hussain et al., 2013; Moreira et al., 2009; van den Hurk et al., 2012). However, the exact 
mechanism which causes this antiviral effect is not fully understood. Despite a small number 
of studies that have elucidated the potential role of microRNAs (miRNAs) (Hussain et al., 
2011; Zhang et al., 2013), reactive oxygen species (ROS) (Pan et al., 2012; Wong et al., 
2015), and competition for resources (Caragata et al., 2013) in Wolbachia-mediated antiviral 
response, the fundamental molecular mechanism(s) underlying virus blocking are yet to be 
explored. One of the possible strategies to discover molecular interactions between DENV-
Wolbachia-Ae. aegypti is to find host factors that facilitate replication of arboviruses and 
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examine their relative abundance in the presence of Wolbachia infection. A recent study in 
Drosophila melanogaster has identified pelo as an important host factor required for efficient 
replication of Drosophila C virus (DCV) providing DCV genome greater access to ribosomes 
for high level synthesis of viral structural proteins (Wu et al., 2014).  
Pelo is an evolutionary conserved protein which plays an important role in the regulation of D. 
melanogaster germ cell meiosis. In the pelo mutant males of D. melanogaster, cell cycle in 
spermatogenesis is arrested at the late prophase stage (Lin et al., 1996; Shamsadin et al., 
2000). In contrast, in mutant female flies, mitotic division during oogenesis is affected along 
with impaired development of the eyes (Eberhart and Wasserman, 1995). Functional studies 
performed for pelo’s homolog, Dom34, in yeast mutants led to the accumulation of free 
ribosomes and decrease in the number of polysomes suggesting its involvement in 
translational regulation (Davis and Engebrecht, 1998).     
In this study, we aimed to characterize Ae. aegypti’s pelo protein in the case of Wolbachia and 
DENV infection. We found that the pelo protein facilitates DENV replication and Wolbachia 
suppresses the protein which may contribute to the inhibition of DENV replication in 
Wolbachia-infected cells. In addition, we explored the subcellular localization of the pelo 
protein in response to Wolbachia and DENV infection. Furthermore, we demonstrate an 
indirect involvement of aae-miR-2940-5p in regulating pelo in response to Wolbachia infection. 
4.3. Materials and Methods 
4.3.1. Mosquitoes, flies and cell lines 
All mosquitoes used in this study had been previously generated by McMeniman et al. (2009) 
by infecting Ae. aegypti mosquitoes with wMelPop-CLA strain of Wolbachia (Pop), and 
uninfected mosquitoes were obtained through tetracycline (Tet) treatment to ensure the 
complete removal of Wolbachia infection (McMeniman et al., 2009). To ensure the availability 
of functional gut microflora the Tet mosquitoes were allowed to feed for two generations on 
water used to raise natural mosquito’s larvae (McMeniman et al., 2009).  Ae. aegypti Aag2 
and Pop cell lines previously described by Frentiu et al. (2010) were maintained in 1:1 
Mitsuhashi-Maramorosch and Schneider’s insect medium (Invitrogen) supplemented with 10% 
FBS (Bovogen Biologicals) (Frentiu et al., 2010). For microRNA direct interaction analysis, 
Spodoptera frugiperda Sf9 cells were used which were maintained in Sf900II medium (Life 
Technologies). All the above-mentioned cell lines were kept at 28C and passaged after every 
3-4 days. 
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4.3.2. RT-PCR and qPCR analyses 
Total RNA was extracted from either cell lines, mosquitoes or flies using Qiazol (Qiagen) and 
then treated with Turbo DNase (Ambion) according to the manufacturers’ guidelines. 1000 ng 
of total RNA was then used to make the 1st strand cDNA using Superscript III (Invitrogen) with 
the help of either oligo(dT) primer for cellular transcripts or DENV-qR primer in order to 
amplify the DENV genomic RNA. The full-length pelo gene was amplified by Taq DNA 
polymerase (New England Biolabs) using 1l of cDNA in 25l reaction together with pelo-
specific primers (all primer sequences are listed in Table S1).  
For qPCR, cDNA produced as above was diluted in 1:5 ratio with water. 2l of the diluted 
cDNA was used for downstream qPCR reaction. Both forward and reverse gene-specific 
primers were used to amplify the target genes, using QuantiFast SYBR Green (Qiagen) in a 
Rotorgene qPCR machine (Qiagen). For mosquito samples, ribosomal protein S17 (RPS17; 
AY927787.2) transcripts were used for normalization of RNA templates, while ribosomal 
protein L32 (RPL32; NM_079843) was used for normalization in the case of D. melanogaster. 
Each qPCR reaction was performed in duplicates with at least three biological replicates with 
the exception for the 12-day tissue-specific qPCRs in which we used two biological replicates. 
All qPCR data were normalized with Qiagen analysis templates and were further analysed by 
Prism 7.0. The qPCR cycling profile included 95°C for 5 min for the initial denaturation and hot 
start Taq activation, and 40 cycles of 95°C for 10 sec, 60°C for 15 sec and 72°C for 20 sec.  
Melt curve analysis was carried out on default settings of the Rotorgene machine to check the 
specificity of the qPCR products. Shapiro-Wilk normality test was performed first to check the 
normal distribution of data. Unpaired t-test was used to identify statistical significance between 
two individual groups while One-way ANOVA with Tukey’s post hoc test was performed to find 
statistical significance between more than two groups of data. 
4.3.3. Nuclear and cytoplasmic fractionation 
Nuclear and cytoplasmic fractions of Aag2 and Pop cells were separated using the PARIS kit 
(Ambion) according to manufacturer's instructions. Briefly, cells were washed with 1xPBS, 
centrifuged at 1500 rpm at 4oC, followed by resuspension of the cell pellet in 300l ice-
cold cell fractional buffer, incubated at 4oC for 10 min, centrifuged at 2000 rpm at 4oC for 5 
min. The supernatant was collected as the cytoplasmic fraction, and the pellet was washed 
five times with 200l ice-cold cell fractionation buffer to ensure removal of traces of the 
cytoplasmic faction and considered as the nuclear fraction. The pellet containing the nuclear 
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fraction was resuspended in 300l of cell disruption buffer. 300l of 4xSDS-PAGE buffer was 
added to both nuclear and cytoplasmic fractions. 
4.3.4. Western blot analysis 
RIPA buffer (Sigma) was used to get total cell lysates from cells and mosquitoes. Briefly, 
samples were homogenised with the help of 2mm glass beads using a TissueLyser II 
(Qiagen) at 30,000 frequency for 90 sec. The lysate was then centrifuged at 4C at full speed 
for 5 min and supernatant was collected for protein analysis. Protein concentrations were 
determined by measuring absorption at 280 nm. 
Protein samples were run on 10% polyacrylamide gels, transferred to nitrocellulose 
membrane and then blocked with 5% skimmed milk. After 3 times washing with 1xTBST, 
membrane was incubated with either anti-rabbit pelo  (Wu et al., 2014), anti-GAPDH (Sigma), 
anti-HSP70 (Sigma) or anti-DENV envelope protein antibody (Abmart) overnight at 4C on 
shaker. For secondary antibody incubation, the blot was washed three times with 1xTBST and 
then incubated with secondary antibodies either conjugated with alkaline phosphatase 
(Sigma) or infrared detection system (IRDye®800CW goat anti-human LICOR). After 1 h of 
incubation, the blot was again washed three times with 1xTBST and then it was further 
incubated with BCIP/NBT ready to use solution (Thermoscientific) or scanned with Odyssey 
imager LI-COR IR detection system.  
4.3.5. Oversupply and inhibition of aae-miR-2940-5p 
Aag2 cells were plated in a 12-well plate and transfected with 100 M of artificially 
synthesized mimic or inhibitor of either aae-miR-2940-5p, aae-miR-2940-3p or non-specific 
control mimic/inhibitor (GenePharma) (sequences in Table S1). Cellfectin was used as the 
transfection reagent (Invitrogen). Cells were collected 72 h post-transfection for downstream 
analyses. 
4.3.6. RNAi-mediated gene silencing 
In order to knockdown the pelo gene for functional analyses in DENV life cycle, primers were 
designed to amplify a 552 bp product from the pelo gene with the addition of the T7 promoter 
sequences at both ends. MEGAscript T7 Transcription kit (Ambion) was then used according 
to the manufacturer’s instructions in order to synthesize dsRNA targeting the pelo transcripts. 
A similar approach was followed to synthesize dsRNA against Ae. aegypti Argonaut 1 (Ago1; 
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XP_001662554), Ago2 (FJ979880.1), and Green fluorescent protein (GFP; X83960). For 
knockdown experiments, cells were double transfected with 5 and 2g of dsRNA, respectively, 
per well against the target gene. dsGFP RNA was used as a non-specific control. 
4.3.7. Virus infection and plaque assay  
For virus inoculation experiments, Ae. aegypti Aa20 cells were seeded at the density of 3x105 
cells per well in 12-well plates. Cells were first double transfected with dsRNA against the 
target gene and after 6 h they were infected with DENV-2 (New Guinea strain) at the 
multiplicity of infection (MOI) indicated in the text. Media were collected 72 h post-infection for 
plaque assay. 
To perform plaque assay, Vero cells were seeded in a 96-well plate and were allowed to form 
monolayers. Virus containing media from the experiments were serially diluted into 100 ,101 
,102 ,103 dilutions and added to Vero cells in duplicates. Cells were incubated with virus at 
room temperature with continuous shaking for 1 h and then incubated at 37ºC for one 
additional hour. After 2 h of incubation, media were aspirated and an overlay was added to the 
cells which comprised of 1.5% carboxymethyl cellulose (CMC) and 2.5% FBS in OptiMEM 
medium (Sigma). Cells were then incubated for 72 h at 37C and 5% CO2 and fixed with 80% 
ice-cold acetone in 1XPBS for 20 min at -20C. Plates were then air dried overnight and then 
blocked with 5% skimmed milk in 1xPBST at 37oC for 30 min. Cells were then incubated with 
the primary antibody against DENV-2-Envelope (human) in 1:1000 dilution in 0.1% skimmed 
milk in 1xPBST for 2 h at 37C as described previously (Watterson et al., 2016). After that, 
plates were washed three times with 1xPBST and then incubated with the secondary antibody 
(IRDye®800CW goat anti-human LICOR) for 1 h at 37C. Plates were washed and dried as 
above and were dried and scanned on the Odyssey imager (LI-COR Biosciences) at 41M 
resolution. Plaques were counted and viral titre was calculated accordingly. Plaque numbers 
obtained for compound titration were performed in triplicates. 
4.4. Results 
4.4.1. Pelo is ubiquitously expressed in mosquito tissues 
Pelo has been demonstrated to be ubiquitously expressed in human and D. melanogaster 
tissues (Chintapalli et al., 2010; Shamsadin et al., 2000). In order to investigate the tissue-
specific expression of Ae. aegypti pelo, we dissected 3-day-old Ae. aegypti female 
mosquitoes into different tissues, including salivary glands, midgut, muscles, ovaries, and fat 
 
 
83 
 
 
body. The pelo transcript sequence (XM_001658653.1) was retrieved from NCBI in order to 
design primers. RT-qPCR results demonstrated that pelo is also ubiquitously expressed in all 
the Ae. aegypti tissues tested, with the highest expression in the salivary glands and the 
lowest in the fat body (Figure 1). 
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Fig. 1: Tissue-specific expression of pelo in Ae. aegypti mosquitoes. RT-qPCR analysis 
of pelo transcript levels in the salivary gland, midgut, muscles, ovaries and fat body of 3-day-
old female mosquitoes (five mosquitoes per biological replicate) showed pelo expression in all 
the tested tissues. Error bars represent standard deviation (SD) of the mean in three biological 
replicates with two technical replicates.  
4.4.2. Wolbachia suppresses pelo in Ae. aegypti  
In order to find the effect of Wolbachia on pelo gene expression, RT-qPCR was carried out 
using pelo gene-specific primers to examine its expression in tetracycline (Tet) treated and 
Wolbachia wMelPop-CLA infected (Pop) female mosquitoes at two different time points that 
were 7-days and 12-days post-emergence. Results showed that the pelo gene is significantly 
downregulated in Pop mosquitoes at both time points (Figure 2A). This result was also cross-
validated in Aag2 and Aag2 cells infected with wMelPop-CLA (Figure 2B). To further 
investigate in which tissue(s) Wolbachia affect pelo, relative expression levels of the gene 
were assessed in different tissues of both uninfected and infected female mosquitoes at 12-
days after emergence by dissecting midgut, muscles, ovaries and fat body from a total of 20 
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mosquitoes divided into two biological replicates. We found decreases in pelo transcript levels 
in almost all the tissues of Pop mosquitoes tested including midgut, muscles, ovaries and fat 
body (Figures 3A-D).   
 
 
Fig. 2: Relative expression of pelo in uninfected and Wolbachia infected Ae. aegypti 
mosquitoes and cell lines.  A) RT-qPCR analysis of pelo transcripts in 7-day- and 12-day-
old female mosquitoes both uninfected (Tet) and infected (Pop) with Wolbachia. Error bars 
represent SD from three biological replicates containing pool of 5 mosquitoes each with three 
technical replicates (**, p<0.001; ****, p<0.00001; One-way ANOVA). B) RT-qPCR 
quantification of the pelo transcript levels in uninfected (Aag2) and Wolbachia-infected (Pop) 
cell lines. Error bar show SD from three independent biological replicates (**, p<0.001; 
unpaired t-test).  
4.4.3. Wolbachia affects the subcellular localization of the pelo protein 
Pelo has been reported to stay mainly in the cytoplasm in D. melanogaster (Xi et al., 2005). 
Although the pelo protein does have a conserved nuclear localization signal (PRKRK), there is 
a lack of experimental evidence of its presence inside the nucleus (Shamsadin et al., 2000); 
therefore, we explored its subcellular localization in Ae. aegypti cells and whether Wolbachia 
affects the localization of pelo. Nuclear and cytoplasmic fractions of both Aag2 and Pop cells 
were separated as described in the methods section. Lysates were run on 5-15% Bis/Tris 
polyacrylamide gels, total proteins were transferred to nitrocellulose membranes and then 
probed with an anti-pelo antiserum along with other control antisera, including anti-histone H3 
(to confirm the nuclear fraction), anti-GAPDH (to confirm cytoplasmic fraction), and anti-WSP 
 
 
85 
 
 
(to confirm Wolbachia infection). Here it is important to note that we detected the WSP protein 
in the nuclear fraction of Pop cells as well, although in smaller amount as compared to the 
cytoplasmic fraction, which is consistent with the earlier report demonstrating the presence of 
Wolbachia (wMelPop) in the nuclei of D. melanogaster cells with the help of electron 
microscopy (Min and Benzer, 1997). Nevertheless, the control antibodies show a very good 
fractionation of the two cellular compartments. Our results demonstrated that in Aag2 cells, 
pelo was only detectable in the cytoplasmic fraction, however, Wolbachia infection leads to 
the nuclear import of the protein thus affecting its subcellular localization as compared to 
uninfected Aag2 cells (Figure 3E). Further investigation is required to elucidate if the pelo 
protein plays any role inside the nucleus of Wolbachia-infected cells.  
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Fig 3: Tissue-specific modulation of pelo by Wolbachia. A-D) Relative expressions of the 
pelo transcripts in different tissues including midgut, muscles, ovaries and fat body of 12-day-
old female mosquitoes in the absence (Tet) and presence of Wolbachia (Pop) showing 
consistent downregulation trend throughout the tested tissues in the presence of Wolbachia. 
Error bars show SD from two biological replicates each containing tissue samples of 10 
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mosquitoes with three technical replications. E) Western blot analysis to examine the effect of 
Wolbachia on subcellular localization of the pelo protein showing translocation of pelo into the 
nucleus during Wolbachia infection. Anti-histone H3 and anti-GAPDH antibodies were used to 
check the efficiency of nuclear and cytoplasmic fractionations, while anti-WSP antibody was 
used to confirm the presence of Wolbachia. 
4.4.4. Wolbachia-mediated downregulation of pelo is highly specific to female Ae. 
aegypti 
We checked the levels of pelo transcripts in both male and female 4-day-old Tet and Pop 
mosquitoes. RT-qPCR analysis showed that there was no significant change in the levels of 
pelo between Tet and Pop male mosquitoes (Figure 4A). Conversely, the level of pelo 
transcripts was significantly reduced in females in the presence of Wolbachia (Figure 4A). 
Although there is no evidence in Ae. aegypti mosquitoes to show differential host response to 
bacterial infections in the two sexes, a study carried out in the parasitoid Asobara tabida has 
highlighted differential immune response in males as compared to females challenged with 
Wolbachia strains wAtab1, wAtab2, and wAtab3, where males showed higher levels of 
immune gene expression upon Wolbachia infection as compared to females (Kremer et al., 
2012). Therefore, our results also point out towards sex-specific response in Ae. aegypti 
mosquitoes during Wolbachia infection. 
As Wolbachia is not a natural symbiont of Ae. aegypti, we were interested to test whether 
Wolbachia has the same suppressive effect on pelo in its natural host D. melanogaster. By 
measuring the relative levels of the pelo transcripts in Tet and Wolbachia wMelPop infected 4-
day-old flies, we found that Wolbachia-mediated suppression of pelo is highly specific to Ae. 
aegypti females as there was no significant change in the levels of pelo in infected and 
uninfected male and female flies (Figure 4B). This pointed out to the fact that Wolbachia-
mediated suppression of pelo could be due to the transinfection of Wolbachia strain wMelPop-
CLA into a novel host that is Ae. aegypti in this case. 
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Fig. 4: Effect of Wolbachia infection on the pelo gene expression in male and female 
mosquitoes and flies, and cell line. A) RT-qPCR for the pelo transcripts levels in 4-day-old 
female and male mosquitoes, both uninfected (Tet) and infected with Wolbachia (Pop) (*, 
p<0.05; One-way ANOVA). B) Relative expression of the pelo gene in uninfected (Tet) and 
Wolbachia-infected (Pop) flies. Error bars represent SD from three biological replicates 
including five mosquitoes/flies per biological replicate (ns represents not-significant; One-way 
ANOVA).  
4.4.5. microRNA aae-miR-2940-5p is involved in regulation of pelo  
microRNAs (miRNA) are known to regulate different target genes. To find out whether the 
suppression of pelo in Wolbachia-infected mosquitoes is mediated by miRNA, we knocked 
down Ago1 and Ago2 genes in Pop cells, as both are important components of the RISC 
complex involved in miRNA functions (Okamura et al., 2004; Okamura et al., 2009). After 
confirming silencing of the Agos with dsRNA specific to the genes (Figure 5A and 5B), we 
employed RT-qPCR and found that after Ago2 knockdown there was a significant increase in 
the expression of pelo (Figure 5C), which suggested that miRNAs might be involved in 
regulating pelo levels. Interestingly, we found that when Ago1 was silenced, Ago2 levels 
increased (Figure 5A), and conversely when Ago2 was knocked down, Ago1 transcript levels 
increased (Figure 5B). This is consistent with previous studies carried out in D. melanogaster 
that Ago proteins may compensate for each other (Yang et al., 2014). 
As Wolbachia-mediated pelo suppression was found to be specific to Ae. aegypti mosquitoes, 
Fig. 4 
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in particular females, we aimed to determine if a mosquito-specific miRNA could be involved. 
Hussain et al (2011) provided evidence that in Wolbachia wMelPop-CLA infected female 
mosquitoes a mosquito-specific aae-miR-2940-5p was significantly up-regulated as compared 
to uninfected mosquitoes (Hussain et al., 2011). Although three targets of this miRNA have 
already been identified (Hussain et al., 2011; Zhang et al., 2014; Zhang et al., 2013), we tried 
to determine if it has any interaction with the pelo gene. RNAhybrid analysis showed potential 
aae-miR-2940-5p target sequences in the ORF of the pelo gene at positions 561-582 with 
significant seed region complementarity and high minimum free energy of -25.8 kcal/mol 
(Figure S1). In order for a miRNA to regulate a target mRNA, it is important that the mature 
miRNA and its target transcript co-localize in the same tissue. Aforementioned results showed 
that pelo is expressed in all the mosquito tissues that we examined and Wolbachia supresses 
its expression in all the tested tissues (Figure 3A-D). We were interested to find out the tissue-
specific expression of aae-miR-2940-5p in mosquito tissues in the presence and absence of 
Wolbachia. Northern blot analysis of RNA isolated from various tissues of Pop and Tet Ae. 
aegypti mosquitoes confirmed induction of aae-miR-2940-5p in Pop mosquitoes, with 
substantial inductions in the midgut and fat body (Figure 6A). These inductions and their 
extents were in inverse correlation with reductions of the pelo transcript levels in the 
corresponding tissues examined (Figure 3A-D). 
To verify the interaction between aae-miR2940-5p and pelo, Aag2 cells were transfected in 
triplicates with synthetic aae-miR2940-5p mimic, control mimic with random sequences. RT-
qPCR results showed that there were significant reductions in the transcript levels of pelo in 
Aag2 cells transfected with aae-miR2940-5p mimic as compared to mock and control mimic 
transfected cells (Figure 6B). Furthermore, the effect of synthetic mimic and inhibitor of aae-
miR-2940-5p on Pelo protein expression was analysed 72 h post-transfection. Western blot 
results confirmed downregulation of the pelo protein in the presence of aae-miR-2940-5p 
mimic while there was an increase in the level of the pelo protein in cells that were treated 
with aae-miR-2940-5p inhibitor (Figure 6C).  
In order to validate the direct interaction between aae-miR-2940-5p and the predicted target 
sequences in pelo, we cloned the target sequences downstream of GFP in the pIZ/V5-His 
vector. The GFP-pelo target sequence clone was co-transfected with the control random 
sequence mimic and aae-miR-2940-5p mimic into Aag2 cells. RNA was collected after 72 h, 
and RT-qPCR was carried out to check the level of GFP transcripts. The results showed that 
there was no change in the levels of GFP in response to aae-miR-2940-5p mimic (Figure 6D), 
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which suggests that likely there is no direct interaction between pelo and aae-miR-2940-5p. 
This result is not surprising as most miRNAs are reported to target transcription factors or 
other proteins that in return fine tune the abundance of different transcripts (Gosline et al., 
2016). To rule out the possibility of another target site for the miRNA in the pelo gene 
undetected by the prediction program, the full-length pelo, including its 3’UTR, was cloned into 
the pIZ/V5-His vector and co-transfected with aae-miR-2940-5p mimic in Sf9 cells. There was 
no downregulation of pelo in the presence of aae-miR-2940-5p mimic (data not shown), which 
confirmed our aforementioned observation.   
Fig. 5: miRNA-mediated regulation of pelo. A-B) RT-qPCR showing dsRNA-mediated 
silencing of Ago1 and Ago2, respectively. C) Relative expression of the pelo transcripts in 
Ago1 and Ago2 silenced Aag2 cells by RT-qPCR showing increase in pelo expression at RNA 
level in Ago2 depleted cells. Each error bar shows SD from three biological replicates with two 
technical replicates (**, p<0.001; One-way ANOVA). 
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Fig. 6: aae-miR-2940-5p dependent regulation of pelo. A) Northern blot analysis of RNA 
isolated from various tissues (OV, ovary; MG, midgut; FB, fat body; SG, salivary gland) of 
wMelPop (P) infected and tetracycline-treated (T) Ae. aegypti mosquitoes hybridized with a 
specific probe to aae-miR-2940-5p probe confirmed increase in the expression of aae-miR-
2940-5p throughout the tested tissues in the case of Wolbachia infection. U6 is shown as 
control to confirm equal loading of RNA. B) RT-qPCR performed to confirm the effect of 
overexpression of aae-miR-2940-5p mimic on pelo transcript levels showing a significant 
decrease in pelo transcript levels in aae-miR-2940-5p mimic transfected cells. Error bars 
represent SD from three biological replicates with two technical replicates (**, p<0.001; ***, 
p<0.0001; One-way ANOVA).C) Western blot analysis to examine the effect of aae-miR-2940-
5p mimic and inhibitor on pelo protein levels using an anti-pelo specific antibody (upper 
panel), while anti-beta-actin antibody was used as control to confirm equal loading of samples. 
D) RT-qPCR analysis of the effect of aae-miR-2940-5p mimic on the level of GFP transcripts 
in Sf9 cells transfected with pIZ/GFP fused with the pelo target sequences along with the 
negative control (NC) or aae-miR-2940-5p mimic. 
4.4.6. Pelo plays a role in DENV virion production 
Recently, it has been reported that pelo is required for efficient replication of Drosophila C 
virus (DCV) (Wu et al., 2014). In order to examine if the pelo protein has a similar effect on 
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DENV replication, we infected Ae. aegypti Aa20 cells with DENV-2 (NGC strain) at 1.8 
multiplicity of infection (MOI). Cells were collected at 1 and 5 days post-infection (dpi) from 
which RNA and proteins were extracted. RT-qPCR results showed no significant change in 
the pelo transcript levels during DENV infection at both 3 and 5 dpi (Figure 7A). However, 
western blot analysis of the cells using an antiserum against D. melanogaster pelo clearly 
showed an increase in the levels of the protein upon infection at both 3 and 5 dpi (Figure 7B). 
The same blot was re-probed with an anti-DENV-Envelope antiserum to confirm infection. 
This suggests that pelo could be regulated at the post-transcriptional level. To check the 
localization of the pelo protein during DENV infection, we fractionated mock and 5 dpi Aa20 
cells (1 MOI) into nuclear and cytoplasmic fractions. Both nuclear and cytoplasmic lysates 
were run on 5-15% Bis/Tris polyacrylamide gels. After transfer to nitrocellulose membrane, the 
blot was probed with the pelo antiserum. Results showed that unlike Wolbachia, DENV 
infection has no effect on the subcellular localization of pelo, which remains in the cytoplasm 
in both uninfected and DENV-2 infected cells (Figure 7C).  
The above results suggest that DENV might increase levels of the host pelo protein in order to 
facilitate its replication, similar to DCV in D. melanogaster. In order to further confirm this link, 
the pelo gene was knocked down in Aa20 cells using pelo specific dsRNAs (Figure 8A) and 
subsequently infected with DENV-2 at 1 MOI. We carried out DENV infection experiments in 
Ae. aegypti cell line Aa20, because Aag2 cell line is persistently infected with insect-specific 
flavivirus cell fusing agent virus (CFAV) (Stollar and Thomas, 1975), but not Aa20 cells. At 3 
dpi, cells were harvested and subjected to RT-qPCR using DENV-2 specific primers to the 
NS1 gene. Surprisingly, RT-qPCR results showed no change in the DENV-2 genomic RNA 
levels in pelo depleted Aa20 cells as compared to mock and dsGFP transfected cells (Figure 
8B). However, plaque assay displayed a significant reduction in the virus titre in the medium 
collected from Aa20 cells treated with dspelo and infected with DENV-2 (Figure 8C). These 
results demonstrated that when pelo was knocked down the number of DENV infectious 
particles significantly declined, but there was no effect on the total genomic RNA of DENV, 
implicating that pelo might play an important role in the translation of the viral genomic RNA 
and/or assembly and release of DENV-2 virions. 
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Fig. 7: Expression pattern of pelo in DENV challenged mosquito cells. A) RT-qPCR 
analysis of pelo transcripts in the presence and absence of DENV challenge (1 MOI) in Aa20 
cells at 3 and 5 dpi. Data was normalised using RPS17 as the control gene. Error bars 
represent SD from three biological replicates with two technical replicates each (ns shows no 
significance; One-way ANOVA). B) Western blot analysis carried out using the anti-pelo 
specific antibody to check the pelo protein levels during DENV infection at 3 and 5 days post-
infection (dpi), respectively, showing an increase in pelo protein expression in DENV infected 
cells at both 3 and 5 dpi. C) Western blot results showing no change in localization of the pelo 
protein at 5 dpi with DENV. Histone H3 detection only in nuclear fractions and GAPDH 
detection only in cytoplasmic fractions shows the success of subcellular fractionations, while 
DENV envelope protein only in the infected cells confirms DENV infection. 
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Fig. 8: Silencing of pelo affects DENV virion production. A) RT-qPCR based confirmation 
of knock down of pelo in Aa20 cells. B) RT-qPCR analysis to examine the genomic RNA level 
of DENV in Aa20 infected cells (1 MOI) transfected with either no dsRNA (Mock) or with 
dsRNA against GFP as control or with dsRNA against pelo to silence the gene. RPS17 was 
used to normalize the qPCR data, showing no effect at the DENV genomic RNA level. C) Viral 
titre determination by plaque assay conducted on the media collected from cells treated as in 
B showed a significant reduction in DENV virion production in pelo depleted cells. Error bars 
represent SD from three biological replicates with two technical replicates (**, p<0.001; ***, 
p<0.0001; ns shows no significance; One-way ANOVA). 
4.5. Discussion 
Despite numerous efforts to unveil the mechanism by which Wolbachia manipulates its host 
environment to restrict virus replication, the exact mechanism(s) that govern this antiviral 
property are largely unknown. In this study, we have found that the Wolbachia supresses pelo 
which in turn may contribute towards restricting DENV virion production in Ae. aegypti. 
Wolbachia is a facultative endosymbiont in many insect species and other invertebrates, 
however, the wMelPop-CLA strain, which most effectively suppresses DENV replication, has 
no natural association with the primary DENV vector Ae. aegypti and has been artificially 
transinfected into Ae. aegypti (McMeniman et al., 2009). Several reports have shown that 
Wolbachia-mediated activation of immune genes in the Imd and Toll pathways could be 
involved in host protection from various viruses in mosquitoes (Bian et al., 2010; Kambris et 
al., 2009; Moreira et al., 2009). Other reports, however, have shown that Wolbachia does not 
elicit the host immune response, in particular in hosts that are naturally infected with 
Wolbachia (Ferreira et al., 2014; Rances et al., 2013; Rances et al., 2012). A recent study 
investigating the role of Wolbachia-induced restriction of Semliki Forest virus within D. 
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melanogaster cells (JW18) suggested that interference occurs at a very early stage of 
infection and at the level of viral RNA translation or host RNA transcription (Rainey et al., 
2016). However, in some Wolbachia-host-virus associations, viral replication is not inhibited 
but rather a tolerance to viral infection is conferred by Wolbachia (Osborne et al., 2009; 
Teixeira et al., 2008). 
Recently, findings of Wu et al. (2014) and Lapidopt et al. (2015) have shed light on the role of 
the pelo protein as an important host factor for effective viral replication in the case of 
Drosophila C virus (DCV) and Tomato yellow leaf curl virus (TYLCV) (Lapidot et al., 2015; Wu 
et al., 2014). However, the potential role of pelo has not been characterized yet in the case of 
the medically important DENV and its controlling agent Wolbachia in the mosquito vector. RT-
qPCR analyses revealed that the pelo gene is expressed ubiquitously throughout all the main 
tissues of Ae. aegypti with the highest expression in the salivary glands, which is consistent 
with the studies conducted on tissue localization of pelo in the case of human and D. 
melanogaster (Chintapalli et al., 2010; Shamsadin et al., 2000). Interestingly, we found that 
pelo is supressed in the presence of Wolbachia in cell line, whole mosquitoes and all the main 
tissues such as the midgut, muscles, ovaries and fat body. However, this suppression is 
mainly female mosquito specific, which was not seen in the male mosquitoes or in either male 
or females of D. melanogaster infected with wMelPop. The difference in pelo regulation in 
Wolbachia-infected Ae. aegypti versus D. melanogaster could be due to natural infection in 
the fly versus transinfection of Wolbachia into the mosquito (Hughes and Rasgon, 2014). 
Pelo is a highly conserved protein in mammals (Shamsadin et al., 2000), and using multiple 
sequence alignments for pelo sequences from different insect species we found that the 
protein is also highly conserved among insect species (Figure S2) with a distinct nuclear 
localization signal (PRKRK), and shows structural similarities with human pelo (Figure S3). 
However, it has been demonstrated that pelo mostly resides in the cytoplasm and there is a 
lack of evidence for the presence of pelo in the nucleus (Xi et al., 2005). This led us to 
investigate the localization of the pelo protein in mosquito cells and in particular in the 
instance of Wolbachia infection. Western blot results showed that the pelo protein is mainly 
found in the cytoplasm of mosquito cells, however, Wolbachia infection leads to a change in 
the subcellular localization of pelo by moving it into the nucleus. This change in the subcellular 
localization of pelo might help Wolbachia to make the protein less available in the cytoplasm, 
which is required for the translation of quickly synthesized viral proteins. This finding is in 
agreement with a previous study in which it was shown that pelo is required for the synthesis 
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of the capsid protein of DCV, which they described as a quickly synthesizing protein (Wu et 
al., 2014). Alternatively, the translocation of pelo into the nucleus may have an inhibitory effect 
on a host gene(s) that normally facilitates viral replication.  
miRNAs are important regulators of different cellular processes including timing, cell 
differentiation, cell proliferation, cell death, metabolic control, transposon silencing and 
antiviral defence (Chang et al., 2008; Schickel et al., 2008; Wang et al., 2009). Recently, our 
group has shed light on the modulation of different cellular miRNAs in the case of infection 
with wMelPop strain of Wolbachia in female mosquitoes (Hussain et al., 2011). Along similar 
lines, in this study we have investigated whether pelo has an interaction with any miRNA by 
silencing both Argonaute 1 (Ago1) and Argonaute 2 (Ago2) genes, which are important 
components of the RISC complex and involved in miRNA function (Hock and Meister, 2008; 
Yang et al., 2014). Interestingly, we found that silencing of one Ago led to the upregulation of 
the other Ago. One possible reason might be class switching between the Agos (Yang et al., 
2014). Increase in Pelo levels in Ago2 silenced cells suggested that pelo downregulation in 
Wolbachia-infected cells could possibly be mediated by miRNA. Hussain et al (2011) provided 
evidence that in Wolbachia wMelPop-CLA infected mosquitoes the mosquito-specific aae-
miR-2940-5p was significantly upregulated as compared to uninfected mosquitoes (Hussain et 
al., 2011). While three targets of this miRNA have already been identified (Hussain et al., 
2011; Zhang et al., 2014; Zhang et al., 2013), we explored whether it has any interaction with 
the pelo gene. Tissue-specific expression analysis showed inverse correlation of the pelo 
transcript levels with aae-miR-2940-5p abundance. The co-localization of both pelo transcripts 
and mature aae-miR-2940-5p highlights the possibility that in Wolbachia-infected cells aae-
miR-2940-5p might be utilized to downregulate pelo transcripts. These results also further 
confirmed differential expression of this miRNA in Wolbachia-infected mosquitoes. Further 
investigation showed that pelo transcript levels were downregulated in the presence of the 
artificially synthesized mimic of aae-miR-2940-5p both at the transcript and the protein levels, 
while there was an increase in the pelo protein in the case of addition of an artificially 
synthesized inhibitor of aae-miR-2940-5p. However, target validation results using GFP as a 
reporter suggested that pelo may not be a direct target of aae-miR-2940. This could be due to 
regulation of a transcription factor(s) or other protein(s) by the miRNA that fine-tunes the 
abundance of the pelo transcripts (Gosline et al., 2016). 
Viruses are well known to modulate transcripts of host cells for their own benefit. Recently, a 
research group examined D. melanogaster mutants that resist DCV replication through a 
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forward genetic screen and demonstrated a DCV-resistant mutant to be deficient of the pelo 
gene (Wu et al., 2014). Pelo protein has also been implicated in TYLCV resistance in tomato 
TY172 cultivar (Lapidot et al., 2015). However, its potential role in the case of DENV has not 
yet been explored. Our results suggest an increase in the levels of pelo in DENV-infected cells 
at the protein level without a change in its subcellular localization, which was mostly 
cytoplasmic. Furthermore, pelo knockdown studies revealed that it is vital for DENV virion 
production. The outcome of this study is in agreement with the previous findings that showed 
pelo is vital for the translation of the capsid protein of DCV thus positively affecting replication 
of DCV. A similar role of pelo was found in other viruses including Cricket Paralysis Virus, 
Double Drosophila X virus, and invertebrate iridescent virus 6 and TYLCV replication (Lapidot 
et al., 2015; Wu et al., 2014), suggesting that pelo might be an important host factor that is 
recruited by viruses to facilitate the translation of viral genome.   
In summary, we have demonstrated that the pelo protein facilitates DENV replication, and in 
female Ae. aegypti mosquitoes, Wolbachia suppresses the pelo protein, which may 
consequently contribute to restriction of DENV replication. This effect could be due to 
relocalization of the pelo protein to the nucleus in Wolbachia-infected cells as compared to 
non-infected cells. In addition, regulation of pelo in Wolbachia-infected mosquito cells appears 
to be mediated by aae-miR-2940-5p. However, the regulation of pelo was found to be female 
mosquito specific and not observed in male mosquitoes or in D. melanogaster males or 
females. Therefore, while suppression of pelo in female mosquitoes may contribute to virus 
inhibition, this does not seem to be the universal mechanism of virus inhibition seen across 
different host-virus interactions. 
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4.8. Supplementary Material  
Table S1: Primers used in this study. 
Gene Name Primer Sequence (5’-3’) 
Ae-pelo-qF CAAGGCCTTCTACGGCAAGA 
Ae-pelo-qR GAATCACGCACCGAATCGAC 
Ae-Ago1-qF CGCAGACAAGAAGGAACAGA 
Ae-Ago1-qR TCCCACAGGACGTGATAATG 
Ae-Ago2-qF CTGGACATGACTTGCCTGAA 
Ae-Ago2-qR AGCTCATGGTTGCTTCCAAT 
Ae-RPS17-qF CACTCCGAGGTCCGTGGTAT 
Ae-RPS17-qR GGACACTTCGGGCACGTAGT 
Dm-pelo-qF CGAGCATGCACATCTCAGGA 
Dm-pelo-qR TCGCTATCGCTATCTGCCAC 
Dm-RPL32-qF GACGCTTCAAGGGACAGTATCTG 
Dm-RPL32-qR AAACGCGGTTCTGCATGAG 
Ae-pelo-RNAi-F TAATACGACTCACTATAGGGTCTTACCATCCGGGTCGAGT 
Ae-pelo-RNAi-R TAATACGACTCACTATAGGGCCAGACGACGAGTGAACCAA 
Ae-pelo-full 
length-F 
GGACTAGTATGAAGTTGGTTCATAAAAACATTG 
Ae-pelo-full 
length-R 
GGTCTAGATCAATCCGAGTCGGAATC 
Ae-Ago1-RNAi-F TAATACGACTCACTATAGGGCGCCAAGGCCTCCAAGTCCG 
Ae-Ago1-RNAi-R TAATACGACTCACTATAGGGATACCGGCTTCAGCGCACCG 
Ae-Ago2-RNAi-F TAATACGACTCACTATAGGGATGTAGACGCGTCCTCTGT 
Ae-Ago2-RNAi-R TAATACGACTCACTATAGGGACAGTTCAAGCAGACGAACC 
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Table S2. Pelo protein sequences used for multiple sequence alignment.  
Species Name Uniprot ID Identity  Score  
Aedes aegypti Q170N2 100 1,946 
Drosophila 
melanogaster  
P48612 81.8 1,673 
Culex quinquefasciatus B0WGL0 91.7 1,813 
Anopheles gambiae Q7Q477 83.6 1,714 
Anopheles sinensis A0A084W4V1 90.1 1,723 
Homo sapiens Q9BRX2 66.1 1,359 
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Fig. S1: Sequence complementarity of aae-miR-2940-5p with its predicted target pelo.		
 
Fig. S1: RNA hybrid analysis of sequence complementarity between aae-miR-2940-5p and 
the pelo transcript (XM_001658653.1) showing very strong binding pattern and very low 
minimum free energy (mfe = -25.8 kcal/mol) 
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Fig. S3: Aedes aegypti pelo is structurally similar to the human pelo: A) I-Tasser 
predicted model of Ae. aegypti pelo protein; B) Ramachandran plot showing more than 90% 
of residues fall in the allowed region thus confirming the strength of the model. C) 
Experimentally verified C-terminus model of human pelo. D) Superimposition of Ae. aegypti 
predicted pelo protein model and human pelo shows that they are highly similar in structure. 
A 
Fig. S3: Aedes aegypti pelo is structurally similar to the human pelo: A) I-Tasser predicted model of Ae. aegypti pelo 
protein; B) Ramachandran plot showing more than 90% of residues fall in the allowed region thus confirming the strength 
of the model. C) Experimentally verified C-terminus model of human pelo. D) Superimposition of Ae. aegypti predicted pelo 
protein model and human pelo shows that they are highly similar in structure.  
B 
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Chapter 5: General Discussion and Conclusion 
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5.1. General Discussion 
Exploiting Wolbachia’s antiviral potential to limit the transmission of DENV by targeting its 
primary host Ae. aegypti has shown tremendous promise (Dutra et al., 2016; Lambrechts et 
al., 2015). This antiviral effect is not just limited to DENV; it also decapitates the ability of Ae. 
aegypti to transmit other medically important arboviruses including ZIKV, WNV and 
Chikungunya virus (Dutra et al., 2016; Hussain et al., 2013; Moreira et al., 2009). However, 
the exact mechanism(s) that induce these antiviral effects are still not well understood. During 
this PhD project, we aimed to find a deeper understanding of potential molecular 
mechanism(s) underlying the virus blocking property exerted by Wolbachia in the particular 
context of Ae. aegypti and DENV. We were able to find three different possible molecular 
mechanism(s) that could contribute towards inhibition of DENV replication in the presence of 
Wolbachia in Ae. aegypti, which are discussed sequentially. 
Chromodomain helicase DNA binding protein 7 plays an important role in Wolbachia-
mediated suppression of dengue virus in Ae. aegypti mosquitoes 
In this study (Chapter 1), we have characterized the role of one of the members of 
chromodomain helicase family named AeCHD7 in the context of Wolbachia-mediated antiviral 
response in Ae. aegypti mosquitoes. We have found that in the case of Wolbachia infection 
there is a reduction in AeCHD7 transcript levels in female mosquitoes suggesting its 
potentially important role in the Wolbachia-host relationship. To date, there has been no report 
on the involvement of CHD7 in bacterial infections, however, recently a study has found that in 
D. melanogaster CHD1 constitutes an important part of immunity and plays a key role in 
mounting resistance against the bacterium Pseudomonas aeruginosa (Sebald et al., 2012). 
Further study conducted in mice embryonic stem cells has revealed that both CHD7 and 
CHD1 perform a similar function by associating themselves with the regulation of similar 
genes including Sox2, Oct4 and Nanog (Zentner et al., 2011). Aforementioned studies 
showing the potential role of the CHD family member in D. melanogaster immunity and the 
similar function of both CHD1 and CHD7 in mice suggest that AeCHD7 might be an immune 
regulator that is altered upon Wolbachia infection that could confer resistance to DENV 
replication. 
There is a whole body of evidence pointing towards the difference in gender specific 
modulation of host immune response (Duneau and Ebert, 2012). Studies conducted on the 
parasitiod Asobara tabida have demonstrated that there is a highly different immune response 
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in males as compared to females upon infection with Wolbachia strains wAtab1, wAtab2, 
and wAtab3, where males showed higher levels of immune genes expression upon Wolbachia 
infection as compared to females (Kremer et al., 2012). To investigate whether Wolbachia-
mediated suppression of AeCHD7 gene is gender specific or not, we analysed the transcripts 
levels of AeCHD7 in Wolbachia-infected male and female Ae. aegypti mosquitoes. We found 
that there was no significant difference in the expression levels of AeCHD7 in male 
mosquitoes (with or without Wolbachia) as compared to female mosquitoes that showed 
significant reduction upon Wolbachia infection, indicating that Wolbachia-mediated reduction 
of AeCHD7 is highly specific to female Ae. aegypti mosquitoes.  
In order to investigate the role of AeCHD7 in DENV replication, we found that there was a 
significant increase in AeCHD7 transcript levels in mosquitoes infected with DENV. We further 
characterized the functional role of AeCHD7 in the case of DENV replication by silencing 
AeCHD7 using RNAi. Subsequently, we employed two different techniques to assess virus 
replication: i) RT-qPCR to quantify the genomic RNA level, showing significant decrease in 
DENV genomic RNA level, and ii) plaque assay to find the role of AeCHD7 in DENV virion 
production, demonstrating reduction in the number of plaques in AeCHD7 depleted cells. 
There is lack of information regarding the role of CHD7 with respect to viral infection and 
replication. However, only recently there seems an increase in exploring the role of CDH 
family members in the events of pathogen infection and their own replication. Few reports 
available on the involvement of CHD family members in viral replication includes studies on 
HIV (Rodgers et al., 2014) and Influenza A virus (Marcos-Villar et al., 2016) showing the 
essential role of CHD family members in the replication of the aforementioned viruses.  
Wolbachia is not a native inhabitant of Ae. aegypti. The wMelPop-CLA strain of Wolbachia 
was therefore transinfected into the mosquito after its isolation from its native host D. 
melanogaster and its adaptation to a mosquito cell line (McMeniman et al., 2008). Our 
experimental results determined that the Wolbachia-mediated reduction in AeCHD7 is highly 
specific to female Ae. aegypti and similar modulation was not observed in D. melanogaster 
flies and Ae. albopictus cells which are natural hosts of wMelPop and wAlb strains of 
Wolbachia, respectively. This finding suggests that Wolbachia-mediated suppression of 
AeCHD7 is not a universal mechanism that Wolbachia uses across different host species to 
impart antiviral ability to its host, but could be an effect induced in a recently introduced host. 
Furthermore, although we have found that AeCHD7 appears to be an important component of 
Wolbachia-Ae. aegypti-DENV interactions (Chapter 2), further in-depth studies are required to 
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find the exact mechanism(s) which leads to Wolbachia-mediated suppression of AeCHD7 and 
its consequent effect on DENV replication. 
The antiviral AeVago1 gene is induced in the presence of Wolbachia  
Vago is an insect-specific secretory protein that was discovered in D. melanogaster to play an 
important role in limiting DCV replication (Deddouche et al., 2008). Recent studies revealed its 
importance in mosquitoes as well by showing that the secreted Vago plays an antiviral role by 
supressing WNV in Cu. quinquefasciatus (Paradkar et al., 2012). This led us to investigate the 
potential involvement of Vago homolog(s) in Wolbachia-mediated suppression of DENV in Ae. 
aegypti. We identified two potential Vago homologs in Ae. aegypti and examined their 
expression in Wolbachia-infected mosquitoes and cells. We found that upon Wolbachia 
infection there was a significant increase in the levels of AeVago1 transcripts in both 
mosquitoes and cells infected with Wolbachia suggesting that as an immune gene, it might 
contribute towards limiting DENV. However, the similar trend of Wolbachia-mediated increase 
of Vago was not observed in Wolbachia-infected D. melanogaster flies and Ae. albopictus 
mosquitoes. This difference in Vago modulation in the presence of Wolbachia might be due to 
the fact that Ae. aegypti is transinfected by Wolbachia and is not a natural host of the 
endosymbiont. 
To characterize AeVago1 further, we investigated the tissue-specific expression of the gene in 
female Ae. aegypti mosquitoes to find that AeVago1 is highly expressed in the fat body of 
mosquitoes, which is consistent with a previous study in D. melanogaster (Deddouche et al., 
2008). Fat body of mosquitoes represents a major site of DENV replication and is the hub of 
host immune response against pathogens (Salazar et al., 2007). This notion suggests that 
AeVago1 is one of the immune genes of mosquitoes that is upregulated in response to 
Wolbachia infection as a part of immune priming. Furthermore, fat body of mosquitoes is one 
of the somatic tissues of higher Wolbachia density (Moreira et al., 2009), suggesting that there 
might be a correlation between induction of AeVago1 and anti-viral response in the mosquito. 
DENV has been reported to induce AeVago1 in Ae. albopictus RML12 mosquito cell line 
(Paradkar et al., 2014), however, we found that in Ae. aegypti whole mosquitoes infected with 
DENV there was no significant change in the expression of AeVago1. Looking at the possible 
reason(s), a study in D. melanogaster has shown Vago to be induced in a Dicer-2 dependent 
manner (Deddouche et al., 2008), while in Cu. quinquefasciatus, another study has looked 
into the mechanism of CuVago activation suggesting Rel2 and TRAF involvement (Paradkar 
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et al., 2014). Our experiments have demonstrated that in DENV-infected whole Ae. aegypti 
mosquitoes there was no clear activation of any of the above reported genes except TRAF 
that was found to be significantly induced at only one time point during early infection. This 
clearly indicates that DENV somehow is able to restrict the AeVago1-mediated antiviral 
response of Ae. aegypti mosquitoes to facilitate its replication and Ae. aegypti responds 
differently upon infection with DENV as compared to Cu. quinquefasciatus infected with WNV. 
To further elucidate the role of AeVago1 in the Wolbachia-mediated suppression of virus 
replication, we knocked down AeVago1 in Wolbachia-infected Ae. aegypti cells finding a 
significant increase in the DENV titre without affecting the density of Wolbachia thus 
confirming its role as an antiviral host gene that is altered in the presence of Wolbachia to 
reduce DENV replication. However, this does not seem to be a widespread mechanism(s) by 
which Wolbachia imparts its virus blocking effect. In light of the abovementioned results 
further investigations are required to find out the exact mechanism(s) governing the DENV 
evasion of AeVago1 induction and how Wolbachia infection leads to alteration of AeVago1 to 
limit DENV replication. 
Decrease in Pelo upon Wolbachia infection and its possible effect on DENV replication 
Flaviviruses are well known to hijack the host cellular machinery, including proteins involved in 
translation. Pelo is a multifunctional protein that is mainly involved in translational regulation 
(Davis and Engebrecht, 1998) and regulation of germ cells meiosis (Lin et al., 1996) along 
with other cellular functions, but also participates in viral protein synthesis in the case of DCV 
(Wu et al., 2014), and TYLC replication (Lapidot et al., 2015). In this study (Chapter 3), we 
looked into the possible role of pelo in relation to Wolbachia-Ae. aegypti-Wolbachia 
interactions. Experiments conducted on Wolbachia-infected and uninfected mosquitoes and 
cells showed that there was a significant decrease in pelo expression in the case of 
Wolbachia infection in only female Ae. aegypti mosquitoes, but not in its natural host D. 
melanogaster (flies) and Ae. albopictus (cell line). This is similar to our observations in regards 
to AeCHD7 and AeVago1. Further experiments carried out at the tissue level also 
demonstrated downregulation of pelo in all major tissues including salivary gland, midgut, 
muscles, ovary and fat body in Wolbachia-infected mosquitoes. Pelo is a highly-conserved 
protein that has a well distinct nuclear localization signal (Shamsadin et al., 2000), however, 
pelo is mainly found in the cytoplasm and there is lack of experimental evidence of its 
localization inside the nucleus (Xi et al., 2005). Here, we showed that Wolbachia infection 
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leads to a change in subcellular localization of the pelo protein resulting in its translocation 
into the nucleus, making it less available in its active location that is the cytoplasm. 
To look into the mechanism(s) involved in the Wolbachia-mediated reduction of pelo, we 
examined the possible involvement of miRNA-mediated regulation by using in silico tools and 
found that aae-miR-2940-5p, that has been previously reported to be highly induced in the 
presence of Wolbachia (Hussain et al., 2011), could be a potential target of the miRNA. A 
series of experiments conducted by transient overexpression of aae-miR-2940-5p showed 
reduction of pelo at both transcript and protein levels, but target validation experiment using a 
reporter gene revealed that pelo is not a direct target of the miRNA. This suggests that pelo 
could be regulated by aae-miR-2940-5p in an indirect manner. This indirect regulation of pelo 
by miRNA could be due to regulation of transcription factor(s) that might fine-tune the 
abundance of pelo transcripts. 
Further investigation of the effect of DENV on pelo protein expression revealed that there was 
a significant increase in the expression levels of the protein upon DENV infection without 
changing its subcellular localization, signifying the potential involvement of the pelo protein in 
DENV replication. Knock down studies of pelo revealed significant reductions in DENV virion 
production without significant reduction in the genomic RNA level, suggesting the potential 
important role of pelo in DENV virion production. This result is consistent with a previous 
finding that has demonstrated involvement of pelo in DCV (Wu et al., 2014) and TYLCV 
replication (Lapidot et al., 2015). 
Although Wolbachia-mediated suppression of pelo appears to lead to reduction in DENV 
virion production in Ae. aegypti mosquitoes, this does not seem to be a general mechanism(s) 
which Wolbachia uses in different species to overcome viral replication. The abovementioned 
findings have identified a novel molecular mechanism that Wolbachia adopts in Ae. aegypti 
mosquitoes to supress another pro-viral protein (pelo) to limit DENV virion production. 
However, further studies are required to gain a deeper understanding of the exact role of the 
pelo protein inside the nucleus, the transcription factor(s) or other protein(s) regulated by aae-
miR-2940-5p which in turn could downregulate pelo transcript levels, and the potential 
Wolbachia proteins that might interact with the host pelo protein. 
5.2. Conclusion 
In this study, we have unravelled the novel molecular mechanism(s) that Wolbachia opts in 
Ae. aegypti mosquitoes to limit DENV replication. Our findings demonstrate that in the 
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presence of Wolbachia Ae. aegypti host factors AeCHD7, AeVago1 and Pelo, which are 
important in regulating DENV replication, are altered. Although all the above said molecular 
mechanism(s) are specific to Ae. aegypti mosquitoes, these highlight the complexity of 
Wolbachia relations with different host species (Bourtzis et al., 2000; Martinez et al., 2014). 
Similar to our findings, a number of studies have highlighted unique effects of Wolbachia on 
transinfected Ae. aegypti including activation of ROS, Toll pathway and antimicrobial peptides 
contributing toward the inhibition of DENV (Pan et al., 2012; Rainey et al., 2014; Rances et al., 
2012). The outcomes of this study will contribute toward better understanding of Wolbachia-
Ae. aegypti-DENV molecular interactions.  
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Abstract
Dengue virus (DENV) is a mosquito-transmitted virus imposing a significant burden 
on human health around the world. Since current control strategies are not sufficient, 
there is an urgent need to find alternative methods to control DENV transmission. It 
has been demonstrated that introduction of Wolbachia pipientis in Aedes aegypti 
mosquitoes can impede DENV transmission with the mechanism(s) not fully 
understood. Recently, a number of studies have found the involvement of 
chromodomain DNA binding helicases in case of Human Immunodeficiency virus 
(HIV) and Influenza A virus infection. In this study, we have identified three 
chromodomain helicase DNA binding protein (CHD) genes in Ae. aegypti and looked 
at their response in the case of Wolbachia and DENV infections. Foremost amongst 
them we have found that AeCHD7/Kismet is significantly downregulated in the 
presence of Wolbachia infection only in female mosquitoes. Furthermore, AeCHD7 
levels showed significant increase during DENV infection, and AeCHD7 depletion led 
to severe reduction in the replication of DENV. Our data have identified AeCHD7 as 
a novel Ae. aegypti host factor that is important for DENV replication, and Wolbachia 
downregulates it, which may contribute towards the mechanism(s) of limiting DENV 
replication. 
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Introduction 
Among arboviruses, dengue virus (DENV) is one of the most important flaviviruses 
having the potential to affect two-thirds of the world’s population 1,2. DENV is 
primarily transmitted to humans through the bit of mosquito vector Aedes aegypti, 
leading to dengue infection and potentially dengue haemorrhagic fever 3-5. Lack of 
availability of an effective vaccine and proper medical care has narrowed DENV 
management strategies to vector control. One of the strategies used to overcome 
DENV vector Ae. aegypti is through the application of pesticides, but due to their 
severe consequences on the environment and the emergence of resistance to 
pesticides, their potential application seems bleak in the near future 6. Therefore, 
new strategies for vector control are urgently needed. One of the novel options is the 
use of an endosymbiotic bacterium Wolbachia which has recently been 
demonstrated to limit DENV, West Nile virus (WNV), and Zika virus (ZIKV) 
replication in Ae. aegypti 7-10.  
Wolbachia pipientis is an alphaproteobacterium that naturally infects almost 40-60% 
of insect species 11,12. This bacterium is maternally transmitted and is usually 
associated with manipulations of host reproduction, such as feminization 13 and male 
killing 14, to promote successful colonization of its host species. Wolbachia naturally 
infects several mosquito species, including Aedes albopictus and Culex pipiens 15. 
However, there is no natural Wolbachia infection in the case of Ae. aegypti, which is 
the most notorious vector for several arboviruses. In order to exploit Wolbachia’s 
potential to limit arbovirus transmission, three strains of Wolbachia, wAlbB (from Ae.
albopictus) 16, wMel (from Drosophila melanogaster) 17 and wMelPop-CLA (from D.
melanogaster) 18 have been successfully transinfected into Ae. aegypti. Among 
these three strains, wMel and wMelPop-CLA are the most promising ones for virus 
blocking 7-10,19,20. However, the exact mechanism(s) by which Wolbachia blocks viral 
replication in Ae. aegypti mosquitoes is still elusive. Few studies that have looked 
into the transcriptional changes in Ae. aegypti mosquitoes upon Wolbachia infection 
have found increased redox and mitochondrial activity along with differential serine 
protease activity 21-23. However, very little is known about the role of chromatin 
remodelers in the case of DENV-Aedes-Wolbachia molecular interactions. 
Chromodomain helicase DNA binding proteins (CHD) represent a class of ATP-
dependent chromatin remodelling enzymes that contribute towards invoking changes 
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in the interaction between DNA and nucleosomes 24, influencing a wide array of 
cellular processes such as replication, transcription, recombination, repair and 
development 25. Members of the CHD family have been found to be involved in 
replication of Human Immunodeficiency virus (HIV) and Influenza A virus 26,27. All the 
CHD protein family members have a pair of chromodomains at their N-terminus 
along with one sucrose non-fermenting (SNF2) domain in the centre 25. In humans, 
the CHD family has nine members. These are further classified, on the basis of 
additional motif features, into three subfamilies: CHD1-2 (class I), CHD3-5 (Class II) 
and CHD 6-9 (class III) 25,28. In D. melanogaster, there are three well characterized 
CHD members named CHD1 29, Mi2 30 and Kismet/CHD7 31. CHD1 is essential for 
the fecundity of both males and females and is indirectly involved in transcriptional 
elongation 32, whilst Mi2 actively participates in transcriptional repression and is vital 
for expression of heat shock proteins 33,34. Drosophila Kismet, that is a homolog of 
human CHD7, mediates transcriptional elongation 35. Apart from characterization of 
the CHD family members’ role in development and chromatin modification, very little 
is known about their potential role in host-pathogen interactions. 
In this study, we have identified functional homologs of the CHD family members in 
Ae. aegypti and looked at the effect of Wolbachia infection on their expression. 
There was significant reduction in the expression of all CHD family members in the 
presence of Wolbachia. Furthermore, we found that AeCHD7 is highly induced 
during DENV infection in Ae. aegypti mosquitoes. A silencing assay demonstrated 
that AeCHD7 is required for the efficient replication and virion production of DENV. 
This study will help to understand the role of AeCHD7 in DENV-Aedes-Wolbachia 
interactions. 
Results 
Screening of the CHD family genes during Wolbachia infection 
Three CHD genes were identified in the Ae. aegypti genome using Vectorbase 36. 
Blastp was run to identify their homologs in D. melanogaster and Culex
quinquefasciatus, and these were determined as AeCHD1 (AAEL004716) having 
58% identity with D. melanogaster CHD1 protein (NP_477197.1), AeCHD3 
(AAEL013136) that showed 70% identity with D. melanogaster CHD3 protein 
(AAD17276.1) and AeCHD7 (Kismet) (AAEL002230) showing 58% identity with D.
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melanogaster Kismet/CHD7 protein (NP_001245820.1). qPCR primers were 
designed for all the three AeCHD family members to experimentally validate their 
expression in Ae. aegypti mosquitoes by RT-qPCR, and the effect of Wolbachia 
(wMelPop) infection on their expression level. For this, we selected two age groups 
of Ae. aegypti mosquitoes, 4-day- and 12-day-old. While expression of all the three 
AeCHD genes was confirmed in the mosquitoes, they were all mostly downregulated 
in Wolbachia-infected mosquitoes (Figure 1A-F), except for AeCHD3, which was 
found to be non-significantly upregulated in 4-day-old Wolbachia-infected 
mosquitoes (Figure 1C). However, AeCHD7 showed the highest change of 2.9-fold 
downregulation in 4-day-old Ae. aegypti female mosquitoes (Figure 1E), which led us 
to further characterise the gene. 
AeCHD7 is ubiquitously expressed in all mosquito tissues 
In order to determine the relative abundance of AeCHD7 across different tissues, the 
salivary gland, midgut, muscle, ovary and fat body were isolated from 3-day-old 
female Ae. aegypti mosquitoes. Following RT-qPCR detection of AeCHD7 mRNA 
transcripts, it was found that AeCHD7 is ubiquitously expressed in all tissues with the 
highest expression level in the salivary gland, which was 2.1-fold higher than its 
expression level in the fat body which showed the lowest relative abundance of 
AeCHD7 transcripts (Figure 2). These results are consistent with the previous 
findings which showed that AeCHD7 is expressed in all human tissues 37. 
Specific Wolbachia-mediated downregulation of AeCHD7 in female Ae. aegypti  
To find out whether Wolbachia-mediated downregulation of AeCHD7 is gender 
specific, we evaluated the transcript levels of AeCHD7 in 4-day-old female and male 
Ae. aegypti mosquitoes with and without Wolbachia infection. RT-qPCR results 
showed that Wolbachia downregulates AeCHD7 only in female mosquitoes and not 
in their male counterparts (Figure 3A). This is interesting in the sense that Wolbachia 
has a gender specific effect on gene expression in the mosquitoes. To examine if the 
effect can consistently be seen in cell lines as well, we cross-validated the AeCHD7 
mRNA expression levels in Ae. aegypti cell lines, Aag2 and Aag2 infected with 
wMelPop-CLA (Pop) and found a similar trend of AeCHD7 transcript downregulation 
in Wolbachia-infected cells (Figure 3B). 
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Furthermore, to evaluate if Wolbachia has a similar effect on the CHD7 gene in its 
natural host D. melanogaster, four 7-day-old male and female flies infected with 
Wolbachia (wMelPop strain) were examined for the relative expression of CHD7. RT-
qPCR results confirmed that there was no significant change in the level of CHD7 
mRNA in both male and female D. melanogaster flies infected with Wolbachia 
(Figure 3C). 
AeCHD7 is upregulated upon DENV infection 
Considering the virus blocking effect of Wolbachia in Ae. aegypti mosquitoes, we 
examined the transcript levels of AeCHD7 in the context of mosquito-DENV 
interaction. For this, the transcript levels of AeCHD7 in DENV-injected mosquitoes at 
three different time points of 2, 6 and 12 days post-infection (dpi) were analysed. To 
have a more consistent and high success rate of DENV infection, mosquitoes were 
injected rather than orally fed with the virus. The results revealed that there was an 
increase in the AeCHD7 transcript levels upon DENV infection at all the time points 
(Figure 4A-C); however, the upregulation was only significant at 2 and 12 dpi, which 
was 2-fold (Figure 4A) and 4-fold higher than that in uninfected mosquitoes (Figure 
4C), respectively. The aforementioned findings were further confirmed in the Ae.
aegypti cell line, Aa20. Cells were infected with DENV2 at 0.1 multiplicity of infection 
(MOI) and were harvested at two different time points that were 1 and 5 dpi. RT-
qPCR analysis showed significant increase in AeCHD7 transcript levels in the case 
of DENV infection at both 1 and 5 dpi (Figure 4D). Infection was confirmed by 
relative quantification of DENV genomic RNA levels, which showed gradual increase 
in DENV genomic RNA over time (Figure 4E). 
AeCHD7 is required for efficient DENV replication 
The upregulation of AeCHD7 in DENV-infected cells suggested that the gene could 
be beneficial for the virus. To investigate whether AeCHD7 is required for efficient 
DENV replication, we knocked down AeCHD7 transcripts in Aa20 cells and 
challenged these cells with DENV at 1 MOI for 72 h. The effect of CHD7 knockdown 
on DENV was evaluated both at the genomic and the virion levels using RT-qPCR 
and plaque assay. RT-qPCR results confirmed ~50% decrease in AeCHD7 mRNA 
level (Figure 5A), which led to 2-fold reduction in DENV genomic RNA (Figure 5B). 
RT-qPCR results were further validated with plaque assay, which confirmed 
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reduction in DENV virion production in AeCHD7 knocked down cells as compared 
with dsGFP or mock-transfected Aa20 cells (Figure 5C). These results indicate that 
AeCHD7 is a host factor that is used by DENV to facilitate its replication in Ae.
aegypti female mosquitoes, and Wolbachia downregulates AeCHD7 as shown 
above, which may contribute to restricting DENV replication.
Discussion 
There is accumulating experimental evidence showing the effectiveness of 
Wolbachia in supressing the replication of several flaviviruses, including DENV, 
ZIKV, WNV, and the alphavirus chikungunya virus (CHIKV) in both mosquitoes and 
mosquitoes-derived cell lines 8,10,38. Perhaps the most well studied is the case of 
DENV replication that is severely compromised in the presence of Wolbachia 39-41. 
However, the exact mechanism(s) of how Wolbachia imparts this antiviral effect is 
not yet fully understood. In this study, we provide experimental evidence that 
chromodomain DNA binding helicase 7 (AeCHD7) is an Ae. aegypti host factor that 
is exploited by DENV to facilitate its replication, and its downregulation by Wolbachia
may contribute to limit DENV replication. 
Wolbachia is an endosymbiont bacterium infecting 40-60% of insect species 
naturally 11 by manipulating host reproduction 12. Despite fitness costs, Wolbachia 
may benefit its host by blocking a variety of RNA viruses15,42. However, Wolbachia 
has not been found naturally infecting the most notorious vector Ae. aegypti, that is 
responsible for transmitting multiple viral diseases 18. McMeniman et al transinfected 
different strains of Wolbachia into Ae. aegypti mosquitoes 43 and found that they 
successfully inhibited replication of DENV and CHIKV 38. Further studies also 
demonstrated Wolbachia’s ability to block WNV and ZIKV in the mosquito 8-10. 
Wolbachia’s potential to be used as an invaluable tool for disease control and 
prevention represents an increasingly promising approach to limit several mosquito-
borne viral diseases, and it is fascinating to explore the exact mechanism(s) that 
induce the antiviral effect. Apart from one study shedding light on the effect of 
Wolbachia infection on the global DNA methylation pattern in mosquitoes 44, there 
lies a huge grey area of the role of chromatin remodelers, in Wolbachia-host 
interactions and possibly the Wolbachia-mediated antiviral effect. 
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CHD proteins represent a class of proteins that belong to SNF2 superfamily of ATP-
dependent chromatin modifiers. In mammals, there are 1-9 CHD proteins; however, 
in D. melanogaster, there are only three CHD proteins named CHD1, Mi2 and 
Kismet 25. Members of the CHD family are involved in conducting a wide array of 
functions, including ATPase activity to maintain chromosome structure and 
regulation of heterochromatic elements 29, nucleosome mobilization 45, 
transcriptional regulation and elongation 46-49, and development and differentiation 31. 
Despite extensive characterization of CHD family proteins, their role in shaping host-
pathogen interactions has not been much investigated. Yet, there are few reports 
supporting the involvement of CHD1 in the case of influenza A virus, and both CHD1 
and CHD2 in the case of HIV as positive regulators 26,27. Furthermore, RNAi screen 
carried out in D. melanogaster S2 cells identified the involvement of CHD7/Kismet in 
antimicrobial humoral response 50. The aforementioned facts led us to investigate the 
possible role of the CHD family in Wolbachia-Aedes-DENV interactions. Data mining 
in VectorBase resulted in the identification of three potential AeCHD proteins in the 
Ae. aegypti genome. Protein blast results identified them as AeCHD1, AeCHD3/Mi2 
and AeCHD7/Kismet. In order to find out whether Wolbachia regulates the AeCHD 
genes during infection, RT-qPCR was performed to examine the transcript levels of 
all the three AeCHDs with and without Wolbachia infection in whole mosquitoes. Our 
results showed that there was a uniform trend of downregulation of the AeCHD 
genes transcript levels in Wolbachia-infected mosquitoes (Figure 1A-F), except 
those of AeCHD3 in 4-day-old Wolbachia-infected female mosquitoes, which showed 
a non-significant upregulation (Figure 1C). The reduction in the CHD genes was 
more pronounced in 12-day-old mosquitoes, which could be due to increases in the 
Wolbachia load as the mosquitoes ages. In particular, the wMelPop strain is a 
virulent strain that may cause tissue damage and sickness. The reductions in the 
AeCHD genes at this late stage may not be of benefit in affecting DENV replication. 
However, AeCHD7 showed the highest fold change reduction (Figure 1E-F) in both 
4- and 12-day-old Wolbachia-infected mosquitoes, which prompted us to further
investigate this gene in the context of Wolbachia-Aedes-DENV interactions.
AeCHD7/Kismet belongs to subfamily III of the CHD proteins that comprises CHD5-9 
proteins. This subfamily is defined by the presence of two chromodomains at the N-
terminus, one SNF2-like ATPase domain located in the central region of the protein 
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structure (9,10) and a Brahma and Kismet (BRK) domain at the C-terminus 25.  To 
find out whether the Ae. aegypti homolog fulfils this particular protein signature, 
NCBI conserved domain finder was used to detect the conserved domains 51. 
Results confirmed the presence of all the domains characteristic of CHD7/Kismet 
proteins (Figure S1). Furthermore, in order to check the conservation of CHD7 
across species, CHD7/Kismet amino acids were retrieved from Uniprot (Figure S2A) 
and subjected to maximum likelihood phylogenetic tree construction. Phylogenetic 
results showed that Ae. aegypti CHD7 is closely related to Cx. quinquefasciatus but 
not to that of D. melanogaster or H. sapiens (Figure S2B). To find out the tissue-
specific expression of AeCHD7, RT-qPCR was performed, which revealed that it is 
ubiquitously expressed across all main mosquito tissues (Figure 2), which is 
consistent with the findings in humans 37. 
In this study we found that AeCHD7 was significantly downregulated in Wolbachia-
infected mosquitoes. To further investigate whether this Wolbachia-mediated 
downregulation of AeCHD7 in female Ae. aegypti is gender specific and can also be 
seen in its natural host D. melanogaster, RT-qPCR was employed. Interestingly, we 
found that in the presence of Wolbachia AeCHD7 was specifically downregulated in 
female Ae. aegypti only (Figure 3A), and there was no change in CHD7/Kismet 
transcript levels in both female and male D. melanogaster with and without 
Wolbachia (Figure 3B). This difference in Wolbachia-mediated regulation of 
CHD7/Kismet in Ae. aegypti and D. melanogaster may be due to the fact that 
Wolbachia is a natural symbiont in D. melanogaster with a long association, while it 
has been recently transinfected into Ae. aegypti 52. In regards to the mechanism by 
which Wolbachia infection may affect expression of AeCHD7, one can only 
speculate at this stage as there is very little information in regards to how Wolbachia 
manipulates its host at the molecular level. Only very recently, some molecular data 
have become available showing that Wolbachia infection leads to changes in the 
transcriptome or small RNA profiles of infected mosquitoes 23,53. Regulation of host 
gene expression could be due to components secreted from the endosymbiont, 
including small non-coding RNAs 54 or host response to accommodating the 
endosymbiont, in particular in new associations. However, how Wolbachia infection 
leads to these changes in the host remains to be investigated. 
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Viruses are the master manipulators of their host environment for their own benefit. 
Recently, it has been reported that CHD1 and CHD2 proteins play a pivotal role in 
the replication of influenza and HIV viruses 26,27. Both viruses replicate inside the 
nucleus. Interestingly, it has further been demonstrated that CHD1 interacts with 
RNA polymerase II to facilitate influenza A virus 27. Little is known about the role of 
CHD7/Kismet in the context of virus infection. However, the presence of conserved 
chromodomains and a SNF2 domain makes it highly likely that all the CHDs share 
similar functions 25. We were intrigued to find what happens to AeCHD7 during 
DENV infection. RT-qPCR performed in DENV-infected mosquitoes at different time 
points suggested a continuous trend of upregulation during DENV infection (Figure 
4A-C), which points to the fact that it might play an important role in DENV 
replication. To investigate the role of AeCHD7 in DENV replication further, AeCHD7 
knockdown study was carried out, which revealed that AeCHD7 is vital for DENV 
replication and virion production (Figure 5A-C). Very few studies that have been 
carried out on the involvement of CHDs in virus replication have predominantly 
focused on viruses that replicate inside the nucleus. Therefore, the role of CHDs in 
the replication of viruses that multiply in the cytoplasm (such as DENV) is not known. 
However, it has been demonstrated that DENV capsid 55,56 and NS5 proteins go 
inside the nucleus 57,58 with NS5 known to be involved in disrupting nucleosome 
formation 59. Therefore, these viral proteins may play a role in modulating AeCHD7 
expression during virus infection. While we have found the involvement of AeCHD7 
in mosquito-DENV interaction, the exact mechanism(s) that govern the interaction 
need further investigation. 
In summary, we have demonstrated that AeCHD7 facilitates DENV replication, and 
Wolbachia-mediated downregulation of AeCHD7 in female Ae. aegypti may 
contribute to restriction of DENV replication. However, this mechanism is highly 
specific to female Ae. aegypti mosquitoes and does not appear to be a universal 
mechanism which Wolbachia employs across different hosts to block viral 
replication.
Materials and Methods 
Mosquitoes and flies 
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For Wolbachia studies, mosquitoes had been previously generated by McMeniman 
et al. (2008) by transinfecting wMelPop-CLA strain of Wolbachia (Pop) into Ae.
aegypti embryos, and uninfected mosquitoes were obtained through tetracycline 
(Tet) treatment of the infected mosquitoes 43. w1118 fly line stably infected with 
wMelPop-CLA and the tetracycline cured line were generated by Min et al. (1997) 60 
and kindly provided by Dr Karyn Johnson from the University of Queensland. 
For DENV infection studies, Ae. aegypti eggs were collected in Townsville in August 
2015 and reared in insectary at Public Health Virology FSS.  Five-day-old Ae.
aegypti (F3) were used for the experiments. DENV2 NGC strain obtained from Prof. 
Roy Hall’s Lab (University of Queensland, School of Chemistry & Molecular 
Biosciences, Brisbane, Australia), was diluted in Opti-MEM (GIBCO Life 
Technologies, Grans Island, NY) supplemented with 3% foetal bovine serum (FBS, 
Bovogen Biologicals, France) and intrathoracically injected (200µl) in 5-day-old 
mosquitoes at 105.8/mL (102.1 per dose).  Mosquitoes were placed into netted 900 mL 
containers at 28°C with light:dark (L:D) 12:12 hours cycle and at high humidity. 
Mosquitoes were offered 15% honey water ad libitum. Mosquitoes were collected at 
2, 6 and 12 dpi for downstream applications. 
Cell cultures 
Ae. aegypti Aag2 cell line and Aag2 cells infected with wMelPop-CLA, previously 
described by 61, were maintained in 1:1 Mitsuhashi-Maramorosch and Schneider’s 
insect medium (Invitrogen) supplemented with 5-10% FBS, while Aa20 cells were 
maintained in L15 medium (Invitrogen) supplemented with 10% tryptose phosphate 
broth (TPB) and 5% FBS. All mosquito cell lines were kept at 28°C and passaged 
every 3-4 days. 
Vero cells were maintained in OptiMEM medium supplemented with 2% FBS and 
were kept at 37°C in the presence of 5% CO2. 
RT-PCR and qPCR analyses 
Total RNA was extracted from mosquitoes (1-5 mosquitoes per biological replicate) 
or flies (1-5 flies per biological replicate) using Qiazol (Qiagen) and then treated with 
Turbo DNase (Ambion) according to the manufacturers’ instructions. 750-1000 ng of 
total RNA was then used to make the 1st strand cDNA using Superscript III 
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(Invitrogen) with either oligo-dT primer for cellular transcripts or with DENV-qR 
primer in order to amplify the DENV genomic RNA. 
For qPCR, cDNA produced as above was diluted in 1:5 ratios with nuclease free 
water. 2µl of the diluted cDNA was used for downstream qPCR reaction. Both 
forward and reverse gene-specific primers were used to amplify the target genes 
(primer sequences in Table S1), using QuantiFast SYBR Green (Qiagen) in a 
Rotorgene qPCR machine (Qiagen). For Ae. aegypti samples, RPS17 transcript 
levels were used for the normalization of RNA templates, while RPL32 was used for 
normalization of D. melanogaster samples. Each qPCR reaction was performed in 
duplicates with at least three biological replicates. All qPCR data were normalized 
with Qiagen analysis templates and were further analysed by Prism 7.0. Unpaired t-
test was used to determine statistical significance between two individual groups 
while one-way ANOVA with Tukey’s post-hoc test was performed to find statistical 
significance between more than two groups of data. 
RNAi-mediated gene silencing 
In order to knockdown the AeCHD7 gene for functional analysis in DENV life cycle, 
primers were designed to amplify a 586 bp product from the AeCHD7 gene with the 
addition of the T7 promoter sequences at both ends (Table S1). MEGAscript T7 
Transcription kit was then used according to the manufacturer’s instructions in order 
to synthesize dsRNA targeting the AeCHD7 transcripts. A similar approach was 
followed to synthesize dsRNA against GFP RNA. For knockdown experiments, Aa20 
cells were double transfected with 2-5µg of dsRNA per well against the target gene. 
dsGFP RNA was used as non-specific control. 
Virus infection and plaque assay 
For virus inoculation experiments, Ae. aegypti Aa20 were seeded at the density of 
3x105 cells per well in 12-well plates. Cells were first double transfected with dsRNA 
against the target gene or GFP control and after 6 h cells were infected with DENV2 
(New Guinea strain) at the 1 multiplicity of infection (1 MOI). Media were collected 72 
h post-infection for plaque assay. 
To perform plaque assay, Vero cells were seeded in a 96-well plate and were 
allowed to form monolayers. Virus containing media from the experiments were 
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serially diluted into 100 ,101 ,102 ,103 dilutions and added to Vero cells in duplicates. 
Cells were incubated with virus at room temperature with continuous shaking on 
shaker for 1 h and then incubated at 37ºC for one additional hour. After 2 h of 
incubation, media were aspirated and an overlay was added to the cells which 
comprised of 1.5% carboxymethyl cellulose (CMC) and 2.5% FBS in Opti-MEM 
medium (Sigma). Cells were then incubated for 72 h at 37oC and 5% CO2 and fixed 
with 80% ice-cold acetone in 1 PBS for 20 min at -20ºC. Plates were then air dried 
overnight and blocked with 5% skimmed milk in 1×PBST at 37oC for 30 min. Cells 
were then incubated with the primary antibody against DENV2-Envelope (human) in 
1:1000 dilution in 0.1% skimmed milk in 1×PBST for 2 h at 37oC as described 
previously 62. Plates were washed 3 times with 1×PBST and incubated with the 
secondary antibody (IRDye 800CW goat anti-human LICOR) for 1 h at 37oC. Plates 
were washed and dried as above and were dried and scanned on the Odyssey 
imager (LI-COR Biosciences) at 41µM resolution. 
Acknowledgements 
We are thankful to Dr Karyn Johnson and Verna Hearne from UQ for providing D.
melanogaster wMelPop-infected and tetracycline cured flies, and Prof Paul Young 
from UQ for providing the anti-DENV antibody. Special thanks to Solomon-Osei-Amo 
(UQ) for critical reading of the manuscript. This project was supported by a National 
Health Medical Research Council grant (APP1062983) to S Asgari and a UQ 
International scholarship to S Asad. 
Authors’ contributions 
SAsa conceived and designed research, carried out experiments, analysed the data 
and drafted the manuscript. SHM carried out experiments and edited the manuscript. 
SAsg designed research and edited the manuscript. All authors read and approved 
the final manuscript. 
Additional Information 
Competing financial interests. The authors declare no competing financial 
interests. 
131 
References 
1 Bhatt, S. et al. The global distribution and burden of dengue. Nature 496, 504-507 
(2013). 
2 Gubler, D. J. Dengue/dengue haemorrhagic fever: history and current status. 
Novartis Found Symp 277, 3-16; discussion 16-22, 71-13, 251-253 (2006). 
3 Diosa-Toro, M., Urcuqui-Inchima, S. & Smit, J. M. Arthropod-borne flaviviruses and 
RNA interference: seeking new approaches for antiviral therapy. Adv Virus Res 85, 
91-111 (2013).
4 Gubler, D. J. Dengue and dengue hemorrhagic fever. Clin Microbiol Rev 11, 480-496
(1998).
5 Lambrechts, L., Scott, T. W. & Gubler, D. J. Consequences of the expanding global
distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis 4,
e646 (2010).
6 Marcombe, S. et al. Insecticide resistance in the dengue vector Aedes aegypti from
Martinique: distribution, mechanisms and relations with environmental factors. PLoS
One 7, e30989 (2012).
7 Iturbe-Ormaetxe, I., Walker, T. & O'Neill, S. L. Wolbachia and the biological control of
mosquito-borne disease. EMBO Rep 12, 508-518 (2011).
8 Hussain, M. et al. Effect of Wolbachia on replication of West Nile virus in a mosquito
cell line and adult mosquitoes. J Virol 87, 851-858 (2013).
9 Aliota, M. T., Peinado, S. A., Velez, I. D. & Osorio, J. E. The wMel strain of
Wolbachia reduces transmission of Zika virus by Aedes aegypti. Sci Rep 6, 28792
(2016).
10 Dutra, H. L. et al. Wolbachia blocks currently circulating Zika virus isolates in
Brazilian Aedes aegypti mosquitoes. Cell Host Microbe 19, 771-774 (2016).
11 Zug, R. & Hammerstein, P. Still a host of hosts for Wolbachia: analysis of recent data
suggests that 40% of terrestrial arthropod species are infected. PLoS One 7, e38544
(2012).
12 Hilgenboecker, K., Hammerstein, P., Schlattmann, P., Telschow, A. & Werren, J. H.
How many species are infected with Wolbachia?--A statistical analysis of current
data. FEMS Microbiol Lett 281, 215-220 (2008).
13 Kageyama, D., Nishimura, G., Hoshizaki, S. & Ishikawa, Y. Feminizing Wolbachia in
an insect, Ostrinia furnacalis (Lepidoptera: Crambidae). Heredity 88, 444-449 (2002).
14 Riparbelli, M. G., Giordano, R., Ueyama, M. & Callaini, G. Wolbachia-mediated male
killing is associated with defective chromatin remodeling. PLoS One 7, e30045
(2012).
15 Caragata, E. P., Dutra, H. L. & Moreira, L. A. Exploiting intimate relationships:
Controlling mosquito-transmitted disease with Wolbachia. Trends Parasitol 32, 207-
218 (2016).
16 Xi, Z., Khoo, C. C. & Dobson, S. L. Wolbachia establishment and invasion in an
Aedes aegypti laboratory population. Science 310, 326-328 (2005).
17 Walker, T. et al. The wMel Wolbachia strain blocks dengue and invades caged
Aedes aegypti populations. Nature 476, 450-453 (2011).
18 McMeniman, C. J. et al. Stable introduction of a life-shortening Wolbachia infection
into the mosquito Aedes aegypti. Science 323, 141-144 (2009).
19 Frentiu, F. D. et al. Limited dengue virus replication in field-collected Aedes aegypti
mosquitoes infected with Wolbachia. PLoS Negl Trop Dis 8, e2688 (2014).
20 Hoffmann, A. A. et al. Successful establishment of Wolbachia in Aedes populations
to suppress dengue transmission. Nature 476, 454-457 (2011).
21 Kambris, Z., Cook, P. E., Phuc, H. K. & Sinkins, S. P. Immune activation by life-
shortening Wolbachia and reduced filarial competence in mosquitoes. Science 326,
134-136 (2009).
132 
22 Pan, X. et al. Wolbachia induces reactive oxygen species (ROS)-dependent 
activation of the Toll pathway to control dengue virus in the mosquito Aedes aegypti. 
Proc Natl Acad Sci U S A 109, E23-31 (2012). 
23 Rances, E., Ye, Y. H., Woolfit, M., McGraw, E. A. & O'Neill, S. L. The relative 
importance of innate immune priming in Wolbachia-mediated dengue interference. 
PLoS Pathogens 8, e1002548 (2012). 
24 Hopfner, K. P., Gerhold, C. B., Lakomek, K. & Wollmann, P. Swi2/Snf2 remodelers: 
hybrid views on hybrid molecular machines. Curr Opin Struct Biol 22, 225-233 
(2012). 
25 Marfella, C. G. & Imbalzano, A. N. The Chd family of chromatin remodelers. Mutat
Res 618, 30-40 (2007). 
26 Rodgers, M. J., Banks, D. J., Bradley, K. A. & Young, J. A. CHD1 and CHD2 are 
positive regulators of HIV-1 gene expression. Virol J 11, 180 (2014). 
27 Marcos-Villar, L., Pazo, A. & Nieto, A. Influenza virus and chromatin: Role of the 
CHD1 chromatin remodeler in the virus life cycle. J Virol 90, 3694-3707 (2016). 
28 Yap, K. L. & Zhou, M. M. Structure and mechanisms of lysine methylation recognition 
by the chromodomain in gene transcription. Biochemistry 50, 1966-1980 (2011). 
29 Bugga, L., McDaniel, I. E., Engie, L. & Armstrong, J. A. The Drosophila melanogaster
CHD1 chromatin remodeling factor modulates global chromosome structure and 
counteracts HP1a and H3K9me2. PLoS One 8, e59496 (2013). 
30 Khattak, S., Lee, B. R., Cho, S. H., Ahnn, J. & Spoerel, N. A. Genetic 
characterization of Drosophila Mi-2 ATPase. Gene 293, 107-114 (2002). 
31 Daubresse, G. et al. The Drosophila kismet gene is related to chromatin-remodeling 
factors and is required for both segmentation and segment identity. Development 
126, 1175-1187 (1999). 
32 McDaniel, I. E., Lee, J. M., Berger, M. S., Hanagami, C. K. & Armstrong, J. A. 
Investigations of CHD1 function in transcription and development of Drosophila
melanogaster. Genetics 178, 583-587 (2008). 
33 Kehle, J. et al. dMi-2, a hunchback-interacting protein that functions in polycomb 
repression. Science 282, 1897-1900 (1998). 
34 Murawska, M., Hassler, M., Renkawitz-Pohl, R., Ladurner, A. & Brehm, A. Stress-
induced PARP activation mediates recruitment of Drosophila Mi-2 to promote heat 
shock gene expression. PLoS Genet 7, e1002206 (2011). 
35 Srinivasan, S., Dorighi, K. M. & Tamkun, J. W. Drosophila Kismet regulates histone 
H3 lysine 27 methylation and early elongation by RNA polymerase II. PLoS Genet 4, 
e1000217 (2008). 
36 Giraldo-Calderon, G. I. et al. VectorBase: an updated bioinformatics resource for 
invertebrate vectors and other organisms related with human diseases. Nucleic Acids
Res 43, D707-713 (2015). 
37 Vissers, L. E. et al. Mutations in a new member of the chromodomain gene family 
cause CHARGE syndrome. Nat Genet 36, 955-957 (2004). 
38 Moreira, L. A. et al. A Wolbachia symbiont in Aedes aegypti limits infection with 
dengue, Chikungunya, and Plasmodium. Cell 139, 1268-1278 (2009). 
39 Bian, G., Zhou, G., Lu, P. & Xi, Z. Replacing a native Wolbachia with a novel strain 
results in an increase in endosymbiont load and resistance to dengue virus in a 
mosquito vector. PLoS Negl Trop Dis 7, e2250 (2013). 
40 Hughes, H. & Britton, N. F. Modelling the use of Wolbachia to control dengue fever 
transmission. Bull Math Biol 75, 796-818 (2013). 
41 Zhang, G., Hussain, M., O'Neill, S. L. & Asgari, S. Wolbachia uses a host microRNA 
to regulate transcripts of a methyltransferase, contributing to dengue virus inhibition 
in Aedes aegypti. Proc Natl Acad Sci U S A 110, 10276-10281 (2013). 
42 Johnson, K. N. The impact of Wolbachia on virus infection in mosquitoes. Viruses 7, 
5705-5717 (2015). 
43 McMeniman, C. J. et al. Host adaptation of a Wolbachia strain after long-term serial 
passage in mosquito cell lines. Appl Environ Microbiol 74, 6963-6969 (2008). 
133 
44 Ye, Y. H. et al. Infection with a virulent strain of Wolbachia disrupts genome wide-
patterns of cytosine methylation in the mosquito Aedes aegypti. PLoS One 8, e66482 
(2013). 
45 Brehm, A., Tufteland, K. R., Aasland, R. & Becker, P. B. The many colours of 
chromodomains. Bioessays 26, 133-140 (2004). 
46 Stokes, D. G., Tartof, K. D. & Perry, R. P. CHD1 is concentrated in interbands and 
puffed regions of Drosophila polytene chromosomes. Proc Natl Acad Sci U S A 93, 
7137-7142 (1996). 
47 Stokes, D. G. & Perry, R. P. DNA-binding and chromatin localization properties of 
CHD1. Mol Cell Biol 15, 2745-2753 (1995). 
48 Srinivasan, S. et al. The Drosophila trithorax group protein Kismet facilitates an early 
step in transcriptional elongation by RNA Polymerase II. Development 132, 1623-
1635 (2005). 
49 Tai, H. H. et al. CHD1 associates with NCoR and histone deacetylase as well as with 
RNA splicing proteins. Biochem Biophys Res Commun 308, 170-176 (2003). 
50 Kleino, A. et al. Inhibitor of apoptosis 2 and TAK1-binding protein are components of 
the Drosophila Imd pathway. EMBO J 24, 3423-3434 (2005). 
51 Marchler-Bauer, A. et al. CDD: NCBI's conserved domain database. Nucleic Acids
Res 43, D222-226 (2015). 
52 Hughes, G. L. & Rasgon, J. L. Transinfection: a method to investigate Wolbachia-
host interactions and control arthropod-borne disease. Insect Mol Biol 23, 141-151 
(2014). 
53 Hussain, M., Frentiu, F. D., Moreira, L. A., O’Neill, S. L. & Asgari, S. Wolbachia
utilizes host microRNAs to manipulate host gene expression and facilitate 
colonization of the dengue vector Aedes aegypti. Proc Natl Acad Sci USA 108, 9250-
9255 (2011). 
54 Mayoral, J. M. et al. Wolbachia small non-coding RNAs and their role in cross-
kingdom communications. Proc Natl Acad Sci USA 111, 18721-18726 (2014). 
55 Bulich, R. & Aaskov, J. G. Nuclear localization of dengue 2 virus core protein 
detected with monoclonal antibodies. J Gen Virol 73, 2999-3003 (1992). 
56 Wang, S. H. et al. Intracellular localization and determination of a nuclear localization 
signal of the core protein of dengue virus. J Gen Virol 83, 3093-3102 (2002). 
57 Brooks, A. J. et al. The interdomain region of dengue NS5 protein that binds to the 
viral helicase NS3 contains independently functional importin beta 1 and importin 
alpha/beta-recognized nuclear localization signals. J Biol Chem 277, 36399-36407 
(2002). 
58 Pryor, M. J. et al. Nuclear localization of dengue virus nonstructural protein 5 through 
its importin alpha/beta-recognized nuclear localization sequences is integral to viral 
infection. Traffic 8, 795-807 (2007). 
59 Colpitts, T. M., Barthel, S., Wang, P. & Fikrig, E. Dengue virus capsid protein binds 
core histones and inhibits nucleosome formation in human liver cells. PLoS One 6, 
e24365 (2011). 
60 Min, K.-T. & Benzer, S. Wolbachia, normally a symbiont of Drosophila, can be 
virulent, causing degeneration and early death. Proc Natl Acad Sci USA 94, 10792-
10796 (1997). 
61 Frentiu, F. D., Robinson, J., Young, P. R., McGraw, E. A. & O'Neill, S. L. Wolbachia-
mediated resistance to dengue virus infection and death at the cellular level. PLoS
One 5, e13398 (2010). 
62 Watterson, D. et al. A generic screening platform for inhibitors of virus induced cell 
fusion using cellular electrical impedance. Sci Rep 6, 22791 (2016). 
134 
Figure legends 
Fig. 1: Relative expression of AeCHD genes in uninfected and Wolbachia-
infected Ae. aegypti mosquitoes. RT-qPCR based quantification of (A-B)
AeCHD1, (C-D) AeCHD3, and (E-F) AeCHD7/Kismet genes in both Wolbachia-
infected (Pop) and uninfected (Tet) 4-day-old and 12-day-old female mosquitoes, 
respectively. Error bars represent standard error of mean (SEM) from three 
biological replicates (*, p<0.05; **, p<0.01). 
Fig. 2: Tissue-specific expression of AeCHD7/Kismet in Ae. aegypti 
mosquitoes. RT-qPCR results of AeCHD7/Kismet transcript levels in the salivary 
gland, midgut, muscles, ovaries and fat body of 3-day-old tetracycline treated female 
mosquitoes. Error bars represent SEM of the mean in three biological replicates. 
Fig. 3: Modulation of AeCHD7/Kismet by Wolbachia infection in male and 
female mosquitoes and flies, and mosquito cell lines. A) RT-qPCR analysis of 
AeCHD7 transcript levels in 4-day-old female and male mosquitoes, both uninfected 
(Tet) and infected with Wolbachia (Pop). B) Relative expression of AeCHD7 in Aag2 
and Aag2 cells infected with wMelPop-CLA (Pop). (C) Relative expression of the D.
melanogaster Kismet gene in uninfected (Tet) and Wolbachia-infected (Pop) flies. 
Error bars represent SEM from three biological replicates (**, p<0.01; ***, p<0.001; 
ns, not significant). 
Fig. 4: Expression pattern of AeCHD7 in DENV infected female Ae. aegypti. A-
C) RT-qPCR quantification of AeCHD7 transcript levels at 2, 6 and 12 days post
DENV infection of female Ae. aegypti mosquitoes. D) Relative transcript levels of 
AeCHD7 in Aa20 cells infected with 1 MOI of DENV2 analysed at 1 and 5 dpi. E) RT-
qPCR quantification of DENV2 genomic RNA in samples used in (D) confirming virus 
infection and replication. Error bars show SEM from three biological replicates (*, 
p<0.05; ***, p<0.001; ****, p<0.0001; ns, not significant). 
Fig. 5: Depletion of AeCHD7 impairs DENV replication both at the genomic and 
the virion levels. A) RT-qPCR analysis of Aa20 cells transfected with either no RNA 
(Mock) or with dsRNA against GFP as a control or with dsRNA against AeCHD7. 
RPS17 was used to normalize the qPCR data. Error bars show SEM from three 
biological replicates (*, p<0.05; **, p<0.01). B) RT-qPCR analysis of Aa20 cells 
treated as in (A) followed by DENV infection at 1 MOI using DENV-specific primers 
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to quantify viral genomic RNA. Error bars show SEM from three biological replicates  (**, 
p<0.01). C) Viral plaque visualization by in vitro cell plaque assay conducted on the 
supernatant media from cells treated as in (A and B). 
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Abstract 
Long intergenic non-coding RNAs (lincRNAs) are appearing as an important class of regulatory 
RNAs with a variety of biological functions. The aim of this study was to identify the lincRNA 
profile in the dengue vector Aedes aegypti and evaluate their potential role in host-pathogen 
interaction. The majority of previous RNA-Seq transcriptome studies in Ae. aegypti have focused 
on the expression pattern of annotated protein coding genes under different biological conditions. 
Here, we used 35 publically available RNA-Seq datasets with relatively high depth to screen the Ae.
aegypti genome for lincRNA discovery. This led to the identification of 3,482 putative lincRNAs. 
These lincRNA genes displayed a slightly lower GC content and shorter transcript lengths 
compared to protein-encoding genes. Ae. aegypti lincRNAs also demonstrate low evolutionary 
sequence conservation even among closely related species such as Culex quinquefasciatus and 
Anopheles gambiae. We examined their expression in dengue virus serotype 2 (DENV-2) and 
Wolbachia infected and non-infected adult mosquitoes and Aa20 cells. The results revealed that 
DENV-2 infection increased the abundance of a number of host lincRNAs, from which some of 
them suppress viral replication in mosquito cells. RNAi-mediated silencing of lincRNA_1317 led to 
enhancement in viral replication, which possibly indicates its potential involvement in the host anti-
viral defense. A number of lincRNAs were also differentially expressed in Wolbachia-infected 
mosquitoes. The results will facilitate future studies to unravel the function of lncRNAs in insects 
and may prove to be beneficial in developing new ways to control vectors or inhibit replication of 
viruses in them. 
Key words: non-coding RNA; Aedes aegypti; lincRNAs; Wolbachia; Dengue virus 
Author summary 
Aedes aegypti is a major vector of several viruses such as dengue and Zika viruses. Understanding 
the intricate interaction of viruses with mosquito vectors and the factors involved in virus 
replication are essential for developing effective arbovirus control strategies. In this study, we 
report a comprehensive list of long intergenic non-coding RNAs encoded by the genome of Ae.
aegypti for the first time. In addition, we show that a number of these long non-coding RNAs are 
differentially expressed in mosquitoes infected with dengue virus, which could be involved in 
DENV-mosquito interaction. The outcomes provide a new avenue to explore mosquito biology and 
mosquito-virus interactions that may lead to the discovery of molecules that could be beneficial for 
vector manipulation.  
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Introduction 
Dengue and Zika viruses are related mosquito-borne viruses that have a common vector,
Aedes aegypti and infect millions of people worldwide [1,2]. Recent outbreaks of Dengue and Zika 
in South America pose a serious risk for other tropical regions in the world as Ae. aegypti is one of 
the most abundant mosquito species in these areas [2]. Although certain vaccines have been 
licensed in some countries, there are no efficient specific therapeutics available for either diseases, 
hence, the best protection against their global spreading is an efficient vector control program [3,4]. 
The genome sequence of Ae. aegypti is available, however, it has not been fully annotated. 
Only 2% of its large genome (1.376 Mb) has been annotated as protein coding genes and it reflects 
the presence of great proportions of non-coding transcripts as well as repetitive elements [5]. 
Transcriptomic changes, including those of non-coding transcripts, could provide a genome scale 
insight into host-pathogen interactions. Previous studies identified a series of small ncRNAs in Ae.
aegypti and demonstrated their interaction with arboviruses [6-9], but our knowledge about their 
long ncRNAs is limited. 
RNA transcripts longer than 200 nucleotides, which do not contain an open reading frame of 
longer than 100 amino acids, are simply defined as long ncRNA [10]. Generally, they are classified 
by their location relative to their neighboring protein-coding genes and include the long intergenic 
ncRNA (lincRNA), intronic lncRNA, antisense lncRNA and enhancer RNA [10]. Although a 
number of mammalian lncRNAs have been characterized and identified in the last few years, 
genome-wide identification of this class of ncRNAs has only recently become possible with the 
arrival of deep sequencing technologies. An expanding body of evidence reveals that lncRNAs, 
once described as dark matter, are involved in many biological processes such as genomic 
imprinting and cell differentiation [11]. They also play important roles in epigenetic and non-
epigenetic based gene regulation [12]. Relatively, little is known about their involvement in 
activation and differentiation of immune cells, but new discoveries have revealed the involvement 
of lncRNA in defense systems [13]. Previous works have also outlined their quick responses to 
different stimuli and stress factors [14-17]. In addition, it has been shown that some lncRNAs 
enhance virus replication or decrease antiviral immunity [18]. 
Although in most host-virus interaction studies typically protein-coding genes have been the 
center of attention, there are few examples of virus and host lncRNA interactions in human and 
mouse models [18,19]. For instance, Hepatitis B virus (HBV) infection altered lncRNA profiles in 
patients, with about 4% of human lncRNAs showing more than 2-fold changes in HBV infected 
liver tissue [20]. Winterling et al. (2014) identified a virus inducible lncRNA, which is induced by 
vesicular stomatitis virus and several strains of Influenza A virus (IAV) [18]. 
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The sequence and structure of lncRNAs are important in their function, in particular for their 
interaction with DNA, RNA, or proteins. In case of extensive base-pairing of lncRNA with target 
mRNA, translation can be stabilized, while partial base-pairing may accelerate mRNA decay or 
inhibit translation of the target mRNA [21]. It has been shown that some lncRNAs interact with 
other small ncRNAs such as miRNAs. For example, in silkworm, 69 lncRNAs originating from 33 
gene loci, may serve as miRNA precursors, and 104 lncRNAs may function as competing 
endogenous RNAs (ceRNAs) [22]. LncRNAs are also targeted by miRNAs similar to mRNAs and 
reduce their stability. They may also act as sponge or decoy of miRNAs, and compete with 
miRNAs for binding to mutual target mRNAs [21]. 
In insects, only a few genes have been experimentally annotated as lncRNA. It has been 
estimated that more than 5000 loci potentially encode non-coding transcripts in Drosophila
melanogaster, however, just seven loci (bxd, Hsrω, pgc, roX1, rox2, sphinx and yar) have been 
annotated as functional regulatory lncRNAs by experimentally derived empirical data [23,24]. We 
recently found that a number of lncRNAs in Plutella xylostella, a pest of cruciferous plants, were 
linked to the insect’s resistance to insecticides and might be involve in detoxification processes 
[14]. Jenkins et al (2015) identified 2,949 lncRNAs in the malaria mosquito vector, Anopheles
gambiae, using RNA-Seq data [25]. They showed that in various Anopheles species, lncRNAs have 
considerably lower sequence conservation as compared with protein-coding genes. In another study, 
it has been shown that 43% of total midgut transcripts of An. gambiae are lncRNAs and 32% of 
them showed some level of homology to other species [26]. 
The current study generated a comprehensive list of Ae. aegypti lincRNAs, which will be a 
complement to the other ncRNAs (microRNAs and piRNAs) that have already been discovered in 
this medically important species. This work also helps to improve the present annotation of the 
genome of Ae. aegypti. We also examined the expression pattern of some selected lincRNAs in 
response to microbial challenge namely dengue virus serotype 2 (DENV-2) and Wolbachia 
infection to identify potential immune related lincRNAs in Ae. aegypti [27,28]. The results help 
better understanding of mosquito-pathogen interactions providing new insights on the potential role 
of lncRNAs as candidates for exploitation to inhibit replication of mosquito-borne viruses. 
Methods 
RNA-Seq Data preparation 
Previously sequenced RNA-Seq raw data of Ae. aegypti were downloaded from NCBI Sequences 
Read Archive and ArrayExpress Archive with accession numbers SRA048559, SRA058076, 
SRA244067 and ERP002530 [29-32]. Raw data were stripped of adapters using CLC Genomic 
Workbench version 7.5.1 and reads with quality score of above 0.05 and maximum 2 ambiguous 
sequences were retained for further analysis. 
Large gap mapping and transcript discovery 
The CLC Genomic workbench’s Transcript Discovery plugin was used for lincRNA 
discovery in the Ae. aegypti genome. New transcripts were identified by large gap mapping of 
1,148,814,115 reads of 35 RNA-Seq libraries to the genomic reference (AaegL3.3). We 
implemented strict mapping criteria (mismatch, insertion and deletion costs: 2: 3: 3 respectively). 
The minimum similarity and length fraction of 0.9 between a mapped segment and the reference 
were allowed as part of the mapping criteria. The large gap mapper algorithm also requires each 
mapped segment to include at least 10% of the read with minimum length of 17 bases. We 
considered a gap with maximum of 50 Kbp distance between mapped read segments to span the 
introns from RNA-Seq data. The annotations were generated by inspecting mapping of reads and 
identifying likely regions corresponding to genes, including their exons and splice sites. The 
algorithm scans each gap in the read mapping to explore whether the gap is assigned to a valid 
splice site or can be relocated to a valid splice site without cost. 
lincRNA identification pipeline 
A rigorous filtering pipeline was developed to remove transcripts that may potentially 
encode proteins. The pipeline for Ae. aegypti lincRNA discovery is summarized in Figure 1. We 
identified 75,069 potential genes using the CLC Genomic Workbench transcript discovery 
algorithm. The genes that were annotated as known Ae. aegypti protein-coding genes were 
discarded and 30,865 potential genes were also checked for any exon or intron overlap with other 
known Ae. aegypti protein-coding genes. We selected 22,079 sequences, which were located more 
than 1kb away from any other known transcripts, for finding putative open reading frames (ORF). 
All possible six frames were produced for all selected sequences and then the translated sequences 
were subjected to a domain search to identify any putative conserved protein domains through Pfam 
v27.0 database [33]. We discarded 8,795 sequences with potential ORF above 100 aa or conserved 
protein domains. The remaining sequences were submitted to a coding potential assessment tool 
(CPAT), which utilizes a logistic regression model made with four sequence features: ORF size, 
ORF coverage, Fickett TESTCODE statistics and hexamer usage bias [34]. We applied the coding 
probability threshold of 0.3, which led to discarding 376 sequences as putative coding RNAs. We 
also implemented an expression threshold on our data to strengthen the identification pipeline. 
Sequences with more than 10 mappable reads in at least 17 out of 35 RNA-Seq libraries were 
considered as valid sequences and were kept for the next step. Any possible similarity with other 
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known proteins was found by using BLASTx algorithm against nr and Swiss port database (E-value 
cut off 10-5). Finally, 3,842 potential lincRNAs were identified and used for further study. 
To identify Ae. aegypti putative lincRNAs that are regarded as small RNA associated 
lincRNAs, we used the Blast algorithm to search for Ae. aegypti precursor miRNA sequences in the 
predicted Ae. aegypti lincRNA dataset. We also used publicly available small RNA libraries from 
DENV-infected and non-infected samples (SRP026241) in this analysis for further characterization 
of lincRNA_1317. All known Ae. aegypti miRNA sequences were mapped to lincRNA_1317 for 
possible best fitting using RNAhybrid, which is a tool for finding the normalized minimum free 
energy (mfe) of RNA. We did not allow G:U pairing in the seed region (nucleotide 2-8) and 
required miRNA-lincRNA duplexes to have a helix in this region. Maximum 5nt were allowed as 
unpaired nucleotides in either side of an internal loop. LncTar algorithm [35] was used to explore 
any potential interaction between lncRNA_1317 and DENV-2 genome (accession no. 
NC_001474.2) by finding the normalized mfe joint structure of two RNA molecules based on base 
pairing. 
Identification of differentially expressed lincRNAs upon infection 
The Ae. aegypti genome was annotated with the final list of lincRNAs and used as reference 
for RNA-Seq analysis in CLC Genomic Workbench. To measure the lincRNA normalized 
expression value, RPKM (Reads Per Kilobase per Million reads) was assigned for each library [36]. 
To find the differential expression pattern in response to DENV infection, data from DENV-2 
(Jam1409) infected midgut and carcass tissues in 4 days post-infection (dpi), were compared with 
their corresponding control groups [30]. Baggerley's test, a count based statistical analysis was done 
on the data. The samples were given weights depending on their total counts. Based on the test “the 
weights are obtained by supposing a Beta distribution on the proportions in a group, and estimating 
these, along with the proportion of a binomial distribution”. We selected 20 potential lincRNAs 
with more than 4-fold change for further analysis with RT-qPCR in DENV-2 (New Guinea C 
strain) infected Ae. aegypti cell line (Aa20) and screened their expression profile in Wolbachia-
infected mosquitoes. 
Ae. aegypti infected with the wMelPop-CLA strain of Wolbachia (+Wol) and without 
Wolbachia (-Wol, tetracycline-cured line) were stocks produced previously [37]. For the 
experiments in this work, 4-day-old female mosquitoes were used from which total RNA was 
extracted with 6-10 adult mosquitoes for each biological replicates.
Expression analysis of Ae. aegypti lincRNAs 
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Detection and validation of the relative abundance of selected lincRNAs was carried 
through lincRNAs’ specific primers using SYBR Green chemistry in real time PCR machine. 
Briefly, total RNA was extracted from cells using Qiazol reagent according to the manufacturer’s 
instructions (Qiagen). The TURBO DNA-free™ kit (Ambion, USA) was used to remove possible 
genomic DNA contamination in RNA samples. First strand cDNA was synthesized from 2.5 Pg of 
RNA using a poly-dT primer and Superscript III reverse transcriptase (Life Technologies). qPCR 
primers were designed using primer design tool of NCBI [38]. QuantiFast SYBR Green PCR 
Master Mix with ROX was used to quantify the relative expression of lincRNAs between different 
treatments. Three independent biological replicates were considered along with three technical 
replicates for each treatment. Reactions were performed in a Rotor-Gene thermal cycler (Qiagen) 
under the following conditions: 95°C for 5 min, and 40 cycles of 95°C for 10s and 60°C for 30s, 
followed by the melting curve (68°C to 95°C). Melting curves were analysed to examine the 
specificity of amplification. Relative expressions were calculated using the Rotor-Gene software 
and the mosquito RPS17 as reference gene for normalization. Unpaired t-test was used to identify 
statistically significant differences. 
RNAi of selected lincRNAs and virus replication assay 
To check the functional importance of the identified novel lincRNAs, dsRNAs were 
synthesized to knockdown selected lincRNAs (2329, 1613 and 1317) to check their effect on 
DENV replication. Briefly, primers with added T7 promoter sequence (Table S1) were used to 
generate 250-600 bp PCR products from selected lincRNAs. Megascript T7 kit (Ambion) was used 
according to the manufacturer’s instruction to generate respective dsRNAs. To induce efficient 
RNA silencing, Ae. aegypti Aa20 cells were double transfected with dsRNAs against selected 
lincRNAs. Aa20 cells were re-suspended and ~3x105 cells were added to each well of a 12-well 
plate. Cell were allowed to settle for ~1 h, medium was removed and replaced with a transfection 
mixture consisting of 0.5 ml medium (1:1 Schneider medium and Mitsuhashi–Maramorosch with 
10% FBS), 8 μl Cellfectin (Invitrogen), and 5 Pg dsRNA either for selected lincRNAs or GFP as 
control. Cells were also treated with 3 Pg dsRNA 72 h after the primary transfection to increase the 
silencing efficiency of selected lincRNAs. Six hours after the secondary transfection, cells were 
infected at 1 multiplicity of infection (MOI) with DENV2-NGC (New Guinea C strain). All the 
treatments were collected three days post-infection. RNA extraction and cDNA synthesis were 
carried out as above. qPCR was performed to confirm the knockdown and the effect of particular 
lincRNA knockdown on the genomic RNA of DENV-2. Each treatment was repeated three times. 
All data from three biological replicates were subjected to one-way ANOVA statistical analysis. 
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Brown-Forsythe test was used to check the equality of group variances and Tukey's multiple 
comparisons test was also used to examine significant statistical differences among treatments. 
Results and Discussion 
Identification and characterisation of Ae. aegypti lincRNAs 
In total, 3,482 putative lincRNAs in 1,114 Ae. aegypti genome scaffolds were identified 
(Table S2). The Ae. aegypti lincRNA genes displayed a slightly lower GC content (mean: 40.1%) in 
comparison to 47.8% in their protein-coding gene sequences (Fig. 2A). The lower GC content or 
AT enrichment is a typical characteristic of lincRNAs and our findings are congruent with other 
predicted lincRNAs in other species [14,39,40]. The majority of Ae. aegypti predicted lincRNAs are 
smaller than 3000 bases and their length distribution is represented in Fig. 2B. These mosquito 
lincRNA candidates are notably shorter in length than protein-coding genes, demonstrating another 
well-known characteristic of lincRNA transcripts (Fig. 2C) [41,42]. The majority of Ae. aegypti
genome scaffolds contain less than five lincRNA loci (~80%), however, 23 of scaffolds (2%) were 
enriched with more than 10 lincRNAs (Fig. 2D). The detailed information of these scaffolds, which 
contain the highest number of lincRNAs are summarized in Table 1. 
We examined all the identified lincRNAs to determine their association with Ae. aegypti 
miRNA precursors and piRNA clusters. We found that the pre-miRNA sequences of aae-miR-2940 
and aae-miR-285 are located in lincRNAs 1431 and 3299, respectively. We could not detect any 
other pre-miRNA sequences identified in Ae. aegypti in the lincRNAs. Also lincRNA 1978 and 792 
are originated from two previously reported piRNA clusters [43] located at supercontig 1.478 and 
1.98,  respectively. 
LincRNAs demonstrate low evolutionary sequence conservation even among closely related 
species [10,14]. We used the BLAST algorithm bit score to identify the level of similarity among 
Ae. aegypti lincRNA sequences with other closely related insect genomes such as Aedes albopictus, 
Culex quinquefasciatus and Anopheles gambiae (Fig. 3A). As expected, most of the identified 
lincRNAs showed high level of similarity with Ae. albopictus genome sequence and probably are 
genus specific. The E-value cut off 10-50 was applied to our screening with the BLAST algorithm to 
identify the conserved sequences. Although the Ae. aegypti lincRNAs shared high level of sequence 
similarity with the genome of Ae. albopictus, only 62 and 7 lincRNAs had sequence similarity with 
C. quinquefasciatus and An. gambiae, respectively (Fig. 3B). They were mostly limited to a single
short region with high conservation. 
Ae. aegypti lincRNAs change upon microbial challenge 
150 
Following the identification of Ae. aegypti lincRNAs, we analyzed their transcript levels in 
DENV-2 infected mosquito tissues. To produce the lincRNA profile of infected and non-infected 
mosquitoes, we re-analyzed previously published RNA-Seq data from Ae. aegypti midgut and 
carcass samples at 4 dpi [30] (Fig. 4). 248 and 203 lincRNAs with fold changes above four were 
identified in the RNA-Seq libraries of midgut and carcass, respectively (Table S2). The majority of 
differentially expressed lincRNAs were considerably overexpressed in both tissues. The abundance 
of only 32% of Ae. aegypti lincRNA candidates decreased in response to DENV-2 infection in the 
mosquito carcass sample. Thirty lincRNAs were differentially expressed in both examined tissues. 
The transcription levels of 72 lincRNAs increased after infection while their expression could not 
be detected in the non-infected midgut tissue sample. 
We selected 20 candidates of those differentially expressed lincRNAs from RNA-Seq 
analysis data for further investigation. The relative expression of lincRNA candidates were 
examined by reverse transcription quantitative polymerase chain reaction (RT-qPCR) upon DENV-
2 infection in Aa20 mosquito cells. Only significantly overexpressed lincRNAs after DENV-2 
infection are represented in Figure 5. Although we used Aa20 cells for the lincRNA expression 
assays, the expression patterns of almost all the examined lincRNAs (5 out of 6) were consistent 
with the RNA-Seq (adult mosquito carcass sample). We used a poly-dT primer to produce cDNA, 
which also confirmed that all of those identified transcripts have poly-A tails and therefore are true 
transcripts. Based on these results, significant increase in the transcription levels of a selected 
number of Ae. aegypti lincRNAs suggests their possible involvement in host-pathogen interaction 
but further investigations are required to confirm their roles in antiviral/immune responses. 
We also examined the impact of an endosymbiotic bacterium, Wolbachia, on some selected 
Ae. aegypti lincRNAs, which showed significant changes in response to DENV-2 infection. This 
gram-negative bacterium is transmitted maternally and potentially infects more than 40% of all 
insect species, manipulating its hosts using strategies [44,45]. A fascinating aspect of Wolbachia 
infection is to limit replication of vector-borne pathogens in mosquitoes [45,46]. However, the 
mechanism(s) behind the inhibition of virus replication is largely unknown. Here, we found that the 
transcript levels of several lincRNA genes significantly increased in Wolbachia-infected Ae. aegypti 
mosquitoes (Fig. 6), which may lead to differential regulation of cellular protein-coding genes. Our 
previous studies showed that Wolbachia could manipulate host small ncRNA such as miRNAs and 
piRNAs [47]. An overall induction of small ncRNAs between 18 and 28 nucleotides was also 
observed in Ae. aegypti cell line infected with wMelPop-CLA strain of Wolbachia [48]. It was 
assumed that the upregulation of small ncRNAs in infected cells may result in an enhanced immune 
response and activated RNAi pathway. However, the role of these modifications in the host 
lincRNA gene expression profile, and potentially in anti-viral responses, is unknown and may lead 
to the discovery of lincRNAs that could be utilized for inhibition of virus replication in mosquitoes. 
A recent study on mouse bone marrow-derived macrophage (BMDM) model reported a 
significant upregulation in 72 lincRNAs after treatment with the synthetic bacterial lipoprotein 
Pam3CSK4, which acts through Toll-like receptor [49]. In another study, differential expression of 
approximately 500 annotated mouse lncRNAs was reported during infection with severe acute 
respiratory syndrome coronavirus [50]. Recently, it has been shown that honeybee’s lincRNAs are 
also differentially expressed during infection with various viruses such as sacbrood virus (SBV) and 
deformed wing virus (DWV), but the biological significance of these lincRNAs is completely 
unknown [51]. Although exploring the in vivo functions of immune-related lincRNAs is one 
exciting area for future studies, the differential expression of some lincRNAs could simply be 
byproducts of mRNA biogenesis or changes in global transcriptional profile due to microbial 
challenges [52,53]. Struhl (2007) believed that the transcriptional machinery is not perfect 
producing RNAs that serve no purpose or have no significant role in infection [54]. On the other 
hand, there are several examples which have shown that lincRNAs could be potentially important 
factors in host antimicrobial responses, and may represent a new class of signaling molecules 
involved in innate immunity or provide a new layer in gene regulation. For instance, two interferon 
(INF) induced lncRNAs, which were upregulated by influenza and vesicular stomatitis viruses, 
regulate the expression of the antiviral factor tetherin in human HuH7 cells [55]. 
RNAi of selcted lincRNAs and enhancement of DENV-2 replication
To confirm the role of DENV-induced lincRNAs on viral replication, we used RNAi-
mediated silencing of two selected lincRNAs (lincRNA_1317 and 1613) using dsRNA in Aa20 
cells followed by DENV-2 infection. Only RNAi-mediated silencing of lincRNA_1317 led to 
enhancement of DENV-2 replication (Fig. 7A). Silencing of the lincRNA was confirmed by RT-
qPCR (Fig. 7B). Interestingly, expression of Ae. aegypti lincRNA_1317 increased substantially 
following the progression of infection (Fig. 7C) suggesting that this lincRNA might be involved in 
antiviral response. This idea is consistent with the finding that lincRNA_1317 was also highly 
overexpressed (2.33 fold) in Wolbachia-infected mosquitoes as compared with non-infected 
mosquitoes (Fig. 6). 
While there are no reports on the involvement of lncRNAs in host-pathogen interactions in 
insects, time-dependent over-expression of host lincRNAs in response to viral infection has been 
observed in humans. A recent study showed more than 80% of host cell lncRNAs were upregulated 
upon an adenovirus infection of human primary lung fibroblast cells [56]. Zhang et al. (2013) 
reported alterations of expression of cellular lncRNAs in HIV-1-infected T cells. Among 
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differentially expressed lncRNAs, NEAT1 expression notably increased in infected cells. When 
NEAT1 was silenced, virus production was enhanced by increasing the nucleus-to-cytoplasm 
export of HIV-1 transcripts containing Rev-dependent instability element [57]. A significant 
induction in this lncRNA expression in response to influenza virus and herpes simplex virus 
infection has also been shown [58]. 
To further investigate the potential role of lincRNA_1317 in mosquito-pathogen interaction, 
we determined its association with host endogenous small RNAs and its possible direct interaction 
with DENV. Although this lincRNA is not located in any of the known piRNA clusters, the 
majority of mappable small RNA reads to its sequence are in the range of 26-29 nt (Fig. S1). 
However, there was no difference in the mapping pattern and mapped read length distribution when 
reads from DENV-infected and non-infected small RNA libraries were mapped to lincRNA_1317 
(Fig. S1). It has been shown that piRNA-like small RNAs have a large impact on lincRNA 
transcriptome [57], but our knowledge about the function of piRNA-mediated lncRNAs is still 
limited. Recently, it has been reported that piRNAs derived from transposons and pseudogenes 
facilitate the degradation of lncRNAs in mouse late spermatocytes [57]. 
Next, we hypothesized that Ae. aegypti lncRNA_1317 response to microbial challenge could 
be due to cross-regulation between miRNAs and lncRNA. Ae. aegypti miRNA recognition elements 
on lncRNA_1317 were identified by calculating the normalized minimum free energy (mfe) of 
hybridization for each Ae. aegypti miRNA and lncRNA_1317 using RNAhybrid core script. 
Binding site enrichment was detected for a few miRNAs with more than two recognition elements 
(Table 2). For instance, more than four recognition sites were predicted for miR-278-5p and miR-
252-3p on lincRNA_1317. We also identified some hot spots for miRNA recognition sites on
lincRNA_1317, which may allow multiple miRNAs to bind to the same regions (Fig. S2). miRNAs 
can reduce lincRNA stability by targeting their transcripts similar to mRNAs. Also, lincRNAs with 
multiple recognition sites may actually be competitive inhibitors of miRNA function and stopping 
them from binding to their genuine targets by sequestering them [21]. Although the mfe for some of 
those miRNA-lincRNA recognition sites suggests high probability of a binding event, further 
experimental investigations are required to validate this interface. 
We also used LncTar algorithm to predict any direct interaction between lincRNA_1317 and 
DENV-2 genome. One potential interaction was predicted in the region 1-3370 of lincRNA_1317 
and the region of 3210-6579 of DENV-2 genome with mfe of -61.73 (normalized dG -0.0184). This 
tool has accuracy rate of 80% [35], but does not consider the tertiary structure of RNA, which could 
play a role in RNA–RNA interactions and further studies are required to validate any potential 
interaction. 
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The involvement of lincRNA_1317 in host response to viral infection might be through its 
interactions with regulatory proteins that are involved in epigenetic changes by directly interacting 
with chromatin modifying enzymes or DNA binding proteins such as transcription factors. This 
interaction has been shown in several examples in mammalian systems, including host-virus 
interactions in which lncRNAs mediate antiviral responses by controlling the expression of 
immune-related genes (reviewed in [58]). 
Although our knowledge of the biological function of this class of ncRNAs in mosquitoes is 
still limited, the results generated from this study will facilitate forthcoming explorations of 
lincRNA functions in insects. Clearly, further research is required to provide concrete experimental 
evidence to support the role of lincRNA_1317 or any other Ae. aegypti lincRNAs in host-pathogen 
interaction. With advances in technology, the mosquito lincRNA-protein interactions can be 
identified using high-throughput sequencing of immunoprecipitated RNA after cross-linking (CLIP-
Seq). Further, functional studies could be carried out to chracterize immune related lincRNAs. The 
involvement of lincRNAs in pathways associated with responses to viral infection and cellular 
stress makes them interesting candidates as potential targets for manipulation to inhibit virus 
replication or control vector populations. 
Acknowledgments 
This work was funded by an Australian Research Council  (DP150101782) and National Health and 
Medical Research Council (APP1062983) to S Asgari, and a UQ scholarship to S Asad. 
References 
1. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. (2013) The global distribution
and burden of dengue. Nature 496: 504-507. 
2. Yakob L, Walker T (2016) Zika virus outbreak in the Americas: the need for novel mosquito
control methods. Lancet Global Health 4: E148-E149. 
3. Hennessey M, Fischer M, Staples JE (2016) Zika virus spreads to new areas - region of the
Americas, May 2015-January 2016. Am J Transplant 16: 1031-1034. 
4. Murray CL, Jones CT, Rice CM (2008) Architects of assembly: roles of Flaviviridae non-
structural proteins in virion morphogenesis. Nat Rev Microbiol 6: 699-708. 
5. Nene V, Wortman JR, Lawson D, Haas B, Kodira C, et al. (2007) Genome sequence of Aedes
aegypti, a major arbovirus vector. Science 316: 1718-1723. 
154 
6. Vodovar N, Bronkhorst AW, van Cleef KWR, Miesen P, Blanc H, et al. (2012) Arbovirus-
derived piRNAs exhibit a ping-pong signature in mosquito cells. PLoS One 7: e30861. 
7. Campbell CL, Harrison T, Hess AM, Ebel GD (2014) MicroRNA levels are modulated in Aedes
aegypti after exposure to Dengue-2. Insect Mol Biol 23: 132-139. 
8. Hess AM, Prasad AN, Ptitsyn A, Ebel GD, Olson KE, et al. (2011) Small RNA profiling of
Dengue virus-mosquito interactions implicates the PIWI RNA pathway in anti-viral defense. 
BMC Microbiol 11: 45. 
9. Hussain M, Torres S, Schnettler E, Funk A, Grundhoff A, et al. (2012) West Nile virus encodes a
microRNA-like small RNA in the 3' untranslated region which up-regulates GATA4 mRNA 
and facilitates virus replication in mosquito cells. Nucleic Acids Res 40: 2210-2223. 
10. Clark MB, Mattick JS (2011) Long noncoding RNAs in cell biology. Semin Cell Dev Biol 22:
366-376.
11. Bonasio R, Shiekhattar R (2014) Regulation of transcription by long noncoding RNAs. Annu
Rev Genet 48: 433-455. 
12. Mercer TR, Dinger ME, Mattick JS (2009) Long non-coding RNAs: insights into functions. Nat
Rev Genet 10: 155-159. 
13. Fitzgerald KA, Caffrey DR (2014) Long noncoding RNAs in innate and adaptive immunity.
Curr Opin Immunol 26: 140-146. 
14. Etebari K, Furlong MJ, Asgari S (2015) Genome wide discovery of long intergenic non-coding
RNAs in Diamondback moth (Plutella xylostella) and their expression in insecticide 
resistant strains. Sci Rep 5: 14642. 
15. Mizutani R, Wakamatsu A, Tanaka N, Yoshida H, Tochigi N, et al. (2012) Identification and
characterization of novel genotoxic stress-inducible nuclear long noncoding RNAs in 
mammalian cells. PLoS One 7: e34949. 
16. Tani H, Onuma Y, Ito Y, Torimura M (2014) Long non-coding RNAs as surrogate indicators
for chemical stress responses in human-induced pluripotent stem cells. PLoS One 9: 
e106282. 
17. Lakhotia SC (2012) Long non-coding RNAs coordinate cellular responses to stress. RNA 3:
779-796.
18. Winterling C, Koch M, Koeppel M, Garcia-Alcalde F, Karlas A, et al. (2014) Evidence for a
crucial role of a host non-coding RNA in influenza A virus replication. RNA Biol 11: 66-75. 
19. Collier SP, Collins PL, Williams CL, Boothby MR, Aune TM (2012) Influence of Tmevpg1, a
long intergenic noncoding RNA, on the expression of Ifng by Th1 Cells. J Immunol 189: 
2084-2088. 
155 
20. Pan Y-f, Qin T, Feng L, Yu Z-j (2013) Expression profile of altered long non-coding RNAs in 
patients with HBV-associated hepatocellular carcinoma. J Huazhong Univ Sci Technolog 
Med Sci 33: 96-101. 
21. Yoon J-H, Abdelmohsen K, Gorospe M (2014) Functional interactions among microRNAs and
long noncoding RNAs. Semin Cell Dev Biol 34: 9-14. 
22. Wu Y, Cheng T, Liu C, Liu D, Zhang Q, et al. (2016) Systematic identification and
characterization of long non-coding RNAs in the silkworm, Bombyx mori. PLoS One 11: 
e0147147. 
23. Legeai F, Derrien T (2015) Identification of long non-coding RNAs in insects genomes. Curr
Opin Insect Sci 7: 37-44. 
24. Marco A (2012) Regulatory RNAs in the light of Drosophila genomics. Brief Funct Genomics
11: 356-365. 
25. Jenkins AM, Waterhouse RM, Muskavitch MAT (2015) Long non-coding RNA discovery
across the genus Anopheles reveals conserved secondary structures within and beyond the 
gambiae complex. BMC Genomics 16: 337. 
26. Padron A, Molina-Cruz A, Quinones M, Ribeiro JMC, Ramphul U, et al. (2014) In depth
annotation of the Anopheles gambiae mosquito midgut transcriptome. BMC Genomics 15: 
636. 
27. Lambrechts L, Ferguson NM, Harris E, Holmes EC, McGraw EA, et al. (2015) Assessing the
epidemiological effect of Wolbachia for dengue control. Lancet Infect Dis 15: 862-866. 
28. Moreira LA, Iturbe-Ormaetxe I, Jeffery JA, Lu G, Pyke AT, et al. (2009) A Wolbachia
symbiont in Aedes aegypti limits infection with Dengue, Chikungunya, and Plasmodium. 
Cell 139: 1268-1278. 
29. David J-P, Faucon F, Chandor-Proust A, Poupardin R, Riaz MA, et al. (2014) Comparative
analysis of response to selection with three insecticides in the dengue mosquito Aedes
aegypti using mRNA sequencing. BMC Genomics 15: 174. 
30. Bonizzoni M, Dunn WA, Campbell CL, Olson KE, Marinotti O, et al. (2012) Complex
modulation of the Aedes aegypti transcriptome in response to dengue virus infection. PLoS 
One 7: e050512. 
31. Akbari OS, Antoshechkin I, Amrhein H, Williams B, Diloreto R, et al. (2013) The
Developmental transcriptome of the mosquito Aedes aegypti, an invasive species and major 
arbovirus vector. G3 3: 1493-1509. 
32. Chandler JA, Thongsripong P, Green A, Kittayapong P, Wilcox BA, et al. (2014) Metagenomic
shotgun sequencing of a Bunyavirus in wild-caught Aedes aegypti from Thailand informs 
the evolutionary and genomic history of the Phleboviruses. Virology 464: 312-319. 
156 
33. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, et al. (2012) The Pfam protein families 
database. Nucleic Acids Res 40: D290-D301. 
34. Wang L, Park HJ, Dasari S, Wang S, Kocher J-P, et al. (2013) CPAT: Coding-Potential
Assessment Tool using an alignment-free logistic regression model. Nucleic Acids Res 41: 
e74. 
35. Li J, Ma W, Zeng P, Wang J, Geng B, et al. (2015) LncTar: a tool for predicting the RNA
targets of long noncoding RNAs. Brief Bioinform 16: 806-812. 
36. Mortazavi A, Williams B, McCue K, Schaeffer L, Wold B (2008) Mapping and quantifying
mammalian transcriptomes by RNA-Seq. Nat Methods 5: 621 - 628. 
37. McMeniman CJ, Lane RV, Cass BN, Fong AWC, Sidhu M, et al. (2009) Stable introduction of
a life-shortening Wolbachia infection into the mosquito Aedes aegypti. Science 323: 141-
144. 
38. Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, et al. (2012) Primer-BLAST: A tool to
design target-specific primers for polymerase chain reaction. BMC Bioinformatics 13: 134. 
39. Broadbent KM, Park D, Wolf AR, Van Tyne D, Sims JS, et al. (2011) A global transcriptional
analysis of Plasmodium falciparum malaria reveals a novel family of telomere-associated 
lncRNAs. Genome Biol 12: R56. 
40. Clark MB, Johnston RL, Inostroza-Ponta M, Fox AH, Fortini E, et al. (2012) Genome-wide
analysis of long noncoding RNA stability. Genome Res 22: 885-898. 
41. Billerey C, Boussaha M, Esquerre D, Rebours E, Djari A, et al. (2014) Identification of large
intergenic non-coding RNAs in bovine muscle using next-generation transcriptomic 
sequencing. BMC Genomics 15: 499. 
42. Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, et al. (2011) Integrative annotation of
human large intergenic noncoding RNAs reveals global properties and specific subclasses. 
Genes Dev 25: 1915-1927. 
43. Arensburger P, Hice RH, Wright JA, Craig NL, Atkinson PW (2011) The mosquito Aedes
aegypti has a large genome size and high transposable element load but contains a low 
proportion of transposon-specific piRNAs. BMC Genomics 12: 606. 
44. Zug R, Hammerstein P (2012) Still a host of hosts for Wolbachia: Analysis of recent data
suggests that 40% of terrestrial Arthropod species are infected. PLoS One 7: e38544. 
45. Hoffmann AA, Ross PA, Rasic G (2015) Wolbachia strains for disease control: ecological and
evolutionary considerations. Evol Appl 8: 751-768. 
46. Frentiu FD, Robinson J, Young PR, McGraw EA, O'Neill SL (2010) Wolbachia-mediated
resistance to Dengue virus infection and death at the cellular level. PLoS One 5: e13398. 
157 
47. Hussain M, Etebari K, Asgari S (2016) Functions of Small RNAs in Mosquitoes. Adv Insect 
Physiol 51: 189-222. 
48. Mayoral JG, Etebari K, Hussain M, Khromykh AA, Asgari S (2014) Wolbachia infection
modifies the profile, shuttling and structure of microRNAs in a mosquito cell line. PLoS 
One 9: e96107. 
49. Carpenter S, Aiello D, Atianand MK, Ricci EP, Gandhi P, et al. (2013) A long noncoding RNA
mediates both activation and repression of immune response genes. Science 341: 789-792. 
50. Peng X, Gralinski L, Armour CD, Ferris MT, Thomas MJ, et al. (2010) Unique signatures of
long noncoding RNA expression in response to virus infection and altered innate immune 
signaling. Mbio 1 (5). 
51. Jayakodi M, Jung JW, Park D, Ahn Y-J, Lee S-C, et al. (2015) Genome-wide characterization
of long intergenic non-coding RNAs (lincRNAs) provides new insight into viral diseases in 
honey bees Apis cerana and Apis mellifera. BMC Genomics 16: 680. 
52. Atianand MK, Fitzgerald KA (2014) Long non-coding RNAs and control of gene expression in
the immune system. Trends Mol Med 20: 623-631. 
53. Ulitsky I, Bartel DP (2013) lincRNAs: Genomics, Evolution, and Mechanisms. Cell 154: 26-46.
54. Struhl K (2007) Transcriptional noise and the fidelity of initiation by RNA polymerase II. Nat
Struct Mol Biol 14: 103-105. 
55. Barriocanal M, Camero E, Segura V, Fortes P (2015) Long non-coding RNA BST2/BISPR is
induced by IFN and regulates the expression of the antiviral factor tetherin. Front Immunol 
5: 655. 
56. Zhao H, Chen M, Lind SB, Pettersson U (2016) Distinct temporal changes in host cell lncRNA
expression during the course of an adenovirus infection. Virology 492: 242-250. 
57. Watanabe T, Cheng EC, Zhong M, Lin HF (2015) Retrotransposons and pseudogenes regulate
mRNAs and IncRNAs via the piRNA pathway in the germline. Genome Res 25: 368-380. 
58. Roberts TC, Morris KV, Weinberg MS (2014) Perspectives on the mechanism of transcriptional
regulation by long non-coding RNAs. Epigenetics 9: 13-20. 
158 
 lincRNAs in different genome scaffolds with more        Table 1. Distribution of potential Ae. aegypti
             than 10 lincRNAs and their comparison with the number of protein-coding genes.
Scaffold Length  (kbp) 
Number of 
known gene 
Number of 
lincRNA 
Length range 
(bp) 
Average size 
of lincRNA 
supercont1.1 5,856,339 124 20 261-7780 1,869 
supercont1.16 4,402,401 62 19 264-7065 1,761 
supercont1.35 3,598,302 34 17 420-6101 1,850 
supercont1.3 5,167,134 61 16 297-5683 1,897 
supercont1.19 4,221,289 48 14 339-6537 1,776 
supercont1.70 2,929,944 29 14 509-6314 2,039 
supercont1.37 3,744,586 35 13 497-8297 3,585 
supercont1.28 3,768,427 45 13 235-7876 2,229 
supercont1.29 3,855,786 42 13 301-5559 2,376 
supercont1.78 2,909,025 17 13 211-5561 1,497 
supercont1.18 4,266,046 76 12 400-7336 2,087 
supercont1.6 5,075,626 93 12 547-3182 1,380 
supercont1.225 1,723,990 19 12 489-4486 1,475 
supercont1.38 3,498,553 45 12 248-8797 2,080 
supercont1.46 3,321,798 42 12 248-7447 2,210 
supercont1.5 5,058,281 60 12 323-4291 2,168 
supercont1.120 2,427,180 38 11 805-5190 2,116 
supercont1.244 1,610,334 30 11 503-6058 2,512 
supercont1.49 3,164,279 51 11 324-5492 1,988 
supercont1.107 2,543,601 42 11 416-8896 2,876 
supercont1.22 4,100,794 51 11 409-4234 1,441 
supercont1.44 3,232,429 47 11 271-8994 2,175 
supercont1.92 2,802,290 34 11 242-4424 1,667 
159 
Table 2. Ae. aegypti miRNA recognition site distribution on lincRNA_1317. 
miRNA No. recognition 
sites 
Mean MFE 
(Kcal/Mol) 
Recognition site start position on 
lincRNA_1317 
miR-278-5p 5 -22.40 307, 749, 1112, 1260, 1491 
miR-252-3p 4 -21.15 162, 629, 1560, 3946 
miR-11-5p 3 -21.67 2248, 2286, 3328 
miR-1890 3 -21.17 1489, 2712, 3602 
miR-263a-3p 3 -21.47 2208, 2545, 3336 
miR-33 3 -24.90 1545, 1810, 2669 
miR-34-5p 3 -25.03 1020, 1232, 1379 
miR-9b 3 -24.03 2034, 2891, 3603 
let-7 2 -22.20 2747, 2817 
miR-1 2 -22.80 1165, 2528 
miR-1175-3p 2 -20.65 1489, 3274 
miR-12-5p 2 -25.60 632, 1575 
miR-1889-3p 2 -20.80 1268, 3988 
miR-1891 2 -21.10 162, 2349 
miR-282-5p 2 -25.70 1232, 1297 
miR-2944b-3p 2 -22.05 1255, 3797 
miR-2945-5p 2 -23.00 770, 1209 
miR-31 2 -25.70 819, 871 
miR-375 2 -22.25 66, 3293 
miR-92b-5p 2 -23.05 1042, 3788 
miR-9a 2 -20.65 170, 3500 
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Figure Legends 
Figure 1. The lincRNA identification pipeline flowchart. 
Figure 2. Aedes aegypti lincRNA characterization. A) Comparison of the GC content in protein-
coding genes and the putative lincRNA genes. B) Sequence length distribution of Ae. aegypti 
lincRNA candidates. C) Comparison of gene length in protein-coding genes and putative lincRNA 
genes. D) lincRNA distribution among different Ae. aegypti genome scaffolds. The majority of 
scaffolds (~77%) only contain 1-4 lincRNAs, while only 23 Ae. aegypti genome scaffolds contain 
more than 10 lincRNAs (~2%). 
Figure 3. Ae. aegypti lincRNAs share some conserved areas with other closely related species. A) 
The similarity bit score showed more similar sequences with high-degree of similarity were present 
in Ae. albopictus. B) The Venn diagram displays the number of Ae. aegypti lincRNAs with 
similarity score above the cut off (E-value above 10-50) in other species using the BLAST 
algorithm. 
Figure 4. Volcano plot of differentially expressed Ae. aegypti lincRNAs in DENV-2 infected 
tissues (midgut and carcass) compared with their corresponding controls. Dots with red color 
represent lincRNAs with more than 4-fold changes due to DENV-2 infection. 
Figure 5. DENV infection leads to changes in the abundance of Ae. aegypti lincRNAs. The relative 
transcript levels of selected numbers of Ae. aegypti lincRNAs were measured by RT-qPCR analysis 
of Aa20 cells infected with 1 MOI of DENV-2 for three days. Three biological replicates were used 
for each treatment with three technical replicates each. *, p < 0.05; **, p < 0.01; ****, p < 0.0001.
Figure 6. The transcript levels of Ae. aegypti lincRNAs were altered in Wolbachia-infected 
mosquitoes. RT-qPCR was used to analyze the relative transcript levels of selected numbers of Ae.
aegypti lincRNAs in response to Wolbachia infection. For this, RNA from 4-day-old female 
mosquitoes from wMelPop (Pop)-infected and their tetracycline-cured line (Tet) mosquitoes were 
used in three biological replicates, each with three technical replicates. *, p < 0.05; **, p < 0.01; 
***, p < 0.001; ****, p < 0.0001.
Figure 7. Possible involvement of lincRNA_1317 in DENV-2 replication in Ae. aegypti Aa20 cells. 
A) Aa20 cells were double transfected with the transfection reagent only (Mock), dsRNA to GFP
161 
(dsCont) or dsRNA to lincRNA_1317 (dslncRNA) for three days followed by 1 MOI infection of 
the cells with DENV-2. Primers to the NS2A region (Table S1) were used for measuring the 
relative DENV-2 genomic RNA levels. B) RNAi silencing of lincRNA_1317 using dsRNA was 
confirmed by RT-qPCR. C) Changes in DENV-2 genomic RNA levels during the course of 
infection analyzed by RT-qPCR on RNA extracted from Aa20 cells at 1, 3 and 5 days post-infection 
(dpi). D) DENV-2 infection increased the transcript levels of Ae. aegypti lincRNA_1317 in 3rd and 
5th days post-infection when RNA from cells were analyzed by RT-qPCR. In all the experiments 
shown in this figure, three biological replicates, each with three technical replicates were used. **, p 
< 0.01; ***, p < 0.001. 
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Figure S1. Length distribution of small RNA reads mapped to lincRNA_1317.
Figure S2. The miRNA recognition hot spot sites on lincRNA_1317.
Table S1. List of primers used in this study. 
Table S2. Identified lincRNA candidates in Ae. aegypti and their genome coordinate. 
Table S3. Differentially expressed lincRNAs in response to DENV-2 infection in midgut and 
carcass. 
Figure Click here to download Figure Figure 1.tif 
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